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Modification dendritique de surface des nanoparticules 
photocatalytiques pour le traitement des tumeurs 
Résumé : L'apparition d’un développement cancérigène est souvent caractéristique des 
tumeurs de la région de la tête et du cou. En raison des altérations prémalignes et malignes 
fréquentes, il n'est souvent pas possible de supprimer complètement la tumeur par chirurgie. 
Il en résulte un risque élevé de récidive tumorale. Par conséquent, cette recherche de doctorat 
vise à développer des nanoparticules photocatalytiques (NPs) qui seront utilisées localement 
en complément de la thérapie tumorale traditionnelle. Ces NPs, une fois absorbées par les 
cellules tumorales induiront la mort des cellules photocatalytiques par activation de lumière 
UV. Des NPs de TiO2 ayant des propriétés photocatalytiques et une taille moyenne inférieure 
à 20 nm étaient donc synthétisées. La biocompatibilité des NPs, leur absorption dans les 
cellules et un ciblage tumoral efficace devraient être garantis par une modification de surface 
des particules avec des molécules organiques dendritiques permettant un contrôle précis de 
la charge de surface des particules ainsi que la possibilité de couplage avec des anticorps. Un 
autre objectif était la combinaison de propriétés thérapeutiques et diagnostiques dans le 
système de NPs par exemple réalisé par incorporation d'agent luminescent. Cette recherche 
était menée à l'Université de Bordeaux (synthèse des molécules organiques pour la 
fonctionnalisation des particules) en coopération avec l'Institut Fraunhofer de recherche en 
silicate ISC à Würzburg, Allemagne (synthèse des nanoparticules). 
 
Mots clés : Nanoparticules, TiO2, photocatalyse, traitement des tumeurs, dendrons, 
fonctionnalisation de surface  
 
 
Dendritic surface modification of photocatalytic nanoparticles for 
tumour therapy 
Abstract : The occurrence of field cancerization is characteristic for tumours of the head and 
neck region. Due to these widespread premalignant and malignant alterations, it is frequently 
not possible to entirely remove the tumour by surgery. This results in a high risk of tumour 
recurrence. Therefore, this PhD research aimed to develop photocatalytic nanoparticles (NPs) 
as completion of the traditional tumour therapy. These NPs are supposed to be incorporated 
by tumour cells and to induce photocatalytic cell death by UV light activation. TiO2 with 
convincing photocatalytic properties and an average size smaller than 20 nm should therefore 
be synthesized. NP biocompatibility, their uptake into cells and an efficient tumour targeting 
should be guaranteed by surface modification of the particles with dendritic organic molecules 
that allow a precise control of the surface charge of the particles as well as antibody coupling. 
A further objective was the combination of therapeutic and diagnostic properties within the NP 
system realized for example via introduction of a luminescent dye. This research was carried 
out at the University of Bordeaux (synthesis of organic molecules for particle functionalization) 
in cooperation with the Fraunhofer Institute for Silicate Research ISC in Würzburg, Germany 
(nanoparticle synthesis). 
Keywords : Nanoparticles, TiO2, photocatalysis, tumour therapy, dendrons, surface 
functionalization 
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En 2016, plus de 48 000 nouveaux cas de cancers des voies aérodigestives supérieures 
(VADS) ont été diagnostiqués aux États-Unis, ce qui représente 3% de tous les nouveaux cas 
de cancer.1 Il est l'un des dix cancers les plus courants au niveau mondial.2 Les régions du 
corps humain qui peuvent être affectées sont la cavité buccale, y compris les lèvres, les parties 
de la langue ou le plancher de la bouche, et le pharynx qui est un tube musculaire entre le nez 
et l'œsophage. En outre, il peut également apparaitre dans le larynx (boîte vocale), les glandes 
salivaires, la cavité nasale et les sinus para nasaux qui sont des espaces creux dans les os 
entourant le nez. Le plus couramment, la lésion ou la tumeur maligne qui se développe dans 
les cellules de la peau ou des muqueuses est un carcinome épidermoïde.2 Les principaux 
facteurs de risque pour ce type de cancer sont le tabagisme, la consommation d'alcool, le 
tabac à mâcher et les infections par le virus du papillome humain (VPH). En outre, la 
combinaison du tabagisme et de la consommation excessive d'alcool a un effet synergique.3,4 
La chirurgie et la radiothérapie sont les traitements standards pour les patients atteints de cette 
maladie aux premiers stades avec des taux de réussite de 60% à 90% selon la localisation et 
l'étendue de la tumeur. Néanmoins, ces patients ont un risque élevé de développer une 
récidive locale ou un second cancer en raison du caractère cancéreux des tissus.2 Un cancer 
étendu se produit lorsque la tumeur n'est pas située dans un endroit bien défini mais largement 
répandue dans les tissus. Habituellement, ces formations sont un mélange de manifestations 
superficielles pré-malignes et malignes avec certaines régions ayant des fractions tumorales 
profondément invasives. Cette étendue mal définie de la tumeur rend une élimination 
chirurgicale très difficile. La chimiothérapie est utilisée dans des cas avancés ou récurrents en 
association avec la radiothérapie comme traitement curatif ou seul comme traitement palliatif. 
Les chimiothérapies couramment utilisées sont des analogues du platine comme le cis-platine 
qui peuvent se coordiner avec l'ADN ou bien les taxanes comme le paclitaxel et le docétaxel 
qui favorisent l'assemblage microtubulaire.2 Ces deux actions conduisent à la mort cellulaire. 
Néanmoins, les traitements de chimiothérapies sont limités en durée et en intensité en raison 
de leur toxicité non spécifique.2 Au cours des dernières années, des agents ciblés ont été 
étudiés, comme des anticorps monoclonaux tels que le cetuximab ayant une activité 
extracellulaire ou des inhibiteurs de la tyrosine kinase ayant une action intracellulaire.2 Ils 
promettent un traitement tumoral plus spécifique réduisant ainsi les effets secondaires 
indésirables des médicaments. Au cours de la dernière décennie, malgré les progrès dans les 
procédures thérapeutiques et une amélioration significative du taux de survie à 5 ans, ce taux 
reste de 66% (aux États-Unis1), y compris avec un risque élevé de récidive tumorale ainsi que 
l'apparition de problèmes de cancers étendus difficiles à traiter.2 Ainsi, de nouvelles stratégies 
thérapeutiques doivent être développées pour améliorer les traitements standard actuels. 
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Les nanoparticules (NPs) sont des matériaux de taille inférieure à 100 nm qui présentent des 
propriétés physiques et chimiques uniques par rapport aux matériaux massifs en raison de 
leurs dimensions. Leur petite taille leur permet traverser les barrières des cellules ou des tissus 
tout en étant assez grands pour être conjugués à des anticorps ou des médicaments. C'est 
pourquoi ces nanoparticules ont un grand potentiel en tant qu'outils pour l'imagerie cellulaire 
ou l'analyse biologique et comme supports de médicaments ou agents thérapeutiques.5 
Concernant les carcinomes à cellules épithéliales, les NPs photocatalytiques (PC) peuvent 
fournir une nouvelle approche thérapeutique complémentaire.6 La thérapie photodynamique 
utilisant des molécules photosensibles telles que les porphyrines ou les chlorines sont une 
alternative non invasive bien connue et établie dans le traitement des malignités cutanées.7–9 
Grâce à leurs propriétés uniques, l'utilisation de NPs PC pour le traitement de la tumeur 
photodynamique est de plus en plus reconnue comme une stratégie prometteuse et les études 
initiales ont déjà été mis en avant en soulignant leur potentiel.5,9,10 Dans cette approche, les 
NPs PC sont appliquées sur un tissu cancéreux et sont absorbées par des cellules malignes. 
L'application de lumière ultraviolette (UV) excite les particules PC (Figure Résumé - 1) en 
raison de leurs propriétés semi-conductrices et de l’écart de bande approprié dans la gamme 
d'énergie de la lumière UV.  
 
Figure Résumé - 1. La destruction des cellules tumorales par photocatalyse induite par la 
lumière par des nanoparticules semi-conductrices. 
Ainsi, des paires électron-trous sont créées qui vont ou bien se recombiner ou bien migrer vers 
la surface de la particule, pour réagir avec l'oxygène et l'eau environnants et créer des radicaux 
hautement réactifs. Ces radicaux sont alors responsables de la destruction cellulaires 
conduisant à l'apoptose.6,11–13 Par rapport aux chimiothérapies, les particules appliquées sont 
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normalement non toxiques dans l'état non activé et donc moins toxiques pour les organes non-
affectés, ou les tissus non-traités aux rayons UV.13 Comme la transmission de la lumière dans 
les tissus est limitée, l'application de la lumière UV et la photocatalyse initiée n'influent que sur 
le tissu superficiel qui est la région d'intérêt lors du traitement des cancers diffus. 
En raison de leur activité PC élevée, les NPs de dioxyde de titane (TiO2) semblent être un 
choix approprié pour la thérapie photodynamique. Bien que la destruction des cellules 
cancéreuses par les UV ait été démontrée, le traitement est en général dépourvu de spécificité 
vis-à-vis de ces cellules.5 En outre, les particules commerciales utilisées sont souvent mal 
caractérisées et ne présentent pas toutes les propriétés requises. Les propriétés des particules 
telles que la charge superficielle sur l'absorption cellulaire et les mécanismes menant à 
l'apoptose cellulaire n'ont pas été étudiés suffisement. Il est par conséquent indispensable de 
préparer des systèmes de nanoparticules TiO2 bien caractérisés et d’affiner leurs propriétés 
de surface, par exemple par une fonctionnalisation spécifique. Si les particules possèdent des 
propriétés de luminescence, alors l'absorption cellulaire peut être étudiée ou, dans des 
applications comme agent antitumoral, leur position exacte dans le tissu peut être déterminée 
avant l'application de lumière UV. En outre, la charge de surface de ces particules peut être 
modulée par une fonctionnalisation organique pouvant améliorer l'absorption cellulaire. Si ces 
particules sont également bioconjugées, fournissant des ligands spécifiques pour le ciblage 
de tumeur, un diagnostic de cancer ou une chirurgie guidée par luminescence peut être 
envisageable. L'application d'un tel système optimisé de particules luminescentes et PC dans 
le traitement du cancer buccal est représenté ci-dessous (Figure Résumé - 2).  
Dans ce contexte, le premier objectif de cette thèse était la synthèse et la caractérisation des 
NPs photocatalytiques de TiO2, plus précisément des NPs d’anatases. Deux systèmes de 
particules avec différents types d'agents complexants et des paramètres d'autoclavage variés 
devaient être synthétisés par un procédé hydrothermique sol-gel. Parmi ces échantillons, il 
fallait sélectionner le plus approprié et le plus prometteur pour le traitement PC de la tumeur. 
Leur application pour les tests de culture cellulaire était l’objectif principal, y compris la 
stabilisation dans les milieux de culture cellulaire et la réalisation de tests de cytotoxicité. Par 
la suite, les surfaces des particules ont été modifiées par des molécules organiques 
appropriées afin de faciliter leur absorption cellulaire et éventuellement fournir un meilleur état 
de dispersion dans les milieux de culture cellulaire. Des molécules organiques linéaires et 
dendritiques avec des fonctions amines terminales ont été synthétisées afin d’induire une 
charge positive favorable à une interaction des particules avec les membranes cellulaires. Les 
structures dendritiques ont été choisies pour augmenter la quantité de fonctionnalités 
terminales sans augmenter le nombre d'ancrages de surface. Ceci était crucial car l'activité 
PC des particules inorganiques doit être préservée malgré l’ancrage de molécules à la surface. 
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Le greffage des molécules organiques a été réalisé par une fonction alcoxysilane. Un objectif 
supplémentaire a été l'introduction de propriétés de luminescence des particules afin de 
combiner les applications thérapeutiques et diagnostiques. La luminescence des particules est 
un atout supplémentaire pour l’études de l'absorption des particules par les cellules dans les 
tests de culture cellulaire. Cet objectif devait être atteint soit par la modification des particules 
inorganiques, par exemple par dopage ou par intégration d'un chromophore dans les agents 
de surface organiques. Enfin, l'objectif final a été alors de prouver que l'activité PC des 
systèmes de particules fonctionnelles développés est maintenue, ainsi que d'examiner leur 
cytotoxicité et leur potentiel comme agents antitumoraux. 
 
Figure Résumé - 2. Application de nanoparticules photocatalytiques et luminescentes 
complétant la thérapie du cancer buccal. 
En ce qui concerne les synthèses inorganiques des NPs réalisées dans ce travail, deux types 
différents des NPs d’anatase ont été synthétisés avec succès. Elles ont été soigneusement 
analysées par DRX, MET, mesures du potentiel zêta, DLS, ATG, sorption d'azote et 
spectroscopie infrarouge (IR). Alors que la morphologie (forme ovale) et la taille (entre 5 nm 
et 6 nm) des deux types de cristaux d'anatase semblent être très similaires, elles diffèrent 
principalement dans les fonctions de surface introduites lors de la synthèse. Alors que le AA-
TiO2 porte des groupes acétonate d'acétyle et acide paratoluènesulfonique, le MEEAA-TiO2 
comporte des fonctions acide 2-[2-(2-méthoxyéthoxy)éthoxy]acétique à sa surface. L'activité 
PC plus élevée du MEEAA-TiO2 par rapport au AA-TiO2 est donc principalement liée aux 
différents groupes de surface ou plus précisément à la plus grande quantité de groupes 
fonctionnels sur le AA-TiO2. Dans la Figure Résumé - 3, les groupes de surface des deux 
systèmes de particules AA-TiO2 et MEEAA-TiO2 sont représentés, ainsi que l'activité PC des 
Résumé 
R5 
 
deux systèmes par rapport aux NPs P25 TiO2 commercialles présentées comme matériau de 
référence. 
 
Figure Résumé - 3. Les groupes de surface des deux systèmes de particules a) AA-TiO2 et b) 
MEEAA-TiO2 et leur activité photocatalytique par rapport aux NPs commerciaux P25. (DCA = 
acide dichloracétique) 
A la vue de ces résultats, l’étude de l'influence des conditions de traitement hydrothermique 
sur les propriétés des NPs a été réalisée avec le système MEEAA-TiO2 le plus prometteur. 
Ainsi, si le temps ou la température de l'autoclave augmente lors de la synthèse, alors la taille 
des cristallites augmente de 4,8 nm à 7,7 nm (1h, 160 ° C à 4h, 200 ° C). Ceci a été vérifié par 
RDX, MET, DLS et des mesures de sorption d'azote. Alors que les propriétés des groupes de 
surface ne sont que marginalement influencées par des changements dans le temps et / ou la 
durée du traitement (comme le montrent les mesures IR, ATG et potentiel zêta), l'activité PC 
de l'échantillon est significativement améliorée avec l'augmentation de la taille des particules. 
Cela contrastait avec l'attente initiale qui était que l'activité des échantillons aurait dû diminuer 
avec la taille croissante des particules du fait de l’accroissement de leur surface spécifique. 
Les performances accrues en photocatalyse avec une surface spécifique décroissante est le 
résultat d'une modification de la morphologie des cristaux (Figure Résumé - 4). Alors que les 
petites cristallites montrent la morphologie bipyramidale tétragonale tronquée à l'état 
d'équilibre typique, la croissance des cristaux conduit à la formation de cristaux en forme de 
tige avec des vacances d'oxygène provoquées par une fixation orientée de particules simples 
(comme le montrent les analyses XAFS, RDX et HR-MET). Le caractère plus anisotrope des 
cristaux et l'augmentation des vacances en oxygène améliorent l'activité PC des échantillons 
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- probablement en raison d'une séparation plus efficace du support de charge. La croissance 
des cristaux par l’émergence des facettes {011} est vraisemblablement causée par les 
conditions aqueuses de traitement hydrothermique et l'adsorption préférentielle de l'acide 
carboxylique utilisé (MEEAA) sur les facettes {001} de haute énergie. 
 
Figure Résumé - 4. L’activité photocatalytique croissante conjointement avec la diminution de 
la surface spécifique est expliquée par un changement de morphologie des nanoparticules et 
une augmentation de défauts en oxygène. 
Après avoir synthétisé et caractérisé avec succès les NPs PC de TiO2, l'incorporation de 
propriétés luminescentes a ensuite été étudiée. Pour introduire les propriétés de luminescence 
dans les particules de TiO2, la synthèse de NPs de type cœur-coquille TiO2@SiO2 dopées 
Rhodamine B luminescente a été réalisée avec succès. La formation homogène d'une coquille 
de silice autour du TiO2 a été prouvée par des mesures de MET, DLS et zêta potentiel. 
L'incorporation de Rhodamine B dans la coquille de silice était une méthode de choix en raison 
de la luminescence résultante des particules finales. Malheureusement, on a montré que 
l'activité PC des particules diminuait progressivement avec l'augmentation de l'épaisseur de la 
coquille de silice. Aussi, en raison de l’auto-extinction du colorant dans la coquille, le dopage 
de la coquille de silice par la Rhodamine B est limité par la concentration de colorant. Cela 
signifie que, plus la photoluminescence souhaitée est élevée, plus la coquille de silice doit être 
épaisse et moins l'activité PC du système de particules TiO2@SiO2 est importante. La synthèse 
d'un système ZnO-TiO2 reste encore difficile. Nous avons synthétisé avec succès des NPs 
ZnO luminescentes, cependant, leur stabilité dans l'eau acide n'était pas suffisante pour la 
synthèse d'une coque TiO2. Néanmoins, il a été possible de prouver la faisabilité d'une 
formation de coque TiO2 autour des NPs inorganiques telles que les NP d'oxyde de fer. Cela 
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signifie que, si l'on trouve un système de particules inorganiques luminescentes suffisamment 
stable à l'acide, on pourrait envisager la formation de coquille TiO2 à leurs surfaces. Pour cela, 
il faut tenir compte du fait que l'excitation du matériau du cœur doit être supérieure aux 
longueurs d'onde d'absorption de l'enveloppe de TiO2 pour assurer l'arrivée de la longueur 
d'onde d'excitation au noyau. En outre, il faut garder à l'esprit que l'activité PC de l'enveloppe 
pourrait être aussi influencée négativement par le noyau. Pour conclure sur les tentatives de 
synthèse des particules de cœur/coquille luminescentes, on peut affirmer que les deux 
systèmes n'ont pas été jugés suffisamment actifs pour être utilisés en photocatalyse. C'est la 
raison pour laquelle il fallait trouver une autre façon d'intégrer les propriétés de luminescence 
dans le système NPs. 
L'intégration d'un colorant organique dans les agents de couplage a été identifiée comme la 
voie la plus prometteuse. Elle est décrite dans la partie suivante de ce travail, dans laquelle 
des agents de couplage organiques ont été synthétisés et ensuite greffés sur les NPs TiO2. 
En ce qui concerne les synthèses organiques, quatre structures dendritiques ou linéaires 
luminescentes ou non luminescentes ont été conçues comme indiqué dans le Schème 
Résumé - 1. Les trois premiers agents de couplage contiennent tous le colorant rhodamine. 
L'agent de couplage I, molécule linéaire sans groupe aminé terminal, a été obtenu avec 
succès et a prouvé la stabilité de l'agent de luminescence pendant toutes les étapes de 
synthèse et de lavage. L'agent de couplage II est une molécule linéaire portant un groupe 
amine terminal et une fonction Rhodamine. Plusieurs étapes de synthèse ont été menées avec 
succès jusqu'au couplage des composants non luminescents de l'agent de couplage au 
colorant par la formation d’une liaison thiourée. Cependant, cette liaison thiourée sur la position 
alpha de la lysine a donné lieu à un réarrangement de la molécule dans des conditions acides. 
La labilité de la liaison amide à côté du thiourée n'a jamais été rapportée dans la littérature 
dans le cas de la lysine dans les conditions réactionnelles utilisées (acides forts, température 
ambiante). Dans ce contexte, le clivage du groupe de protection Boc et Z n'a pas été possible 
et la voie synthétique n'a pas été poursuivie. 
Résumé 
R8 
 
 
Schème Résumé - 1. Des agents de couplage organiques synthétisés dans ce travail. 
Néanmoins, les connaissances acquises lors des étapes de synthèse de l'agent de couplage 
II ont contribué à synthétiser l'agent de couplage III (molécule dendritique de 1ère génération 
luminescente et porteuse de fonctions amines). Ce travail de synthèse a été le plus complexe 
car nous avons rencontré plusieurs obstacles à surmonter. Par exemple, nous avons dû faire 
face à la formation de dipeptides lors de la protection Fmoc de la Z-lysine. Ce problème a été 
contourné par l'utilisation de DMF comme solvant organique (au lieu de THF ou dioxane). 
L'instabilité de la liaison ester due à des réactions de trans-estérification (en présence d'un 
alcool) a également été inattendue et a initié d'autres études de la stabilité de cette liaison. 
Ceci qui nous a permis d’établir que ces liaisons ester sont sensibles aux réactions de 
transestérification en milieu aqueux-alcoolique basique. L’utilisation d’un amide au lieu d’un 
ester, a fourni une structure moléculaire plus stable jusqu'à l'étape de réaction finale. Ainsi, du 
NHS-rhodamine a été utilisé dans l’étape finale de formation de l’agent de couplage III à la 
place de l'isothiocyanate de rhodamine (qui avait été utilisé dans le cas de l’agent de couplage 
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II). Nous avons ainsi garanti la stabilité de la structure moléculaire pour les étapes de réaction 
ultérieures. L'agent de couplage III a donc été obtenu avec succès. L'agent de couplage IV 
(molécule dendritique analogue non luminescent de l'agent de couplage III). Ce composé a 
également été obtenu avec succès. Alors que la quantité d'agent de couplage III était trop 
faible pour procéder à la réaction de greffage, les agents de couplage I et IV ont pu être 
synthétisés en quantité suffisante pour procéder à leur greffage sur les NPs TiO2. 
Dans l’étape de greffage, la procédure a été mise au point avec des silanes commerciaux ([3-
(2-aminoethylamino)propyl]-trimethoxysilane, N1-(3-trimethoxysilylpropyl)diethylenetriamine). 
Les conditions basiques de greffage hydroalcoolique semblent être plus efficaces que dans 
un milieu acide, même si les deux procédures ont conduit à une modification des particules. 
La charge de surface des particules a été effectivement modifiée comme indiqué par les 
mesures du potentiel zêta, tandis que l'activité PC des particules de TiO2 a été légèrement 
réduite (une réduction de 20 à 40 % a été généralement enregistrée). Dans le cas de MEEAA-
TiO2 (4 h, 200 °C), une quantité de 1 à 4 μmol de silane ajouté par mg de NPs a donné des 
résultats similaires concernant la charge de surface et l'activité de PC. Une quantité minimale 
de silane de 1 μmol/mg est nécessaire pour obtenir une monocouche sur les particules. Ceci 
est en accord avec la quantité théorique calculée de 1,09 μmol/mg (pour MEEAA-TiO2). L'ajout 
de quantités de silane considérablement plus élevées (testé avec AA-TiO2) conduit 
vraisemblablement à la croissance de couches moléculaires supplémentaires autour des NPs. 
La quantité optimale pour le greffage des agents de couplage synthétisés I et IV sur MEEAA-
TiO2 (4h, 200 °C) a été fixée 2 μmol de silane par mg de NPs. Le greffage de l'agent de 
couplage I a été confirmé par plusieurs les méthodes d'analyse utilisées (IR, DLS, potentiel 
zêta). Le potentiel de surface des NPs a été significativement modifié, ce qui a conduit à une 
charge superficielle considérablement plus négative, à pH physiologique. Dans le contexte 
des applications de tests de culture cellulaire, une charge de surface positive est souhaitée et, 
par conséquent, ces NPs ne sont pas adéquates en l’état pour de telles applications. 
Egalement, l'état de dispersion des particules modifiées dans l'eau était relativement mauvais, 
ce qui n'est pas surprenant, car on sait que la rhodamine a une faible solubilité. Ainsi, 
l’introduction de groupements amine à la surface des NPs devrait améliorer la dispersibilité de 
celles-ci en milieu aqueux. Les NPs modifiées ont montré également une photoluminescence 
très élevée (Figure Résumé - 5 a) et une excellente activité PC (Figure Résumé - 5 b), allant 
même au-delà des propriétés des NPs non modifiées. Ce phénomène inattendu est sans doute 
dû à la charge superficielle significativement modifiée qui favorise l'adsorption des molécules 
prenant part aux réactions PCs. 
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Figure Résumé - 5. A) Spectre de photoluminescence de MEEAA-TiO2 pur (bleu) et 
fonctionnalisé (noir) (avec l’agent de couplage I); Excité à 556 nm (c'est-à-dire au maximum 
d'absorption du système de particules fonctionnalisées). En outre, des photos des deux 
échantillons de particules comme dispersion dans l'eau à pH = 10 sont représentées. b) 
Activité photocatalytique de MEEAA-TiO2 fonctionnalisé avec l'agent de couplage I (noir) par 
rapport au MEEAA-TiO2 non modifié (bleu). (DCA = acide dichloracétique) 
Le greffage réussi de l'agent de couplage IV a été confirmé par IR même si les bandes 
d'absorption caractéristiques détectées étaient de faible intensité. L'IEP de l'échantillon n'a pas 
été modifié de manière significative, ce qui peut être dû à l'absence de groupes ioniques dans 
l'agent de couplage. Les tentatives qui ont été réalisées pour cliver le groupement protecteur 
phtalimide des agents de couplage IV greffés n'ont pas été concluantes à ce jour. 
En résumé, la synthèse des agents de couplage dendritiques luminescents et non 
luminescents ainsi que leur greffage sur les TiO2 NPs précédemment synthétisés ont été 
démontrés avec succès. Les avancées ainsi que les obstacles rencontrés lors des synthèses 
organiques et les procédures de greffage de ces agents de couplage ont été clairement 
montrés. Pour les études futures, la synthèse des agents de couplage luminescents (en 
particulier) devrait être étudiée et optimisée. En outre, le clivage du groupe protecteur du 
phtalimide des agents de couplage greffés doit encore être développé. 
Avant les premiers essais de culture cellulaire sur les NPs synthétisés, les échantillons doivent 
être transférés dans des milieux de culture cellulaire. Pour éviter l'agglomération et la 
sédimentation, un agent de stabilisation approprié pour les NPs TiO2 doit être recherché. La 
stabilisation des NPs TiO2 avec du sérum fœtal de veau (FBS) et des éthers de 
polycarboxylate Melpers® V4343 ou Sika® ViscoCrete®-10110178 a amélioré la dispersion des 
NPs dans divers milieux de culture cellulaire. L’éther de polycarboxylate Melflux® 4930 F 
(Melflux) semble être l'agent stabilisant le plus approprié dans cette étude car on observe une 
absence d'agglomération et de sédimentation jusqu’à 24 h dans les trois milieux de culture 
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cellulaire testés. La stabilisation assure un dosage précis des particules pour les tests de 
culture cellulaire et des études fiables de l'absorption de particules par les cellules en fonction 
de la concentration car les particules ne sédimentent pas. Dans la Figure Résumé - 6, la 
sédimentation d'un échantillon stabilisé avec Melflux est comparée à un échantillon non 
stabilisé et à un échantillon stabilisé par FBS.  
 
Figure Résumé - 6. Etude de la sédimentation de AA-TiO2 (0,5 mg/ml) stabilisé avec FBS (1 
mg NP: 100 mg FBS) ou Melflux (1 mg NP: 0,4 mg Melflux) et non stabilisé: a) pourcentage 
de particules non-sédimentées déterminées par mesure d'absorbance et b) photographies des 
échantillons à 0 h et 24 h après l'addition du stabilisateur à la dispersion des NPs (* particules 
sédimentées). 
Contrairement au FBS, qui est couramment utilisé comme stabilisant dans la littérature, 
Melflux n'a pas d'influence sur la cytotoxicité des particules. Par conséquent, il est approprié 
en tant qu'agent stabilisant de NPs TiO2 et peut être d'un intérêt particulier pour les études sur 
la toxicité ou le potentiel thérapeutique de ces NPs. De plus, ce travail de recherche a mis en 
évidence que les systèmes testés AA-TiO2 et MEEAA-TiO2 se sont tous deux révélés non 
toxiques contre les cellules malignes et non malignes dans leur état non activé - à la fois 
particules bien stabilisées et agglomérats non stabilisés. Cela ouvre une voie prometteuse 
pour leur application en tant qu'agent de traitement tumoral car leur non-toxicité peut permettre 
un traitement spécifique de la tumeur spécifique à la lumière UV. 
L'activité antitumorale détectée des échantillons de MEEAA-TiO2 pré-activés pendant 24h par 
lumière UV est probablement causée par la dégradation par PC du MEEAA en composés 
toxiques pour les cellules. Ce travail, d'une part, a fourni des résultats impressionnants 
concernant un traitement spécifique de la tumeur, et d'autre part, il a souligné que le transfert 
de composés commerciaux et chimiques dans des applications biomédicales peut provoquer 
des obstacles inattendus concernant la toxicité des impuretés non identifiées. Cependant, pour 
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les NPs modifiées par les agents de couplage synthétisés dans ce travail, cette toxicité n'est 
pas pertinente car les particules sont purifiées pendant la procédure de fonctionnalisation. 
A terme, ce travail devrait inclure l'évaluation de la cytotoxicité des échantillons fonctionnalisés 
de MEEAA-TiO2 ainsi que le développement du traitement tumoral par PC par l'application de 
lumière UV sur des cellules traitées avec les échantillons deNPs PC. 
Une avancée majeure de ce travail de recherche a été le développement de systèmes de NPs 
fonctionnalisées pour les applications biomédicales à partir de particules fonctionnalisées par 
des agents de couplage organiques. Ainsi, ce travail a aboutit au greffage des particules, à 
leur test en culture cellulaire et à l’étude de cytotoxicité. Bien que la plupart des recherches se 
concentrent uniquement sur une seule de ces étapes, nous avons mené à bien toutes ces 
étapes au sein d’un même projet. Ceci a permis de mieux comprendre l’influence de chaque 
étape entre elles et la possibilité de résoudre les problèmes antérieurs qui se produisent. Des 
travaux récents ont montré que la morphologie des cristaux influence la performance PC des 
NPs anatase. Il est donc possible d’optimiser les croissances cristallines lors des synthèses 
sol-gel hydrothermales des TiO2 NPs pour les rendre hautement actifs en photocatalyse. La 
stabilisation de ces NPs dans les milieux de culture cellulaire avec Melflux® 4930 F peut être 
transposée aux autres systèmes de particules et peut donc être particulièrement intéressante 
pour les études sur la toxicité ou le potentiel thérapeutique des NPs en général. La preuve de 
la faisabilité du greffage des organo-silanes sur les particules de TiO2 synthétisées ouvre la 
voie à leur utilisation dans une large gamme d'applications, du fait de leurs propriétés de 
surface modulables. Elles pourraient éventuellement être utilisés comme additifs, par exemple 
dans des revêtements plastiques ou fonctionnels, comme supports de médicaments ou dans 
des cellules solaires. Le développement de nouveaux agents de couplage dendritiques 
luminescents n'est pas seulement d'une grande importance pour la fonctionnalisation des NPs 
PC utilisées pour le traitement des tumeurs, mais aussi pour la modification de surfaces de 
drug-carriers, par exemple. En outre, la caractérisation de l'internalisation des particules par 
les cellules pourrait être facilitée par la fonctionnalisation des NPs avec ces agents de 
couplage luminescents, car ils pourraient permettre la détection des NPs par luminescence. 
En conclusion, les systèmes de NPs TiO2 PC fonctionnalisés ou non modifiés qui ont été 
développés dans ce travail sont d'un grand intérêt pour la thérapie tumorale photodynamique. 
Mise en pratique, cette approche thérapeutique consisterait en l'application de particules sur 
le tissu d'intérêt puis elles seraient l'internaliser par les cellules. Par la suite, une irradiation UV 
serait appliquée sur la zone à traitée pour activer les NPs et induire la photolcatalyse des 
composants cellulaires conduisant à l'apoptose cellulaire et à la destruction de la tumeur. En 
raison de la non toxicité des NPs, les zones qui ne sont pas traitées avec de la lumière UV ne 
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seront pas endommagées et la photocatalyse du TiO2. Nous visons donc à détruire 
spécifiquement les cellules tumorales. En plus du traitement photodynamique de la tumeur, 
les systèmes de NPs développés pourraient être appliqués à la purification photocatalytique 
de l’eau ou pour le développement de dispositifs photoniques et optoélectroniques. Dans le 
cas de la purification de l'eau, les échantillons NPs dispersées pourraient être utilisés pour 
décomposer les contaminants organiques dans les eaux usées comme les pesticides ou les 
médicaments. Pour le développement de dispositifs photoniques et optoélectroniques, les NPs 
d'anatase semi-conductrices à larges bandes interdites sont idéales pour la conversion 
d'énergie lumineuse. Ainsi, la possibilité de fonctionnaliser leur surface donne la possibilité de 
coupler des sensibilisateurs tels que par exemple des colorants pour construire des cellules 
solaires à colorant.  
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In 2016, over 48,000 new cases of head and neck cancer were estimated in the USA which 
represents 3% of all new cancer cases.1 This cancer counts as one of the ten most common 
cancers globally.2 Regions of the human body that can be affected by head and neck cancer 
are the oral cavity, including the lips, parts of the tongue or the floor of the mouth, and the 
pharynx which is a muscular tube between the nose and oesophagus. In addition, it can also 
occur in the larynx (voicebox), salivary glands, nasal cavity and paranasal sinuses which are 
hollow spaces in the bones surrounding the nose. The most common entity of head and neck 
cancer is the squamous cell carcinoma.2 Major risk factors for this type of cancer are smoking, 
alcohol consumption, smokeless tobacco use and human papillomavirus infections. 
Furthermore the combination of smoking and excessive alcohol consumption has a synergistic 
effect.3,4 Surgery and radiotherapy are the standard treatments for patients with this disease 
in the early stages with success rates of 60 % to 90 % depending on the tumour localization 
and extent. Nevertheless, these patients have a high risk of developing a local recurrence or 
a second primary due to field cancerization.2 Field cancerization occurs when the tumour is 
not situated in a well-defined location but widely spread over the tissue. Usually these 
formations are a mixture of pre-malignant and malignant superficial manifestations with some 
regions having deeply invasive tumour fractions. This unclear extent of the tumour makes a 
surgical removal very difficult. Chemotherapy is used in advanced or recurrent cases in 
combination with radiotherapy as a curative regime or alone as a palliative treatment. Common 
chemotherapeutics are platinum analogues like cisplatin that act by forming covalent bonds 
with the DNA or taxanes like paclitaxel and docetaxel that promote microtubular assembly.2 
Both of these actions lead to cell death. Nevertheless, the chemotherapeutic treatments are 
limited in duration and intensity due to their non-specific toxicity.2 In recent years, targeted 
agents have come to the research fore, including monoclonal antibodies such as cetuximab 
possessing an extracellular domain activity and small tyrosine kinase inhibitors acting 
intracellularly.2 They promise a more specific tumour treatment thereby reducing unwanted 
side-effects of drugs. Despite the advances in therapy procedures and a significant 
improvement in the 5-year survival rate during the last decade, the rate remains at 66 % (in 
the USA1) including a high risk of tumour recurrence as well as the appearance of difficult-to-
treat field cancerization.2 Thus, novel therapy strategies need to be developed to enhance the 
current standard treatments.  
Nanoparticles (NPs), materials smaller than 100 nm in size, exhibit unique physical and 
chemical properties compared to bulk material due to their dimensions. Their small size makes 
them ideal to cross cell or tissue barriers while being large enough to be conjugated to 
antibodies or drugs. This is why they have a great potential as tools for cell imaging or biological 
analysis and as drug carriers or therapeutic agents.5 Concerning squamous cell carcinomas, 
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photocatalytic NPs can provide a novel, complementary therapy approach.6 The photodynamic 
therapy using photosensitive molecules such as porphyrins or chlorins is a well-known and 
established non-invasive alternative in the treatment of dermal malignancies.7–9 Thanks to their 
unique properties, the use of photocatalytic NPs for photodynamic tumour treatment is 
increasingly recognized as a promising strategy and initial studies have already been carried 
out stressing their potentials.5,9,10 For this approach, photocatalytic NPs are applied onto 
carcinogenic tissue to be taken up by malignant cells. Ultraviolet (UV) light application excites 
the photocatalytic particles (Figure Intro - 1) because of their semiconductor properties, 
including an appropriate band-gap within the energy-range of UV light. Thus, electron-hole 
pairs are created which either recombine or migrate to the particle surface, react with 
surrounding oxygen and water and create highly reactive radicals. These radicals are then 
responsible for the destruction of cell components leading to apoptosis.6,11–13 Compared to 
chemotherapeutics, the applied particles are normally non-toxic in the non-activated state and 
therefore less toxic towards non-affected organs or non-UV light treated tissue.13 As the 
transmission of light within tissue is limited, the UV light application and the initiated 
photocatalysis will only affect superficial tissue which is the region of interest when treating 
field cancerization. 
 
Figure Intro - 1. Tumour cell destruction via light-induced photocatalysis by semiconductor 
nanoparticles. 
Due to their high photocatalytic activity, titanium dioxide (TiO2) NPs seem to be an appropriate 
choice for the photodynamic therapy. Though the killing of cancer cells by UV light activated 
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TiO2 NPs has been demonstrated, the treatment is in general lacking specifity towards these 
cells.5 Furthermore, the particles used are often not well characterized and do not show well-
tailored properties as they were commercially obtained. In addition, the dependency of particle 
properties such as surface charge on the cellular uptake and mechanisms leading to cell 
apoptosis have not been studied thoroughly. Hence, in order to make advances in this research 
area, it is indispensable to prepare well-characterized TiO2 nanoparticle systems and to be 
able to finely tune their surface properties, for example by functionalization. If the particles 
additionally possess luminescence properties, cellular uptake can be studied or, in later 
applications as an anti-tumour agent, their exact position in the tissue can be confirmed prior 
to UV light application. Additionally, a fine manipulation of the surface charge of these particles 
by organic functionalization may enhance the cellular uptake. If these particles are also 
bioconjugated, providing specific ligands for tumour targeting, even cancer diagnosis or 
luminescence guided surgery can be possible. The hypothetical application of an optimized, 
luminescent and photocatalytic particle system in oral cancer therapy is depicted below (Figure 
Intro - 2). 
 
Figure Intro - 2. Application of photocatalytic, luminescent nanoparticles complementing the 
therapy of oral cancer.  
In order to realize this approach, the first goal was the synthesis and characterization of 
photocatalytic TiO2 NPs, more precisely anatase NPs. Two particle systems with different 
types of complexing agents and varied autoclaving parameters were to be synthesized via a 
hydrothermal sol-gel process. Out of these samples, the most suitable and promising 
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candidate for photocatalytic tumour treatment had to be selected. Furthermore, their transfer 
to cell culture tests was a main objective, including their stabilisation in cell culture media and 
the realization of cytotoxicity tests. Subsequently, the particle surfaces were then to be 
modified with suitable organic molecules to facilitate their cellular uptake and possibly provide 
a better dispersion state in cell culture media. The task was to synthesize linear and dendritic 
organic molecules with terminal amine functions as their positive charge is favourable for an 
interaction of the particles with cell membranes. Dendritic structures were chosen to increase 
the amount of terminal functionalities while not increasing the number of surface anchors. This 
was crucial as the photocatalytic activity of the inorganic particles should be inhibited as little 
as possible by the molecules anchored to the surface. For the grafting of the organic molecule 
with an alkoxysilane serving as an anchor group, suitable grafting procedures were to be 
developed. This also includes proving the feasibility of grafting onto the developed TiO2 NPs. 
An additional goal was the introduction of luminescence properties into the particle system in 
order to combine the therapeutic with diagnostic applications. Luminescence would also 
facilitate cell culture studies on the particle behaviour such as the particle uptake by cells. This 
objective was meant to be achieved either by the modification of the inorganic particles e.g. 
via doping or by the integration of a chromophore into the organic surface agents. The final 
objective was then to prove the maintained photocatalytic activity of the developed functional 
particle systems, as well as to examine their cytotoxicity and potential as possible anti-tumour 
agents. 
 
The following work is structured into four main chapters: 
The first chapter comprises a bibliographic study, which includes an introduction to TiO2 NPs, 
their synthesis, photocatalytic activity and potential as tumour treatment agents. Additionally, 
different approaches to obtain luminescent TiO2 NPs are presented. For the surface-
modification of TiO2 NPs, possible anchoring moieties are first introduced, followed by the 
description of dendritic surface agents for NP functionalization. Subsequently, a short overview 
of the introduction of luminescent moieties into dendritic structures is given. 
The second chapter deals with the synthesis and characterisation of anatase NPs. First, two 
particle systems synthesized with different coordinating agents are compared in their size and 
morphology, their surface moieties and their photocatalytic activity. Next, the influence of 
processing parameters, such as hydrothermal treatment time and temperature, on the particle 
characteristics (including size, morphology, surface moieties and photocatalytic activity) are 
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described. The last part of the chapter presents two approaches in order to obtain luminescent 
inorganic particle systems via core-shell strategies. 
In the third chapter, the synthesis of organic coupling agents for the particle functionalization 
is described, including the development of dendritic non-luminescent molecules and the 
synthesis approach of linear and dendritic structures incorporating the dye rhodamine. 
Subsequently, the grafting of coupling agents is treated. After optimizing the grafting procedure 
with the help of commercial silanes, the grafting of synthesized molecules is described. These 
steps also include the analytical characterization of the functionalized NPs. 
The fourth chapter reports the transfer of the synthesized particle systems into cell culture 
tests. The stabilisation of the as-synthesized TiO2 NPs in cell culture media with the help of 
stabilising agents is presented. Furthermore, cytotoxicity tests of these particles are discussed. 
Finally, a detected anti-tumour activity of one of the synthesized particle systems is 
investigated. 
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I. Bibliographic study 
I.1. Titanium dioxide particles 
Since its first commercial production in the beginning of the twentieth century,1 titanium dioxide 
(TiO2) has been widely used in sunscreens2,3 or as a pigment,4–6 for example in paints.7,8 
Nowadays it is utilized for a variety of applications including: hydrogen sensing, storage and 
separation; lithium batteries and photovoltaic technologies, as an additive in food, and 
cosmetic; and as a catalyst or coating for medical implants.9–12 The wide range of applications 
is thanks to the fact that TiO2 not only provides semiconductor properties but also has an 
excellent chemical stability.9,13 Its four natural crystal structures are rutile (tetragonal), anatase 
(tetragonal), brookite (rhombohedral) and TiO2 (B) (monoclinic).14 The two photocatalytically 
active polymorphs, rutile and anatase, are the most intensively studied. Their crystal structures 
are shown in Figure I - 1 and can be described as an assemblage of TiO6 octahedrons; each 
Ti4+ ion at the centre of the octahedron is coordinated by six O2- ions. The two crystal lattices 
only differ in the distortion of each octahedron and in the octahedron arrangement structure.1,15 
These differences in lattice structure cause slight differences in their mass densities and 
electron band structures while their physical properties remain very similar.1,11 Nevertheless, 
the anatase form is commonly most preferred because of its high photocatalytic (PC) activity 
and its more negative conduction band edge potential giving a higher potential energy of 
photogenerated electrons. Furthermore, it offers non-toxicity, photochemical stability and a 
relatively low price.13,16 
 
Figure I - 1. Crystallographic structure of a) rutile and b) anatase consisting of octahedrons 
containing titanium atoms (white) in their centre and oxygen atoms (red) at their corners.11 
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In recent decades the synthesis of TiO2 nanostructures, which are structures possessing 
between one and three dimensions smaller than 100 nm, has become an important field of 
research. As TiO2 is a semiconductor material, in its nano form (1 to 25 nm) its electronic and 
optical properties deviate substantially from those of bulk materials due to the quantum 
confinement effect.17–19 This effect describes the fact that if the diameter of a particle is smaller 
than the exciton Bohr radius, its energy levels are discrete instead of continuous. As the 
particle size is varied, the energy levels shift, with an increasing separation of valence and 
conduction bands with decreasing radius. As the confining dimension decreases and reaches 
a certain limit, typically in nanoscale, the energy spectrum becomes discrete. As a result, the 
bandgap becomes size-dependent which results for example in a blue shift in light emission 
with decreasing particle size.17 Nanomaterials also possess a very high surface area and 
surface-to-volume ratio which increases the efficiency in applications that are based on surface 
or interface interactions between the TiO2 device and an interacting medium.1 
 
I.1.1. TiO2 nanoparticle synthesis 
Titanium dioxide nanostructures can be synthesized via a vast variety of reactions1,16 such as 
sol-gel reactions,20,21 micelle and reverse micelle methods22–24 and solvo- and hydrothermal 
processing,25,26 as well as chemical and physical vapour deposition.27,28 Further synthesis 
methods are flame hydrolysis (commercial Degussa P25),16 sonochemical29,30 and microwave-
assisted31,32 reactions or a combination of various methods.33 A combined sol-gel and 
hydrothermal processing is frequently chosen34–37 as it unites the advantages of sol-gel 
reactions with hydrothermal treatments. Typical characteristics due to the sol-gel process are 
a controlled stoichiometry and excellent reproducibility,34 while a high density of the particles, 
high crystallinity with a minimum of defects and controlled morphology are due to the 
hydrothermal treatment.1,34,35 The resulting nanostructures are of high purity, with narrow size 
distributions and can carry organic surface moieties of the synthesis, hence ensuring a high 
reactivity for further treatments.  
Sol-gel reactions are characterized by the hydrolysis and condensation of metal alkoxide 
precursors (Scheme I - 1) resulting in colloidal suspensions or sols. In the case of titanium 
dioxide synthesis, the hydrolysis is often acid-catalysed.1,35,38–40  
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Scheme I - 1. Hydrolysis and condensation reactions of a titanium alkoxide precursor. 
Transition metals like titanium are commonly not fully coordinated in the molecular precursor 
state for example in metal alkoxides. This is why a chemical modification with chelating ligands 
is needed to retard hydrolysis and condensation rates preventing uncontrolled precipitation 
and mediating the formation of smaller titanium-oxo species.41–43 Possible chelating agents 
can be alkoxy- and aminoalcohols, beta-diketons, beta-ketoester, carboxylic and phosphonic 
acids.41–43 Furthermore these ligands can have positive effects on the formation of non-
aggregated nanoparticles (NPs), as well as their growth behavior.44,45 Examples for the 
complex formed by titanium alkoxide and beta-diketon46 or carboxylic acid47 are shown in 
Scheme I - 2.  
 
Scheme I - 2. Titanium alkoxide complexed with chelating agents: a) acetyl acetone and b)  
2-[2-(2-methoxyethoxy)ethoxy]acetic acid. 
Hydrolysis (Scheme I - 1, 1st reaction equation) of the alkoxy ligands (Ti-OR) of these 
precursors, leading to hydroxyl groups (Ti-OH), is achieved by the addition of water while the 
hydrolytically stable chelating agents remain unmodified.45 Condensation (Scheme I - 1, 2nd 
and 3rd reaction equation) can start as soon as Ti-OH groups are present. Two competitive 
mechanisms can occur depending mainly on the experimental conditions: oxolation and 
olation. Olation is the formation of hydroxo bridges between two titanium atoms while water or 
an alcohol is released (Scheme I - 3 a). For this nucleophilic substitution reaction, the OH 
ligand represents the nucleophile which only changes its coordination from a terminal to a 
bridging ligand. The reaction is kinetically controlled by the lability of the M-OHR bond (with a 
metal M or in this case M = Ti) which is usually rather high. This is why without complexing 
ligands or steric effects, olation is fast and diffusion-controlled.48,49 In contrast to olation, 
oxolation is the formation of “oxo” bridges (M-O-M) between two metals that do not possess 
aquo ligands (Scheme I - 3 b). It usually proceeds via a 2-step SN2 associative mechanism; 
first, a nucleophilic addition forming an “ol” (M-OH-M) bridge takes place, followed by the 
proton transfer from the “ol” bridge to a terminal OH ligand, which results later on in the removal 
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of the aquo ligand. The reaction rate is mainly dependent on the acidity of the medium.48,49 
Continuous polycondensation reactions (either olation or oxolation) lead first to polymeric 
chains and rings before the formation of an amorphous Ti-O-Ti network. Depending on the 
presence and ratio of water and titanium precursors, the resulting TiO2 appears as a 3D 
polymeric skeleton or (either loosely or closely packed) first-order particle sols. Complete 
condensation of the precursor and loss of solvent leads to the conversion of the sol to a solid 
gel.1  
 
Scheme I - 3 : Condensation via a) olation and b) oxolation (with R = H or organic group of 
alkoxy ligand). 
However, to obtain TiO2 nanocrystals the solution must be heated in order to favour ion 
diffusion and crystallization rate.43,50 In the case of titanium stabilised by complexing ligands, 
heating also helps to remove the ligands, thus allowing the formation of further Ti-O-Ti bonds.43 
The formation of either anatase or rutile crystals (without addition of strong complexing agents) 
can be explained by taking into account the first stage (of olation) which is the formation of the 
dimer [Ti2(OH)8(OH)2]0.48 This is a structure of two octahedrons sharing an edge as depicted 
in Figure I - 2. This “embryo” grows by olation with further monomers forming nuclei and 
subsequent condensation of these nuclei by oxolation is likely to result in rutile or anatase 
crystals. Considering that the TiO6 octahedrons in anatase only share edges while in rutile both 
edges and corners are shared, it is more likely that anatase is formed. The probability that the 
“embryo” grows through edge sharing only in the same plane is smaller than in different planes. 
This is why curved or bent edge sharing chains are formed, inhibiting the sharing of corners 
between different planes. Nevertheless, rutile as the thermodynamically stable phase is said 
to be formed based on Ostwald ripening (dissolution/crystallization mechanisms).48 For the 
heating to produce crystal structures, hydrothermal treatment is ideal as the synthesis is 
conducted in a steel pressure vessel and the reaction temperature can exceed the boiling point 
of water, reaching the pressure of vapour saturation. The temperature and the filling grade of 
the autoclave with solution determines the internal pressure produced.1,51 In contrast to 
calcination or thermal annealing,52 this method does not lead to unwanted phase 
transformation, sintering or grain growth of the particles and therefore loss of surface area.50 
Additionally, it is less energy consumptive and an environmentally friendly process. Moreover, 
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with hydrothermal treatment the crystallization temperature for anatase phase is below 200 
°C.44  
In conclusion, the properties of the final TiO2 particles, such as the degree of crystallization, 
crystal phase composition, size, morphology and surface chemical properties, are controlled 
by the type and concentration of the precursors, solvent, additives, catalysts, pH and 
hydrothermal reaction conditions.44,50 
 
Figure I - 2. Ongoing growth via olation of the first formed dimer during condensation.48 
 
I.1.2. Photocatalytic activity* 
TiO2, especially in its nano-form, is often used for photocatalysis as it efficiently catalyses a 
broad variety of reactions if activated by light.53 Applications include waste water treatment,53,54 
catalysis of chemical reactions,55 disinfection56 and tumour therapy.56 Anatase has an energy 
band gap of 3.2 eV with an absorption edge at 386 nm, while rutile possesses a band gap of 
3.02 eV with an absorption edge at 416 nm.11 Both forms can be activated by light with an 
energy equal to or greater than the band gap; in general ultraviolet (UV) light with wavelengths 
from 280 to 400 nm. This provokes the elevation of an electron (e-) from the valence band to 
the conduction band. A hole (h+) in the valence band is therefore created resulting in a so-
called electron-hole pair:11,57,58 
TiO2 + hν → e- + h+. 
After excitation there are different processes taking place that compete with each other (Figure 
I - 3); the separated electron-hole pair can either recombine within the volume of the particle 
                                               
*
 Parts of this chapter have been submitted to Nanoscale for publication. The submitted title is 
“Discovering the determining parameters for the photocatalytic activity of TiO2 colloids based on an 
anomalous dependence on the specific surface area”. 
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dissipating energy like light or heat or it can migrate onto the particle surface. On the surface, 
either - once again - a recombination occurs or the electron and the hole react with their 
surrounding environment (for example adsorbed inorganic or organic species or solvent) by 
electron transfers.57 In this case, the electron can reduce an electron acceptor, typically oxygen 
in an aerated solution:11,57 
e- + O2 → •O2-.  
Further reactions of superoxide radicals (·O2-) with holes can also lead to singlet oxygen (1O2). 
In the meantime, the hole combines with an electron from a donor species like water or 
hydroxyl groups, oxidizing it:11,57 
h+ + OH- → •OH 
h+ + H2O → •OH + H+.  
Reactions of water and hydroxyl groups and its resulting radicals can also produce hydrogen 
peroxide (H2O2) or protonated superoxide radicals (HOO•).59 
 
Figure I - 3. Photoexcitation in a semiconductor particle followed by deexcitation events.57  
These reactive oxidizing species (ROS) react with other surface adsorbed organic, inorganic 
or biological species, decomposing them.11,59 The probability and rate of charge transfer 
responsible for photocatalysis depends on the band energy positions of the material and the 
redox potential levels of the adsorbate species. The potential level of the acceptor species has 
to be thermodynamically lower (more positive) than the conduction band position of TiO2 to be 
able to accept the electron. The donor has to show a higher (more negative) potential level 
than the valence band for the transfer of an electron to the hole.57  
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As recombination and electron transfer processes are competing which each other, it is evident 
that the efficiency of a photocatalyst increases, when the recombination of the photoexcited 
electron-hole pair is retarded. This is achieved by charge carrier trapping which suppresses 
recombination and increases the lifetime of the separated pair. Traps can be provided by 
(surface) defect sites in the crystal lattice naturally created during the synthesis but also by 
manipulations like the creation of heterojunctions or doping with ions.57–59 The presence of a 
certain concentration of oxygen vacancies in the TiO2 crystal lattice can on the one hand 
improve the PC performance due to enhancement of the charge carrier separation (e- and h+). 
On the other hand, if the amount of oxygen vacancies is too high, they act as recombination 
centres and therefore decrease the PC activity.60–62 The PC performance of TiO2 NPs not only 
depends on their defect concentration but also on their crystallite size, surface area, 
morphology and phase structure.16,44 Concerning the phase of TiO2, the anatase phase is said 
to be more active than rutile because of its superior mobility of electrons and holes and a higher 
surface hydroxyl density.11,59 Regarding the size, monodispersed particles with small crystallite 
size are favoured as they benefit from a high surface area and a reduced bulk recombination 
of electrons and holes. Nevertheless, the particle should not be too small in order to avoid 
increased surface recombination and low crystallinity. The perfect particle size for a high PC 
activity cannot be generally identified as it depends on several factors such as the synthesis 
or the photocatalysis test chosen.53,58  
Recently, the type and ratio of exposed facets of anatase crystals was also found to influence 
the PC performance of TiO2 NPs.61,63–73 Under equilibrium conditions, anatase has the shape 
of a slightly truncated tetragonal bipyramid enclosed with eight {101} facets (which contribute 
94% of the surface area) and two {001} facets (according to the Wulff construction).64,68,69 This 
seems logical as the {101} facet is the thermodynamically most stable one with a calculated 
surface energy (0.44 J m-2) lower than that of the {001} (0.90 J m-2) and {100} (0.53 J m-2) 
facets.70,74 Nevertheless, under certain reaction conditions, the appearance of a “belt” 
consisting of {100} is also predicted.75,76 Both morphologies are depicted in Figure I - 4. The 
main difference between these facets is their surface atomic structure and therefore their Ti-
coordination; both {001} and {100} facets expose 100% 5-fold-coordinated titanium atoms (5c-
Ti) as compared to 50% 5c-Ti (and 50% 6-fold-coordinated Ti; 6c-Ti) on the {101} surface 
(Figure I - 5).60,68 Due to their surface structure, the high energy facets with 100% 5c-Ti allow 
a dissociative adsorption of water molecules while {101} facets only permit a molecular 
adsorption.68,73,77,78 As for PC reactions, the pre-adsorption of molecules on the catalyst surface 
is a determining step, the increase in 100% Ti5c surface area, i.e. the enhancement of pre-
adsorption of water molecules, results in a higher PC performance.68,73,77,78 
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Figure I - 4. Equilibrium shape anatase exposing {101} and {001} facets and anatase 
additionally exposing {100} facets appearing as a belt around the centre of the crystal. 
 
Figure I - 5. Surface atomic structures of anatase {101} and {001} facets.60 
Thus, numerous approaches have already been carried out to obtain TiO2 nanoparticles with 
well determined exposed facets to increase their PC performance using appropriate solvents 
or additives.65,66,68–73,78–87 The solvent-solute interactions along different orientations of a crystal 
vary significantly because of the surface atomic arrangements. This results in different surface 
affinities of the solvent or additive towards each facet. A high affinity of either the solvent or 
additive to a certain facet results in their stabilisation as it for example lowers the surface 
energy or changes the surface tension of the bound plane.68,76,80 
To determine the PC activity of particle samples, various degradation tests have been 
developed such as the degradation of organic dyes (e.g. crystal violet, methylene blue, 
orangeG or methyl orange)88,89 or phenols.90 Most of these methods follow the degradation 
process with the help of the absorption or luminescence of these substances and for this, the 
particles have to be removed from the measurement to avoid errors caused by NP absorption, 
luminescence or scattering.90 This is why the PC decomposition of dichloroacetic acid (DCA) 
into CO2 and Cl- (HCl) has been frequently preferred over other test methods as an in-situ 
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measurement is possible with the help of a chloride ion sensitive electrode.90–93 Furthermore, 
the DCA does not degrade with UV light application alone, which is a concern when using dyes 
as this can falsify the measurement results.90 The behaviour of DCA and influence of testing 
parameters on the degradation results have been intensively studied.91–93 The main 
degradation mechanisms of this substance are shown in Figure I - 6. While the interaction of 
the photogenerated electrons with DCA on the surface of TiO2 is seen as very unlikely, the 
reaction of photogenerated holes (h+) with the organic molecule (photo-Kolbe reaction, Figure 
I - 6 bottom; anticlockwise reaction pathway), freeing CO2 and initiating further degradation 
steps seems to be the main degradation pathway.92,94,95 Additionally, hydroxyl radicals can 
abstract the proton from the α-carbon in the initial step of the degradation of DCA (Figure I - 6 
top; clockwise reaction pathway). These radicals are generated through the trapping of 
photogenerated holes by surface OH- ions or adsorbed water, or by the reaction of H2O2 with 
photogenerated electrons. The dominant reaction is most likely dependent on the catalyst 
material (as it is documented in detail for acetate degradation).92,94–97  
 
Figure I - 6. Main photocatalytic degradation mechanisms of dichloroacetic acid (DCA): primary 
H-abstraction leading to the reaction pathway on the top and photo-Kolbe reaction leading to 
the reaction pathway on the bottom.92,98–100 
 
I.1.3. Photocatalytic tumour therapy with TiO2 particles 
Because of their unique properties NPs are often considered for biomedical applications.101 In 
particular their small size makes them ideal to cross cell or tissue barriers while being large 
enough to be conjugated to antibodies or drugs. TiO2 NPs have already been used as drug 
delivery systems, carriers for cell imaging, biosensors in biological assays and for genetic 
engineering. In addition to these uses, PC tumour therapy is also a potential application field.102 
PC tumour therapy with TiO2 NPs is a form of the so-called photodynamic therapy.10,102,103 For 
this treatment, a photosensitizer, a light source and the presence of oxygen (and/or water) are 
required. The photosensitizer, i.e. a macromolecule, an organic or an inorganic NP,102,104–106 is 
introduced into living tissue, for example into a tumour. They have to be non-toxic and excitable 
by photons (of the light source). After excitation they transfer their energy (i.e. electron-hole 
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pairs) to the surrounding oxygen or water creating highly reactive radicals. Those species 
readily destroy cell components leading to apoptosis. This therapy form seems to be a 
promising alternative to conventional cancer therapies thanks to a high safety record, minimal 
invasiveness, low cost and high localization.10,107 Photodynamic therapy is ideal for dermal 
illnesses and exposed body cavities such as the oral cavity, vagina, rectum or bladder. Small 
and superficial tumours located above or just below the skin tissue can be easily treated via 
this method.10 In contrast, for deeply infiltrating tumours or tumours located inside the body 
photodynamic therapy is not applicable as most photosensitizers are excited by UV light (≤ 
400 nm). This wavelength range lies outside the phototherapeutic window (600-1300 nm)108,109 
and therefore does not deeply penetrate the tissue. Furthermore, DNA damage by UV light is 
an unwanted side effect.10 Up to now the research concerning photodynamic therapy with TiO2 
is still in its early days. This mainly includes in vitro studies to examine the PC killing of cancer 
cells by UV light activated TiO2 NPs.110–114 One study even indicated the preferential 
destruction of tumour cells while non-malignant cells were less affected.115 A few in vivo studies 
were able to confirm the anticancer effect, stressing the potential of TiO2 as a potential cancer 
treatment agent.13,116 
Nevertheless, future applications of NPs in human bodies always cause concern about the 
potential toxicity. In the last decade, the toxicity and biodistribution of (non-activated) TiO2 
particles has been controversially discussed.10,117–123 In order to understand contradicting 
outcomes of studies, one has to consider that the toxicity is strongly dependent on the TiO2 
crystal phase, morphology and size, NP number and mass concentration. Also the 
agglomeration state, charge and added functional groups or impurities influence the NP 
toxicity. Therefore toxicological results can be different for every synthesized NP system.118,124 
Additionally, the exposure routes and dose greatly influence the toxicity of the applied 
particles.118,120 This is why, on one hand inhalation of TiO2 NPs is proven to cause 
inflammation, lung damage and may cause cancer.118,120 This initiated the International Agency 
for Research on Cancer (IARC) to classify it as possibly carcinogenic to humans (Group 2B).118 
On the other hand, TiO2 NPs in sunscreens and cosmetics have been applied on the skin for 
years and are considered non-toxic as they cannot penetrate through skin.118,120 Moreover, in 
1969 the Joint FAO/WHO Expert Committee on Food Additives (JECFA) approved TiO2 as an 
ingredient in human food as no significant absorption or tissue storage was found.117 For other 
organs besides the lungs and skin, toxicological data is still too limited for a reliable 
assessment of TiO2 risks.118 Nevertheless, it is assumed that if they enter circulation, they 
could translocate in organs such as the spleen, liver, and kidney117,125 while the rate of such 
translocation remains undetermined.122 This is why the possible toxicity of TiO2 should be kept 
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in mind if used for biomedical applications and should be evaluated for every newly developed 
particle system. 
 
I.1.4. Luminescent TiO2 nanoparticles  
In the last decades, the combination of therapy and diagnosis within one tool (also called 
theranostics), for example within a NP system, has really come to the fore in research. The 
clear advantage of theranostics is the simultaneous diagnosis and treatment of a disease. 
Additionally, the release or efficacy of a therapeutic agent and its biodistribution may be 
monitored.126,127 The theranostic approach is especially promising for tumour diagnosis and 
therapy128: Particle systems targeting malignant cells or cumulating in the pathologic tissue, 
can indicate the location and degree of the disease. This is visualized via an imaging method 
including resonance imaging, x-ray computed tomography, ultrasound, bioluminescence or 
fluorescence imaging, and single photon emission computed or positron emission 
tomography.129 Then, therapy can be conducted thanks to specific particle properties like 
hyperthermia or photocatalysis but also drug-conjugates on the particle surface or incorporated 
into the NP system. Typical examples for inorganic theranostic NP systems are gold130,131 and 
superparamagnetic NPs132 which can be used for surface plasmon resonance or resonance 
imaging, while both offer the possibility of hyperthermal cancer therapy. Polymeric particle 
systems incorporating for example luminescent dyes or paramagnetic complexes and drug-
conjugates are promising approaches as well.133,134  
In the case of TiO2 NPs, photoluminescence (PL) properties for imaging in later applications 
as a treatment agent but also in cell culture studies are widely discussed in literature. While 
bulk TiO2 does not exhibit PL, small NPs show band-band PL. This light emission is caused 
by the electron transition from the conduction band to the valence band, emitting radiation with 
an energy (in general) equal to the band gap energy (Figure I - 7). Due to the band gap energy 
of TiO2, this PL is in the blue wavelength range. Anatase NPs with sizes around 4 to 6 nm 
synthesized by hydrolysis, nonhydrolytic preparations or hydrothermal synthesis were reported 
to exhibit under excitation at 300 to 365 nm a blue light emission (400-450 nm) visible by eye, 
which was in all cases assigned to band-band PL of the anatase NPs.135–139 Because of the 
band-band transition, the higher the PL intensity, the higher the recombination rate of excited 
electron-hole pairs and therefore the lower the PC activity of the sample.140 Another possibility 
to obtain luminescent TiO2 materials is the introduction of dopants into the crystal lattice. The 
doping of TiO2 crystals has already been widely explored for a large range of elements, mainly 
to increase the PC activity of the samples. As the excitation of electron-hole pairs depends on 
the TiO2 band gap, dopants in the crystal lattice have been used to modify it, for example to 
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enable photocatalysis under visible light excitation which also increases the efficiency of the 
catalyst.141–143 It is also known that the photoreactivity of TiO2 is related to its defect disorder 
which is why introducing new defect sites through doping can be used to increase the PC 
activity.142,144–146 Additionally, the doping of TiO2 can result in luminescence in the visible 
wavelength range (as mentioned before).147,148 In this case, the radiation is normally caused 
by surface oxygen vacancies or defects and can be identified as excitonic photoluminescence 
processes: the excited electrons first transit from the conduction band to a different sub-band 
or surface state without radiation (Figure I - 7). Subsequently, radiative transition from this state 
to the valence band occurs.140 The emitted energy is lower than the band gap energy. The 
introduction of a dopant impacts all listed properties of the semiconductor material and 
therefore the properties of the two components can either compete or intensify each other. 
This means that an increasing luminescence of the doped TiO2 can result in a higher or lower 
PC activity of the sample, depending on the dopant species.140  
 
Figure I - 7. Simplified main photophysical processes of a semiconductor excited by light with 
equal to band gap energy. Photoexcitation results in electron/hole (e-/h+) pair formation and is 
followed by the 3 competing recombination processes of band-band photoluminescence (PL), 
excitonic PL and non-radiative transition.140 
Elements most often used to create materials with visible luminescence properties are rare 
earth elements due to their sharp luminescence bands and visible transition of the triply 
charged ions; examples include erbium, europium, terbium or cerium in the red, green or blue 
region of the light spectrum.149,150 There are already several reports on TiO2 NPs doped with 
europium (showing red light emission),151–153 with erbium (red and/or green emission)154,155 and 
with lanthanum (blue emission).140,156 Nanofibers with visible luminescence have also been 
shown thanks to praseodymium and cerium doping.157 In addition, visible light emitting 
europium-samarium co-doped nanocrystalline TiO2 microspheres158 and thin films with 
luminescence between 400 to 600 nm caused by terbium doping159 have been developed. For 
all given examples, calcination or annealing was necessary to induce photoluminescence 
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properties or to obtain high enough intensities for later applications.148,151,153,154,160,161 The only 
exception was a rutile film prepared with very high amounts of europium which resulted in 
strong red luminescence without annealing.147 In general, the particle samples aggregated 
during calcination which resulted in larger particle sizes and a decrease in specific surface 
area.137,152 An example for calcinated, europium (Eu3+) doped anatase NPs in their aggregated 
powder form is shown in Figure I - 8. 
 
Figure I - 8. Luminescence of anatase nanoparticles, doped with europium (Eu3+; 5 mol-%) and 
calcinated at 200 °C or 400 °C; excited at 365 nm. 
Another method to obtain luminescent particle systems, is the functionalization of the inorganic 
particles with an organic dye. This strategy was so far primarily used for the production of dye-
sensitized solar cells162–164 which did not focus on the fluorescence of the system but on a more 
efficient light-activation of the TiO2 catalyst. Nevertheless, labelling of TiO2 NPs with dopamine-
modified dyes (1-pyrenemethylamine, piperazinyl-4-chloro-7-nitrobenzo-furazane, TexasRed 
or tetramethylrhodamine) has been realized and examined by confocal laser scanning 
microscopy.165,166 Adsorption of a conjugate of rhodamine B and phenylphosphonic acid onto 
TiO2 particles was carried out for stem cell labelling.110 In one study, these semiconductor 
particles were first functionalized with 3-glycidoxypropyl tri-methoxylsilane and then reacted 
with dyes such as xanthene dye rhodamine B, 4-phenylazo-phenol and 4-phenylazoaniline.167 
Adsorption of a perylene diimide dye onto TiO2 also resulted in fluorescent samples applicable 
for finger-mark detection.168 All the herein cited examples for a functionalization of particle 
systems with a dye imply their surface modification causing significant changes to their 
properties. How this enables the fine manipulation and tuning of the particle behaviour 
depending on the desired application is discussed in the following chapter.  
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I.2. Surface modification of nanoparticles for biotechnological applications† 
There are several reasons why the surface of synthesized particles is modified. First, particles 
in a colloidal dispersion agglomerate and sediment if they are not electrostatically (between 
equally charged particles)169 or sterically stabilised (for example by hydrocarbon chains/bulky 
polymers adsorbed or grafted onto the particles)170. These two types of particle repulsions are 
shown in Figure I - 9. Electrostatic stabilisation is always limited to a certain pH range as at a 
particular concentration of OH− or H3O+, these ions may neutralize the surface charge of the 
particles up to their isoelectric point resulting in flocculation.171 In the same way, an increase 
in ionic strength of the solution, for example caused by dissolved salts, results in destabilisation 
of the colloidal dispersion, which is well described by the DLVO theory.172 By contrast, steric 
stabilisation − in a very simple picture − keeps NPs apart due to the space taken up by the 
organic molecules that are attached to the NP surfaces. For entropic reasons, distance is 
maintained between the chains of different particles. In theory this stabilisation mechanism is 
therefore indifferent to pH changes or varying salt concentrations.173,174 However, when 
particles are used in the biomedical field and applied in a physiological environment, they tend 
to agglomerate and sediment in physiological solutions because of their pH and salt 
content.175–177 This issue needs to be addressed in order to ensure a consistent assessment 
of the therapeutic and diagnostic potential of NPs in cell culture experiments or animal testing. 
Studies concerning particle concentrations are only reliable when carried out with stable 
dispersions that guarantee an accurate dosing. The effect of different sized particles on cells 
can only be studied if the particles do not form large agglomerates.175,178,179 Furthermore, 
agglomeration leads to a reduction in accessible surface area. If TiO2 NPs are applied as 
therapeutic photosensitizing agents13, a decrease in surface results in a lower PC efficiency of 
the particles.175,180 
 
Figure I - 9. a) Electrostatic repulsion between equally charged particles and b) steric repulsion 
of particles. 
                                               
†
 Parts of this chapter have been published and are reused in this work by courtesy of Elsevier, original 
article: S. Koch et al., Colloids Surf., B, 2016, 143, 7–14. 
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Second, in the last decade studies focused more and more on the influence of particle surface 
charges on their uptake by cells. Apart from the particle size, shape, dispersion state and 
composition, the surface charge was determined to be a crucial particle property for this.181–184 
Numerous studies examined particles with sizes from below 10 nm up to 500 nm consisting of 
various materials185 such as chitosan,181 PLGA186, hydroxyapatite,187 zinc sulphide,188 cerium 
oxide,189 silica,190,191 titanium dioxide,192,193 magnetite194–198 or gold.182 The particle surface 
charge or hydrophilicity was manipulated with the help of surface groups, for example 
hydroxyls,189,190 thiols,190,194,196 amines,182,187,188,190,192,194 carboxylic acids,181,187,188,190,192,194–196 
glucans,194,196,197 alkanes,188,192 as well as polymethylsiloxane,193 glycerol,193 polyvinyl 
alcohol186,198 or polyethylenglycol chains.188,195 The uptake of these surface modified particles 
was tested with a variety of non-malignant cells, malignant cells and macrophages. In the first 
instance the studies indicated that the particle uptake is cell type dependent.181,191 It was also 
stated that the adsorption of components of the cell culture medium onto the particles often 
makes the analysis challenging as it covers the surface and changes the surface charge and 
properties.182,188,189 Hydrophobic particles and those with very high positive or negative charges 
or sizes over 150 nm are taken up by macrophages,181 while no or less uptake by other cell 
types is detected for hydrophobic particles.188,192 If the particles provide neutral surface charge, 
no internalization takes place192,194 due to lower particle-cell membrane interaction.185 
Negatively charged particles can be taken up by cells even if their charge is unfavourable for 
interaction with the negatively charged cell membranes. It is believed that internalization 
occurs through binding of the particles on scarce cationic sites on the membrane and 
subsequent endocytosis.185 Logically, positively charged particles are taken up better than 
negatively charged ones because of their increased interactions with the cell 
membrane.182,185,187,190,192,194,197  
Third, surfaces can be modified via bioconjugation with agents that fulfil a special purpose like 
targeting an organ or cell type of interest or mediating the cellular uptake.183 Especially for 
tumour therapies, this is a powerful tool; targeting ligands or antibodies specifically bind to cell-
surface antigens or receptors that are, for example, exclusively expressed on tumour cells 
(Figure I - 10).199 In this way, the drug or particle conjugated to the targeting moiety is directed 
to the place of interest and then internalized into the targeted cell by receptor-mediated 
endocytosis. As a target, the folate receptor is often used as it is expressed in tumour tissue 
and can bind vitamin folate but also folate-particle or folate-drug conjugates.200–206 Transferrins 
which are non-heme iron-binding glycoproteins and bind to the transferrin receptors, are also 
considered as targeting agents for tumours as the transferrin receptor is overexpressed by 
them.207 Similarly, the epidermal growth factor receptor is overexpressed by many types of 
epithelial tumours and can therefore be targeted by anti-epidermal growth factor receptor 
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monoclonal antibodies.208 Lectins are proteins which bind to glycans present on the cell 
membrane. As the glycans expressed by tumour cells are often different to those of their non-
malignant counterparts, lectins can be used as cancer targeting agents.209 Furthermore, 
aptamers which are olignucleic acids like DNA or RNA with unique 3-D conformations, can 
bind specifically to target antigens and are therefore interesting as targeting agents bound to 
particles or drugs.210–214 
 
Figure I - 10. Nanoparticles with ligands targeting a receptor which is overexpressed by 
malignant cells.  
Due to these three above mentioned purposes, particle surfaces usually have to be 
functionalized for their intended biomedical applications. The modification of the surface for 
example with targeting agents will always influence the other particle properties such as the 
dispersion state in physiological media and their cellular uptake. Additionally, the surrounding 
liquid medium and its composition strongly influences the particle behaviour. This is why the 
functionalization of NPs is very complex and has to be studied intensively to avoid unwanted 
side effects caused by the modification.  
 
I.2.1. Surface modification of TiO2 particles 
In literature, the surface of TiO2 particles has already been modified for several decades. For 
example as photosensitizers for optoelectronic and photonic devices, the particles (as electron 
acceptors) were decorated with organic structures serving as electron donors.162,215 The 
particles were functionalized with organic dyes for several biological and non-biological related 
applications as mentioned in I.1.4. For biomedical uses, TiO2 was also modified with DNA-
oligonucleotides for potential gene therapy216 or with PEG-ligands113 and carboxylic acids217 to 
improve their biocompatibility. Anti-body linked NPs were developed for active tumour 
targeting115 or polymer-NP conjugates as a versatile toolbox for molecule immobilization.165 
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TiO2 NPs can either be surface modified during particle synthesis (in situ modification) or by 
grafting of organic groups onto the NPs (post-synthesis modification). The advantage of in situ 
functionalization lies in the double function of the organic ligand controlling the particle growth 
and/or morphology and serving as functional surface group.218 Post-synthesis modification has 
the benefit of an easy processing and the organic molecule can be chosen depending on the 
specific demands of later applications without considering the requirements for particle 
synthesis.219 Most of the examples for the functionalization of TiO2 particles (mentioned in this 
chapter) are post-synthesis modifications.110,115,163,166–168,216,220–223 However, in the case of sol-
gel syntheses a coordinating agent is often used to control the hydrolysis and condensation 
reactions and after NP synthesis this agent serves always a functional surface molecule as 
well.165,218,224,225 The surface groups obtained by in situ modification can sometimes be 
transformed by a ligand exchange which still provides a certain flexibility in the modification of 
the NPs independent of the synthesis procedure.112,217 
Irrespective of the aimed application area and the chosen modification procedure, the 
modification of TiO2 particles requires an adequate anchoring group that attaches the 
functional molecule onto the surface via direct linkage of the anchoring group with the hydroxyl 
groups of the oxide surface.215 One possible group are phosphonic acids (P(O)(OH)2) that can 
bind via a phosphonate ester linkage (Scheme I - 4 a) onto the TiO2 surface;215,226 examples 
include phenylphosphonic acid,226 rhodamine-phosphonic acid110 or 2,2-bipyridine-4-
phosphonic acid.215 Another commonly used class of ligands are carboxylic acid derivatives 
that can attach to TiO2 with both the oxygen and hydroxyl moiety (Scheme I - 4 b). 
Mercaptosuccinic acid,112,217 ascorbic acid,227 oleic acid,225 thiolactic acid,223 maleic acid,113 
anthracene acetic acids164 and various others215,217 have already been utilized as surface 
functionalities. Furthermore, enediol ligands such as dopamine,163,165,166,216,220 cyanidin 3-
glucoside,163 catechol,221,222 gallic acid221 or pyrogallol221 can also modify TiO2 surfaces as they 
covalently link to the surface with both hydroxyl groups (Scheme I - 4 c). A salycilate binding 
type has been shown for ligands like 2-hydrobenzoic acid and 2,5- or 2,3-dihydrobenzoic acid 
(Scheme I - 4 d).222 Finally, silanes have been readily applied onto TiO2 NPs,228 for example 
3-glycidoxypropyl tri-methoxylsilane,167 N-(Tri-methoxysilylpropyl) ethylene diamine triacetic 
acid,229 tetraethoxysilane114,230–233 or 4-(trichlorosilylethyl)-4-methyl-2,2-bipyridin.215 They react 
with the surface hydroxyl groups to form a silyl bond (Scheme I - 4 e). The binding of anchoring 
groups is in general reversible, this is why in aqueous solutions of higher pH values, hydrolysis 
and de-chelation from the surface can occur.162,215 As well as the anchoring group, the structure 
and properties of functional groups of the ligand are very important as they dictate the later 
particle behaviour and allow tailoring for specific applications.  
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Scheme I - 4. Possible binding modes of the anchoring groups onto TiO2: a) Phosphonate 
ester linkage215, bidentate binding of a carboxyl group162, c) binding of enediol ligands shown 
with catechol as example222, d) binding of 2-hydrobenzoic acid222 and e) silyl linkage on TiO2215. 
 
I.2.2. Surface modification of particles with dendrons 
Whilst linear ligands162,215 are most commonly applied, since 2001, the substitution of linear 
coupling agents by dendrons has been increasingly studied in the field of NP surface 
modification. The concept of such dendritic molecules compared to a linear one is shown in 
Figure I - 11.  
 
Figure I - 11. Concept of dendritic molecules: a) linear (one branch), b) 1st generation (2 
branches) and c) 2nd generation (4 branches). 
The amount of functional terminal groups is increased via symmetric branching of the 
molecule, while one focal point is maintained. Dendrons typically possess a precise 
architecture and low polydispersity as they are synthesized by increasing the generation of the 
branches step by step.234 Additionally, in contrast to polymer synthesis purification during their 
growth at intermediate steps is in general possible.234 This allows the control and manipulation 
of the size, branching points and number or type of terminal functions.221 In comparison to 
linear molecules or polymers, dendritic structures show very unique physicochemical 
properties which are due to the so-called “dendritic effect” caused by the multiplicity of 
functional groups, architectural steric effects and a differing nature in the internal dendritic 
structure.235 While the multiplicity of the functional terminal groups is mainly responsible for the 
solubility or chemical reactivity of these molecules, the first linear and with increasing 
generations 2D or even 3D architecture results in eminent changes in the shape and 
flexibility.234,235 Because of terminal groups and several branch generations, the inner core of 
dendritic structures is sterically protected from the outside environment which provides the 
possibility of hosting other organic, inorganic or metallic compounds and protecting them from 
solvent effects of the outside.235 
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The synthesis of these molecules can be carried out via either a divergent or convergent 
approach (Figure I - 12).234  
 
Figure I - 12. a) Divergent and b) convergent synthesis of dendritic molecules.234 
Both procedures consist of coupling and activation steps; during coupling the number of 
branches is increased while side reactions between other functionalities of the reactants are 
disabled, then a subsequent activation of either the peripheral points or the focal points of the 
molecules enables a further coupling step. The divergent synthesis produces growth starting 
from the focal point and forming the branches stepwise by repeated coupling and activation of 
the peripheral groups (Figure I - 12 a).234 For a convergent synthesis the dendritic growth 
begins from the exterior molecules and proceeds via reactions at the focal point of each branch 
(Figure I - 12 b).234 
In order to modify NP surfaces with dendrons, the focal points of these molecules also need 
to represent the anchoring groups. As both anchor and core of the dendron, various ligands 
have already been studied236 including siloxanes,237–241 thiols,242–252 amines,253,254 
enediols,255,256 phosponates257–259 and carboxylates.260,261 The nature of the anchor mainly 
depended on the studied NP type which was most commonly Au242–246,248–251 or iron 
oxide.238,253,255–257,259,260,262–264 Additionally, a few other inorganic particle types have been 
studied: silica,241 TiO2,240 Pd,265,266 ZnO,237 CdSe/ZnS,254 CdSe/CdS247,261 and CdSe252,258 NPs.  
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The increase in functionalities by dendritic surface agents (compared to linear molecules) 
results in a better NP colloidal stability enhanced by their conical structure and allows the 
coupling of more biofunctions. Additionally, their cone-like structure is appropriate for the 
functionalization of ultrasmall NPs which possess a high curvature, as the density of radial 
functional groups decreases to a lesser extent with increasing distance from the surface. This 
guarantees a dense surface functionalization. Furthermore, the dendritic framework is suitable 
for the adsorption and encapsulation of small molecules such as drugs or pollutants providing 
opportunities for applications such as drug release or waste water treatment.267 Even if the 
synthesis of dendrons is more difficult and time consuming compared to (hyperbranched) 
polymers,268 the precise control of the molecule architecture allows a better tailoring of the 
properties, which can be crucial for later uses and reproducibility. These can not only be 
tailored by the increase of generations and therefore terminal groups, but also by the structure 
of the spacer itself. The most studied dendritic structure for particle functionalization clearly is 
poly(amidoamine).237,239,241,244,262,265 Although, the functionalization of particles with various 
other structures has been studied; for example poly(ester amine)s,238 lysine based 
structures,243,269 poly(benzyl ether)s,266 poly(oxymethylphenylene)s,250 polycarbazoles,245 as 
well as Newkome-type248 and Fréchet-type dendrons.242 
Particle functionalization with dendrons has been carried out after NP synthesis in most of the 
before mentioned references. There are only a few exceptions in which the dendritic molecules 
have already been applied during synthesis.240,243,245,264,266 This was mainly to combine later 
tasks as surface groups with the function as capping agents for size and morphology control 
during synthesis.236,243 Moreover, the dendron has usually been grafted as an entire molecule 
onto the particle surface which allows the complete characterization of the dendron before 
grafting. Additionally, the perfect integrity of the applied molecules is ensured as defective 
structures like incomplete branches can be separated before grafting and the formation of 
rather polymer-like disordered structures is avoided.270 This functionalization procedure can 
be called “grafting onto” while “grafting from” means the building of the dendron onto the NP 
after anchoring of the focal point.260 The latter method was suitable in a few cases to prevent 
the occurrence of NP clusters since possible reactions of one dendritic molecule with two 
particles at the same time are avoided.238,239,241,260 The disadvantages of both the “grafting 
onto” and “grafting from” approaches are also depicted in Figure I - 13. 
In the last two decades, the unique properties of dendrons have been used for the design of 
NPs for applications such as catalysis239,253,255,265,266 and water purification.241 Redox-active 
dendron-functionalized NPs were synthesized for future nanoelectronics or sensors.242,246,250 
Systems with switchable solubility in various solvents244,248 or temperature induced NP 
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aggregation256 have been developed. With aims such as improving the solubility of 
hydrophobic particles in water,237,254,261 stabilisation at physiological pH257 and 
biocompatibility,251,254 as well as coupling or incorporating drugs,249,269 NP-dendron systems 
have been designed for a broad variety of biotechnological uses.101 These include cell 
labelling,237 biosensors for pathogen detection,254 DNA recovery262,271 or delivery,249,269 magnet 
resonance imaging255,257,259 and drug delivery.260,272 
 
Figure I - 13. Possible problems occurring during grafting procedures: a) reaction of one 
dendron with two particles resulting in the formation of nanoparticle cluster during “grafting on“ 
and b) formation of defective dendritic structures on the particle during “grafting from”. 
Currently, a new form of dendrons is gaining scientific interest; luminescent dendritic structures 
as luminescence offers the monitoring of basic properties as well as of its surroundings. The 
combination of dendritic properties and luminescence can therefore lead to novel functions 
and new applications.273,274 While the incorporation of luminescence into dendrimers is already 
well established, only a few studies have been carried out on luminescent dendrons for the 
functionalization of NPs.275–280 Luminescence properties can be incorporated into a dendron 
with the help of metal complexes such as [Ru(2,2’-bipyridine)3]2+, fullerenes or organic 
chromophores, including metal complex chromophores such as porphyrins or azo-
compounds.273 There are several possibilities for the location of a luminescence centre; 
besides dendron structures that consist out of chromophores themselves,275 the luminescence 
agent can be situated “off-centred” (i. e. not integrated into the dendron, Figure I - 14 a),281,282 
in its periphery (Figure I - 14 b),276–278,283 or at the focal point (i. e. as anchor or between anchor 
and dendritic branches, Figure I - 14 c).279,280,284 
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Figure I - 14. Integration of a luminescence centre into the coupling agent, a) “off-centred”, b) 
in the periphery of the dendritic structure or c) at the focal point. 
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I.3. Conclusion 
In this chapter, titanium dioxide was introduced, including its crystal structures, main physical 
properties and benefits in its nano form. The hydrothermal sol-gel synthesis was explained, 
stating its advantages and the mechanisms that are responsible for the nanocrystal formation. 
After this the PC properties of TiO2 were described comprising the principles of photocatalysis 
and factors influencing the PC performance such as defects, exposed facets and surface area. 
While the synthesis of TiO2 NPs is already well developed, their PC properties still require 
further study to understand the basic mechanisms and factors that influence their performance. 
The connection between its PC properties and applications in tumour therapy were 
established, giving a short overview of the treatment and its pros and cons. The use of TiO2 
NPs as anti-tumour agents is still in its infancy, giving rise to a lot of controversial discussions 
debating their potential as nano-medicine against their possible toxicity. As a final point, a 
possible integration of luminescence properties into TiO2 nanosystems was discussed 
including the intrinsic luminescence, excitonic luminescence via doping or the particle 
functionalization with organic dyes. While several studies on luminescent TiO2 have been 
carried out, no general concept for an efficient luminescence incorporation into the crystals 
without compromises to their PC performance was found. Nevertheless, the particle 
modification with an organic dye seems to be the most feasible approach. 
 
This led to the next topic, namely the surface modification of NPs for biotechnological 
applications. First, the main reasons for such a modification were stated: stabilisation in 
physiological media, enhancement of cellular uptake and bioconjugation. Then surface 
modifications of TiO2 for various uses were cited and possible anchoring groups presented. 
Similar to other NPs, the surface modification of TiO2 is crucial for their adaption to high 
application requirements. This is why several approaches have been carried out using a vaste 
variety of anchoring groups and organic molecules. However, the influence of these surface 
agents on the PC performance of TiO2 was generally neglected. Finally, the NP 
functionalization with dendritic structures was introduced, including their basic concept, 
grafting methods, state of the art applications and luminescent dendritic structures. In contrast 
to other NPs such as iron oxide or gold, TiO2 NPs have not readily been functionalized with 
dendritic structures. Interestingly, the advantages of luminescent dendritic structures are 
already frequently studied in the case of dendrons but particle functionalization with them is 
still scarce.  
This bibliographic study confirmed prevailing motivations for this work, as many research 
issues have not been addressed yet and give opportunities for new outcomes as well as 
controversial discussions.  
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II.  Inorganic syntheses: Titanium dioxide nanoparticles  
Various photocatalytically active nanomaterials have already been studied in the last decades, 
including CdS, SnO2, ZnO, Nb2O3 or ZrO2. Nevertheless, nano-TiO2 remains one of the most 
well-known and widely-used photocatalysts due to its high efficiency, low cost, physical and 
chemical stability, widespread availability, and noncorrosive properties.1 Due to these 
properties combined with their non-toxicity, TiO2 nanoparticle (NP) systems are very promising 
candidates for medical applications such as photodynamic therapy for cancer, cell imaging, 
biological analysis, genetic engineering or drug delivery.2 To synthesize them, hydrothermal 
sol-gel synthesis is the preferred method due to its excellent reproducibility, high particle 
density and crystallinity, as well as a controlled morphology and narrow size distribution of the 
obtained NPs. Additionally, depending on the chosen reactants the obtained NPs carry 
characteristic organic surface moieties which for example ensure a perfect particle 
dispersibility.3–6  
II.1. Influence of the coordinating agent on TiO2 nanoparticles 
Two synthesis approaches characterized by different coordinating agents have been selected. 
The first TiO2 NPs were synthesized in the presence of acetyl acetone (AA) and para-toluene 
sulfonic acid (PTSA). This system has already been intensively studied for the use of 
photocatalytic (PC) coating materials in terms of their organic surface properties with TGA, 
crystal structure with x-ray diffraction (XRD) and PC activity mainly after coating onto surfaces 
and annealing.7–10 Therefore, in this particle case its suitability as a PC material has already 
been proven and the objective was mainly to determine its properties as a colloid. The second 
TiO2 NP system was chelated by 2-[2-(2-methoxyethoxy)ethoxy]acetic acid (MEEAA). It has 
been chosen as this acid has a polyethylene glycol like structure which may be favourable for 
cellular uptake and may only show a low cytotoxicity. This particle system has not yet been 
studied in detail.  
For studying the differences of these two particle types, here named AA-TiO2 and MEEAA-
TiO2, samples with a hydrothermal treatment time of 4 h at 160 °C were selected. First their 
sizes and morphologies, then their surface moieties and PC activities are discussed in the 
following. 
 
II.1.1. Size and morphology  
To determine differences in their size and morphology due to the chelating ligands of the 
synthesis, XRD, TEM, N2 sorption and DLS measurements were conducted. The XRD patterns 
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for both particles types are shown in Figure II - 1. They are typical for NPs as their signals are 
very broad in contrast to well-defined sharp signals caused by bulk materials.11  
 
Figure II - 1. Powder X-ray diffraction (XRD) patterns of AA-TiO2 and MEEAA-TiO2 assigned 
to anatase crystal phase. (*background signal due to measurement set-up). 
Their patterns were both assigned to the anatase phase; all signals were attributed to hkl 
indices of this crystal phase. It had already been expected to obtain the anatase phase as in 
general it can be easily formed at low temperatures as used in these syntheses, while the rutile 
phase is usually obtained at elevated temperatures of 400 – 1200 °C.10,12 Furthermore, the 
formation of the anatase phase in the case of AA-TiO2 has already been reported.8,10 The XRD 
patterns of both TiO2 NP types do not show any differences and even their crystallite sizes 
determined using the Scherrer equation (using the diffraction peak from the anatase (101) 
plane) were in both cases between 5 nm and 6 nm (5.5 nm for MEEAA-TiO2 and 5.6 nm for 
AA-TiO2 respectively). TEM images of both particles samples (Figure II - 2) also showed 
average particle sizes around 5 to 6 nm with slight variances (5.7 ± 1.0 nm for MEEAA-TiO2 
and 6.3 ± 1.5 nm for AA-TiO2 respectively). This indicates that the obtained NPs are 
monocrystals. Furthermore, the particles exhibit a prolate spheroidic morpholoy. Like the XRD 
spectra, the TEM images do not reveal significant differences between both particle types. 
Nevertheless, the size of the NPs of the AA-TiO2 sample seems to vary slightly more as larger 
particles (e.g. 10 nm) were also found on occasion. 
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Figure II - 2. Transmission electron microscopy (TEM) of AA-TiO2 a) and MEEAA-TiO2 b) and 
their size distribution, obtained from counting at least 100 particles per sample.  
To further examine the particle properties the specific surface area (according to Brunauer 
Emmet Teller (BET)13) was determined by N2 sorption measurements. The AA-TiO2 shows a 
specific surface area of 207.5 m²/g while the surface area of MEEAA-TiO2 is slightly higher 
with 231.2 m²/g. This difference may be due to the marginally smaller crystallite size. The 
obtained experimental surface areas can be compared to the theoretic specific surface 
area 𝑆𝑐𝑎௟𝑐 = ௦௠ of a TiO2 sample. For the calculation one expects ρ = 3.9 g/cm3 as the density 
of anatase14 and the particle shape is simplified to a perfect sphere with the volume 𝑣 = ଷସ  ߨݎଷ, 
surface ݏ = 4 ݎଶ ߨ (r = radius) and the mass 𝑚 =  ߩ ∗ 𝑣. From this, the obtained theoretic 
surface area 𝑆𝑐𝑎௟𝑐 = ௦௠ =  ସ ௥మగఘ∗𝑣 =  ସ ௥మగఘ∗రయ௥యగ =  ଷఘ∗௥ is 275 m²/g for MEEAA-TiO2 and 280 m²/g for 
MEEAA-TiO2 if the crystallite sizes obtained from the XRD measurements are utilized for the 
calculation. These values are higher than the experimentally determined specific surface 
areas. The discrepancies between measured and calculated values are not surprising, if taken 
into consideration that the specific surface area (determined via BET) and the theoretic 
calculation can differ up to ± 20 % due to errors such as a wide particle size distribution or 
particle morphology.15 Therefore, this measurement confirms the measured particle sizes by 
XRD and TEM. 
While the last 3 methods only analysed the particles as dried powder, dynamic light scattering 
(DLS) measurements allowed the examination of particle behaviour in dispersions. For this, 
the hydrodynamic diameter was determined using the so-called Z-Average size which is the 
primary and therefore most stable parameter produced by this technique. The hydrodynamic 
diameter displays the diameter of a hypothetical hard sphere showing the same translational 
diffusion coefficient as the examined particle with an assumed hydration layer.16 Depending 
on the agglomeration state of the sample, this value shows the size of an agglomerated group 
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of particles plus hydration layer instead of the size of a single particle. Therefore, this method 
indicates the dispersion state of the sample or the agglomerate size of the particles, rather 
than the real particle size. The following Table II - 1 represents the hydrodynamic diameters 
after synthesis and after an ultrasonic (US) treatment to optimize their dispersion. After 
synthesis, both particle systems were dispersed in water at pH 2 to 3. This pH is caused by 
remaining unbound organic acids from the synthesis (i.e. MEEAA or acetic acid which is 
discussed in detail in II.1.2). Right after synthesis, the hydrodynamic diameter is around 80 nm 
for both samples. This value can be significantly decreased by dispersion of the particles with 
US treatment (Branson Sonifier 450, 4 min, duty cycle 30%, strength 7). Therefore, one can 
assume that after synthesis, the sample is already well dispersed, but small agglomerates can 
be measured. After US treatment the agglomerates are separated and the particles may even 
be dispersed as single particles with a hydration layer as the hydrodynamic diameters are only 
about four times larger than the determined crystallite size of the particles. The polydispersity 
index (PDI) given shows the width of the measured particle size distribution. The scale ranges 
from 0 (monodisperse sample) to 1 (polydisperse sample).17 If the measured PDI is smaller 
than 0.15 (0.3), the sample is considered to be monodisperse (relatively monodisperse).18 
Thus, the measurement confirms the small particle size distribution of the samples that had 
already been observed via TEM studies. The (indeed very small) differences in agglomerate 
sizes between AA-TiO2 and MEEAA-TiO2 may be due to the diverse character of the surface 
ligands. 
Table II - 1. Agglomerate sizes of AA-TiO2 and MEEAA-TiO2 dispersions at pH = 2 – 3; 
determined via dynamic light scattering measurements directly after synthesis and after 
ultrasonic treatment. 
 
after synthesis after US treatment 
hydrodynamic diameter 
[nm] 
PDI [-] hydrodynamic 
diameter [nm] 
PDI [-] 
AA-TiO2 79.4 ± 1.5 0.2 22.5 ± 0.8 0.2 
MEEAA-TiO2 84.1 ± 1.2 0.2 25.5 ± 0.9 0.2 
 
II.1.2. Surface moieties  
While no significant differences in size and morphology were detected for AA-TiO2 and 
MEEAA-TiO2, IR studies revealed discrepancies in their surface functionalities due to the 
educts utilized for their synthesis. All potential organic surface moieties of both systems are 
shown in Figure II - 3. Beside hydroxyl groups which are typical for TiO2 NPs, AA-TiO2 is 
coordinated by sulfonate and acetyl acetonate groups which decompose into acetates due to 
heat treatment during their synthesis (Figure II - 3 a). MEEAA-TiO2 bears MEEAA derivatives 
on its surface (Figure II - 3 b). 
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Figure II - 3. Scheme of potential surface molecules of AA-TiO2 a) and MEEAA-TiO2 b). 
For the IR studies, the particle samples were washed with ethanol via centrifugation to remove 
water and unbound organic molecules from synthesis. Both DRIFT (diffuse reflectance infrared 
Fourier transform) spectra (Figure II - 4a) show signals caused by the carboxylate (both NP 
types) or acetylacetonate (AA-TiO2) groups coordinated onto the particle surface such as their 
asymmetric stretching vibration19 at 1529 cm-1 (AA-TiO2) and 1554 cm-1 (MEEAA-TiO2).  
 
Figure II - 4. IR (DRIFT) spectra a) of AA-TiO2 and MEEAA-TiO2 (with * marking a background 
signal) and scheme b) of the 3 different possible coordination modes of carboxylates onto TiO2. 
The carboxylate groups can be bound onto the particle surface via three different coordination 
types (Figure II - 4b): bridging, unidentate and bidentate coordination. While in the asymmetric 
stretching vibration the coordination modes cannot be distinguished, the symmetric vibrations 
show bands at different wavenumbers: The symmetric stretching of their bridging coordination 
can be found at 1442 cm-1 (AA-TiO2) and 1456 -1423 cm-1 (MEEAA-TiO2).19 Unidentate and 
I. Inorganic syntheses: Titanium dioxide nanoparticles 
- 50 - 
 
bidentate coordinations cause signals at 1348 cm-1 (AA-TiO2, only weak) and 1327 cm-1 
(MEEAA-TiO2) due to symmetric stretching vibrations.19 MEEAA-TiO2 additionally shows the 
symmetric C-O-C vibration at 1126 cm-1 20, while for AA-TiO2 the stretching vibration of C-CH3 
(1236 cm-1)21 is seen as a signal. The spectrum of AA-TiO2 also proved the presence of 
sulfonates due to vibration bands at 1159 cm-1 and 1124 cm-1 (symmetric stretching of SO2).20 
The signals at 1045 cm-1 and 1012 cm-1 may also be caused by sulfonate groups (asymmetric 
stretching vibrations).20 The stretching vibration of the Ti-O-Ti bond (400 – 900 cm-1)22 can be 
detected for both NP systems as expected. Furthermore, the stretching and bending vibrations 
of the hydroxyl groups of the particles produce signals at about 3200 cm-1 and 1620 cm-1, 
respectively.23 Those might cover eventual signals caused by other organic groups such as 
CH2 and CH3 (2900 cm-1)20 vibrations. 
The isoelectric points (IEPs) of AA-TiO2 and MEEAA-TiO2 in dispersion (as synthesized) were 
determined by zeta potential measurements as a function of pH. Figure II - 5 shows both 
determined curves which exhibit typical zeta potential progressions for TiO2 NPs. Their IEPs 
were found at a pH of around 6.3 (AA-TiO2) and 6.7 (AA-TiO2), respectively. These values 
coincide with the general literature values for titanium dioxide NPs (pH(IEP) = 3-7).24 
Furthermore, the isoelectric point also explains the fact that the NP dispersions after synthesis 
are very stable and mainly without agglomerates as at pH 2 to 3 the particles are highly 
electrostatically stabilised due to highly positive zeta potentials. It is generally accepted that 
zeta potentials over ± 30 mV indicate a stable particle dispersion.25–27 
 
Figure II - 5. Zeta potential titrations of AA-TiO2 and MEEAA-TiO2 water dispersions as a 
function of pH. 
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To complete the analysis of the surface groups of both particle systems, thermogravimetric 
(TGA) and differential thermal analyses (DTA) of the (first washed and then dried) particle 
samples were carried out. The results are shown in Figure II - 6. AA-TiO2 shows a mass loss 
of 13 % and MEEAA-TiO2 of 9 % when heated up to 800 °C (Figure II - 6 a). As at this 
temperature all organic material is supposed to be eliminated while TiO2 remains, one can 
conclude that an AA-TiO2 particle bears 13 mass-% of organic groups while a MEEAA-TiO2 
particle only 9 mass-%. DTA reveals a broad exothermic signal over the entire measured 
temperature range for both sample (Figure II - 6 b). MEEAA-TiO2 shows a maximum between 
300 and 400 °C, compared to between 400 and 500 °C for AA-TiO2.  
 
Figure II - 6. Simultaneous thermogravimetric (TGA, a) and differential thermal analysis (DTA, 
b) performed on dried AA-TiO2 and MEEAA-TiO2 particle samples.  
The TGA curve of AA-TiO2 can be divided into 3 sections: under 500 °C there is a fast and 
almost continuous mass loss, from 500 to 700 °C only a slight mass loss and over 700 °C a 
second phase of strong mass loss. Comparing these observations to the evolved gas analysis 
via mass spectroscopy (MS) during the experiment (Figure II - 7), it can be seen that in the 
first section mainly adsorbed water or hydroxyl groups on the particle surface (because of ionic 
mass fragments: OH+, OH2+) and only small amounts of organics (C3H5+, CO2/C2H4O+) are 
released around 100 °C. This is followed by a degradation of PTSA (SO2+, SO+, CH3, C2H6+) 
and acetate as well as acetylacetonate groups (C2H5O+, C2H5OH+, C2H4O2+, CO2/C2H4O+) 
around 200 °C. Finally there is only a release of CO2/C2H4O+ probably due to further 
degradation of acetate and acetylacetonate around 300 to 400 °C. The low degradation in the 
second part is confirmed by the MS data as from 500 to 700 °C, there is only a minimal amount 
of CO2/C2H4O+ detected which indicates that all organic components of the surface groups are 
eliminated. The mass loss in the last section is due to a further decomposition of the inorganic 
parts of PTSA (SO2+, SO+) over 700 °C. 
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Figure II - 7. Evolved gas analysis by mass spectrometry during TGA/DTA experiments on 
dried AA-TiO2 particle sample.  
In the case of MEEAA-TiO2 the TGA curve (Figure II - 6) can also be divided into characteristic 
decomposition zones and compared to the evolved gas analysis (Figure II - 8). Under 250 °C 
a first continuous mass loss can be observed, which slows down nearing temperatures close 
to 250 °C. During this phase, mainly liberated water or hydroxyl groups on the particle surface 
and only small amount of organics (C3H5+, CO2/C2H4O+) can be detected around 100 °C, 
followed by the main decomposition of the MEEAA (C2H5O+, C2H5OH+, C2H4O2+, CH3, some 
CO2/C2H4O+, and small amounts of C+). Between 250 and 450 °C, the mass loss increases 
again, while only small organic fragments are evolved (CO2/C2H4O+ and C+). Above 450 °C, 
there is almost no mass loss indicating that all organic components are already eliminated 
(only small amounts of evolved CO2/C2H4O+ can be still detected).  
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Figure II - 8. Evolved gas analysis by mass spectrometry during TGA/DTA experiments on 
dried MEEAA-TiO2 particle sample. 
 
II.1.3. Photocatalytic activity 
After having analysed the size, morphology, dispersion state, surface properties and organic 
surface groups of both particle systems, their PC activity was examined due to its importance 
for later applications. For the photocatalysis test, dichloroacetic acid (DCA, 1 g/l) was added 
into the NP (100 mg/l) water dispersion and compressed air was bubbled into the experimental 
set-up. When UV light was applied, DCA was photocatalytically degraded into CO2 and Cl- 
(HCl) as already discussed in Chapter I.1.2. and the produced chloride ions were measured 
in-situ. The in-situ measurement was chosen as other degradation tests require the removal 
of the NPs. This would especially be challenging for the particles examined here as they are 
very small and in a very good dispersion state, making removal by centrifugation difficult and 
time consuming. The results of the PC degradation tests with AA-TiO2 and MEEAA-TiO2 
compared to commercial P25 TiO2 NPs (from Degussa/Evonik) are shown in Figure II - 9. P25 
particles were chosen as reference samples as these particles are the best analysed 
commercial TiO2 particles, showing an superior PC activity and have therefore often been used 
as the benchmark system.28–31 These particles consist of 80 to 90 % anatase and 10 to 20 % 
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rutile and possess a primary particle size of 20 to 30 nm.29,32 They do not bear organic surface 
groups and are obtained as powder, which is in general not perfectly dispersible, showing 
aggregates around 100 nm and agglomerates in solution.31,32 
 
Figure II - 9. Photocatalytic activity of AA-TiO2 and MEEAA-TiO2 in comparison to a commercial 
standard TiO2 NP (P25); determined by measurement of produced Cl- during the degradation 
of dichloroacetic acid (DCA). The values are normed on the amount of degraded DCA 
(produced Cl-) by P25 after 3 h photocatalysis test (= 100 %). 
If P25 is compared to the synthesized particle samples, its superior PC activity becomes 
evident. Nevertheless, this is not very significant as the synthesized samples are only obtained 
in the pure anatase phase and bear organic surface groups, which may both be factors for a 
decrease in PC activity. Comparing both synthesized particle systems, MEEAA-TiO2 seems to 
be twice as active as AA-TiO2. This can be deduced from the higher amount of organic groups 
that was found during TGA measurements (II.1.2) on the AA-TiO2 particle surface. These 
prevent the possible absorption of DCA or water onto the particle surface as well as decreasing 
the amount of possible hydroxyl groups bound on the surface, which are crucial for the PC 
degradation reactions.28 Taking into consideration the later biological or medical applications 
of the particles, these results may not be representative as the DCA degradation took place 
under strongly acidic conditions (due to the acidity of this organic compound). In contrast to 
that, all biological tests have to be carried out at physiological pH (∼7.4) and it has already be 
indicated that the PC activity of a sample can also be influenced by the pH.31,33–36 This can be 
explained by the change of the surface charge on the particle if the pH is varied. It leads first 
to a different adsorption behaviour of the organic molecule onto the particle surface and 
second, to a completely changed dispersion state of the sample.31 If there are more 
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agglomerates in the dispersion, less free surface area is offered for photocatalysis resulting in 
a decreased activity. Furthermore, the PC efficiency of a material can also depend on the 
nature of the degradable compound which means that the success of the degradation of 
biological cell components can be significantly different from what was measured for  
DCA.31,36–38 This is first due to the absorption properties of the compound onto the particle 
surface and second, due to functional groups of the molecule that facilitate OH radical 
attacks.31 Still, this PC activity test is a promising, first indicator for the efficiency of the 
synthesized particle samples.  
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II.2. Influence of hydrothermal processing parameters on MEEAA-TiO2 particles 
For the examination of the hydrothermal processing parameters on the properties of the 
synthesized TiO2 particles, only MEEAA-TiO2 samples are discussed in this chapter as this 
system seemed to be the more promising one concerning its PC activity. Additionally, AA-TiO2 
samples showed the same trends (Appendix I) as MEEAA-TiO2 in the changes of its size, 
surface groups and PC activity manipulated by the hydrothermal processing parameters. As 
well as the standard sample MEEAA-TiO2 which was treated in the autoclave at 160 °C for 4 
h, it was decided to examine four additional samples: 2 treated with other temperatures (180 
and 200 °C) for 4 h and two treated with varied durations (1 and 16 h) at 160 °C. First the sizes 
and morphologies, then the surface moieties and PC activities are discussed in the following 
analysis (similar to II.1). 
 
II.2.1. Size and morphology* 
To determine differences in the size and morphology of MEEAA-TiO2 treated with different 
autoclaving parameters, XRD, TEM, N2 sorption and DLS measurements were conducted. The 
results of all analyses are summarized in Table II - 2 and will be discussed in detail in the 
following. 
Table II - 2. Particle (XRD, TEM) and agglomerate sizes (DLS) as well as experimental (BET) 
compared to theoretic specific surface area of MEEAA-TiO2 samples treated with varied 
autoclaving parameters. 
sample: 
treatment 
time / 
temperature 
crystallite 
size  
[nm]  
 
(XRD) 
NP size 
[nm]  
 
 
(TEM) 
hydrodynamic 
diameter [nm] / 
PDI [-] 
pH 2-3, US-treated  
(DLS) 
specific 
surface 
area [m²/g]  
 
(BET, N2 
sorption) 
theoretic 
specific 
surface 
area [m²/g]  
1 h / 160 °C 4.8 5.5 ± 1.2 17.8 ± 0.2 / 0.2 253.1 320.5 
4 h / 160 °C 
(standard 
sample) 
5.5 5.7 ± 1.0 23.8 ± 0.3 / 0.2 231.2 279.7 
16 h / 160 °C 6.9 6.5 ± 1.0 28.8 ± 0.6 / 0.1 200.8 223.0 
4 h / 180 °C 6.5 7.1 ± 1.1 29.0 ± 0.6 / 0.1 214.2 236.7 
4 h / 200 °C 7.7 8.1 ± 1.3 32.8 ± 0.8 / 0.1 185.2 199.8 
 
                                               
*
 Parts of this chapter have been submitted to Nanoscale for publication. The submitted title is 
“Discovering the determining parameters for the photocatalytic activity of TiO2 colloids based on an 
anomalous dependence on the specific surface area”. 
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XRD measurements (Figure II - 10) confirmed for all samples a pure anatase crystal phase 
without any detectable amorphous TiO2.  
 
Figure II - 10. Powder X-ray diffraction (XRD) patterns of MEEAA-TiO2 samples treated with 
varied autoclaving parameters. 
In Table II - 2, the crystallite sizes calculated from XRD, using the Scherrer equation, are 
compared to the particle sizes determined on TEM images (Figure II - 11). The TEM 
micrographs show the same size range for the NPs as obtained from XRD, while their average 
size is slightly larger. This is not significant, however, as the size determination of particles on 
TEM images yields a large standard deviation due to difficulties to measure the diameter of 
slightly oval shaped particles uniformly and correctly. Both methods indicate the expected39,40 
particle growth with increasing treatment time or temperature. The measured specific surface 
area of the samples Sexp, done via gas sorption, confirms the increase in size by declining 
surface area. It can be compared to the theoretic, calculated specific surface area Scalc of a 
TiO2 sample. Scalc for each sample is listed as well in Table II - 2. These values are close to 
the experimental ones, confirming the reliability and quality of all experimental measurements. 
The slight discrepancy between measured and calculated values is not surprising, keeping in 
mind the unavoidable errors such as a wider particle size distribution and the particle 
morphology deviation, which are made upon the simplification of assuming a perfect sphere to 
represent the NPs. To complete the analysis of the influence of processing parameters on the 
particle size and morphology, dynamic light scattering measurements were carried out (Table 
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II - 2). The measurements confirm in all cases monodisperse or almost monodisperse samples 
with probably no agglomerates as already stated for the standard sample in II.1.1. 
 
Figure II - 11. Transmission electron microscopy (TEM) of MEEAA-TiO2 samples treated with 
varied hydrothermal processing parameters and their particle size distributions, obtained from 
counting at least 100 particles per sample: a) 1 h, 160 °C; b) 4 h, 160 °C; c) 16 h, 160 °C; d) 4 
h, 180 °C; e) 4 h, 200 °C. 
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To study eventual changes in the particle morphology or in the exposed facets. TEM 
micrographs and XRD diffractions were studied more intensely. Low magnification TEM does 
not indicate major difference in morphology between the 5 particle samples. Nevertheless, with 
increasing treatment temperatures the particles appear to be slightly oval. This visual tendency 
can also be confirmed by the size evaluations as the measured sizes for the samples with 
higher processing temperatures (Figure II - 11 d) and e) are statistically scattered over a wider 
size range. As shown in literature, the morphology of anatase crystals also influences the 
appearance of their XRD diffraction patterns i.e. the relative intensities of certain diffraction 
signals.41–45 If one takes a closer look on the acquired XRD diffractions, it becomes evident 
that the relative intensities especially around 38 °2θ and 54 to 55 °2θ change depending on 
the autoclaving parameters. In Figure II - 12 a) and b), two enlarged studies of the reflex 
patterns are shown in which the relative signal intensities change with increasing autoclaving 
time or temperature of the samples.  
 
Figure II - 12. Powder X-ray diffraction (XRD) patterns of MEEAA-TiO2 samples treated with 
varied autoclaving parameters – enlarged studies of the signals of a) the reflexes 103, 004 and 
112 and of b) the reflexes 105 and 211. 
The relative intensity of (004) increases compared to (103) and (112) and the relative intensity 
of (211) decreases compared to (105). If these tendencies are compared to literature, it 
becomes evident, that the equilibrium shape of anatase with eight {011} facets and two {001} 
facets shows a pattern similar to the sample 1 h, 160 °C. The intensity increase of (004) 
diffraction peak and therefore the narrowing of its full width at half-maximum has been 
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observed for the crystal growth along [001] direction.41,44,46 This sharpening of the signal at 
37.9 °2θ was both shown for crystals exposing 4 additional facets, namely {010},42,47–49 and for 
rod-like morphologies without this type of facets.50 A higher intensity of (105) compared to 
(211) is obtained for rod-like crystals while disc-like morphologies with a high percentage of 
{001} facets would lead to a lower intensity of (105).44,50 Therefore, the XRD analysis suggests 
an elongation of the crystals with increasing hydrothermal treatment time or temperature i.e. 
with decreasing specific surface area.  
In order to gain further insights, high resolution TEM studies were carried out on the two 
samples 1 h, 160 °C and 4 h, 200 °C showing the largest differences in their specific surface 
area. All below discussed images are shown along [100] zone-axis as determined from FFT 
(see Figure II - 13). 
 
Figure II - 13. Equilibrium shape anatase nanocrystal; a) Structural and corresponding FFT 
model along [100] view direction as well as 3D sketch with named exposed facets. b) High 
resolution TEM image and corresponding FFT along [100] view direction.  
In the sample 1 h, 160 °C only truncated bipyramidal crystals with {011} and {001} facets were 
identified (Figure II - 14 a1, a2) which confirm the findings of XRD analysis. In addition, several 
unexpected crystal morphologies were found, formed by the attachment of at least two primary 
crystals at the {011} facets (Figure II - 14 a3). This phenomenon has already been reported for 
hydrothermally coarsened anatase particles in acidic water.51 Nevertheless, these 
morphologies are not considered to have a high impact on the properties of the examined 
sample due to their rare appearance. The sample 4 h, 200 °C contains, in addition to truncated 
bipyramidal crystals (Figure II - 13), several other morphologies (Figure II - 14 b). The 
nanoparticle in Figure II - 14 b1 shows the standard set of {011} and {001} facets, however, 
elongation is along [011] direction. The crystal in Figure II - 14 b2 shows a similar rod-like 
morphology, however, this time it is joined with another nanocrystal near the end of {011} facet. 
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Finally, Figure II - 14 b3 shows a nanoparticle where the surface has a curvature rather than 
facets.  
 
Figure II - 14. High resolution transmission electron microscopy images of TiO2 nanoparticle 
samples synthesized at a) 1h, 160 °C and b) 4 h, 200 °C.  
In order to discuss the formation of rod-like particles during increased hydrothermal treatment 
times and/or temperatures, one has to consider that the formation of nanocrystals from solution 
consists of nucleation and subsequent crystal growth. Crystal growth in solution (driven by the 
reduction of surface energy) can either proceed via the growth of a large particle at the expense 
of smaller ones by addition of single Ti ions (Ostwald ripening) or by oriented attachment of 2 
or more nanocrystals. This involves the spontaneous self-organization of neighboring particles 
in order to share a common crystallographic orientation and subsequent attachment of the 
particles at their planar interface leading to the development of single homogeneous 
crystals.51,52 The presence of additives can for example impede one of these mechanisms 
(most commonly the oriented attachment) or guide the growth along a certain crystal  
plane.51–53 The solvent-solute interactions along different orientations of a crystal vary 
significantly because of the surface atomic arrangements. This results in different surface 
affinities of the additive towards each facet and in the stabilisation of a specific crystal surface 
plane as it e. g. lowers the surface energy or changes the surface tension of the bound  
plane.54–56 Some experimental procedures have already reported that carboxylic acids as 
additives lead to elongated or rod-like crystals.50,57,58 However, in contrast to the obtained 
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nanorods elongated along [011] direction, the crystals were shown to grow preferentially along 
[001]. Nanorods grown along [001] direction are most probably formed due to either the 
preferential stabilisation of {010} facets by an additive or the oriented attachment of {001} 
facets of several single crystals.46,51,59 Deduced from these findings, the obtained nanorods 
grown along [011] direction could be formed due to absorption of MEEAA onto {001} facets 
leading to a commonly not favored51 attachment of {011} facets (Figure II - 14 a3, b2). Also the 
acidic pH and the presences of an excess of water is said to favor the crystal growth via 
oriented attachment compared to Oswald ripening (even though the cause has not been 
clarified yet).51 
 
II.2.2. Surface moieties† 
To continue the study of the influence of the processing parameters on the NP properties, the 
following section deals with the behaviour of the surface moieties of the MEEAA-TiO2 NP 
systems. For this, zeta potential titrations, TGA studies and IR measurements have been 
carried out. The IEPs obtained by zeta potential titrations are shown in Table II - 3. All IEP 
values are between pH 6.4 and 6.7. It is expected that the measuring error for the 
determination of the IEP is around ± 0.2 and therefore it can be stated that all samples provide 
the same surface potential. This could be a first indicator that the amount of organic MEEAA 
groups on the particle surface do not change when the autoclaving parameters are varied. In 
order to examine this assumption more closely, IR measurements were carried out. 
Table II - 3. pHs at IEP of MEEAA-TiO2 samples with varied processing parameters determined 
by zeta potential titrations. 
treatment 
time / 
temperature 
1 h / 160 °C 4 h / 160 °C 
(standard 
sample) 
1 h / 160 °C 4 h / 180 °C 4 h / 200 °C 
pH at IEP [-] 6.5 6.7 6.6 6.4 6.6 
 
In Figure II - 15, the obtained DRIFT transmission spectra are shown. It is evident, that the 
structure or composition of the surface groups is not influenced by the autoclaving parameters. 
All spectra show the IR bands typical for this NP type which has been discussed in II.1.2. If 
there is a small change in the amount of organic surface groups on the particle, it cannot be 
determined by this method. To determine the amount of organic surface groups in the different 
samples, TGA and DTA measurements were carried out.  
                                               
†
 Parts of this chapter have been submitted to Nanoscale for publication. The submitted title is 
“Discovering the determining parameters for the photocatalytic activity of TiO2 colloids based on an 
anomalous dependence on the specific surface area”. 
I. Inorganic syntheses: Titanium dioxide nanoparticles 
- 63 - 
 
 
Figure II - 15. IR (DRIFT) spectra of MEEAA-TiO2 samples synthesized with varied 
hydrothermal treatment parameters. (* marks a background signal). 
In Figure II - 16, both diagrams are displayed. The mass loss takes for all of the samples a 
similar course due to a characteristic decomposition process of the MEEAA-TiO2 samples 
which has been described in II.1.2. 
 
Figure II - 16. a) Simultaneous thermogravimetric (TGA) and b) differential thermal analysis 
(DTA) performed on dried MEEAA-TiO2 particle samples synthesized with varied hydrothermal 
processing parameters. 
The amount of organic groups that is removed when heating up to 900 °C, was determined to 
be between 9 % and 13 %. To examine the amount of surface groups on the particles, the 
obtained mass of total evolved organic moieties was divided by the experimentally determined 
specific surface area of each sample (Figure II - 17). The thereby obtained mass of organics, 
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which can be related to surface groups per square meter, is plotted in dependence of the 
specific surface area. The results indicate that the amount of organic surface moieties per 
square meter is the same for all samples. A slight variance such as for sample 4 h, 160 °C 
may be caused by experimental errors in mass or temperature determination or small sample 
heterogeneities.60,61 
 
Figure II - 17. Mass of organic surface groups per square meter calculated based on TG 
analysis and plotted versus the specific surface area of the samples. 
The exothermic DTA curve does not show any differences for the MEEAA-TiO2 samples 
treated for different time spans; the signal maximum can always be found around 350 °C. In 
contrast, if the autoclaving temperature is increased, the signal maximum shifts slightly to 
higher temperatures from ~ 350 °C to ~ 400 °C for an autoclaving temperature of 180 °C and 
~ 450 °C for an autoclaving temperature of 200 °C. This may indicate that because of the 
higher autoclave treatment the organic acid (which is complexed onto the particles) is slightly 
more heat resistant. This impression can be confirmed by the evolved gas analysis using mass 
spectrometry during TGA and DTA experiments (Figure II - 18). While most of the evolved 
mass curves do not show any changes for all samples, in the case of CO2+/C2H4O+, C2H5O+ 
and C+ the ion current stays higher up to a temperature of around 750 °C for the samples 
treated with a higher autoclaving temperature.  
To conclude, one can state that the MEEAA coordinated onto the particle surfaces is not 
significantly modified. In the case of zeta potential titrations and IR measurements, no 
differences between the samples were measured. Only the evolved mass analysis during TGA 
studies indicated a small change in the properties of the organic surface groups when the 
hydrothermal treatment temperature is increased. 
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Figure II - 18. Evolved gas analysis by mass spectrometry during TGA/DTA experiments on 
dried MEEAA-TiO2 particle samples synthesized with varied hydrothermal processing 
parameters. 
 
II.2.3. Photocatalytic activity‡ 
To complete the study of MEEAA-TiO2 samples treated with varying processing parameters, 
the PC activity of the particles was examined. For this, the PC DCA degradation was carried 
out for all samples and compared to commercial P25 TiO2 NPs. The results are shown in Figure 
II - 19. As one can see in Figure II - 19 a) the same PC activity as of the bench mark material 
P25 can be achieved or even surpassed by the particle sample treated for 4 h at 200 °C. 
Furthermore, the photocatalysis curve of P25 is rather linear while of the synthesized particles 
it seems to be less efficient initially but increases with longer UV-light application time. To 
explain this, one has to keep in mind that P25 is synthesized via a high temperature pyrogenic 
process62 and therefore does not bear organic surface groups. That is why it decomposes 
                                               
‡
 Parts of this chapter have been submitted to Nanoscale for publication. The submitted title is 
“Discovering the determining parameters for the photocatalytic activity of TiO2 colloids based on an 
anomalous dependence on the specific surface area”. All XAFS measurements, analyses, modelling 
and discussion were carried out by the researchers of the “Bundesanstalt für Materialprüfung BAM”, 
mainly Wojciech Szczerba. It is used here with Wojciech Szczerba’s permission. 
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directly the test substance DCA right from the beginning. In contrast the MEEAA-TiO2 particles, 
are possibly first degrading their own surface groups before starting to decompose the DCA. 
This explains why at first a smaller amount of generated chloride ions is measured. Moreover, 
this diagram indicates that the particle samples show in general a higher PC activity with 
increasing hydrothermal treatment time or temperature. This phenomenon is rather surprising 
as with increasing treatment temperature or duration, the particles grow resulting in a smaller 
surface area. According to the literature,31,34 the PC activity of NPs decreases with smaller 
specific surface area as the photocatalysis is a surface-dependent process. In this study the 
effect is vice versa as displayed in Figure II - 19 b).  
 
Figure II - 19. Photocatalytic activity of MEEAA-TiO2 samples synthesized with varied 
processing parameters in comparison to a commercial standard TiO2 NP (P25); determined by 
measurement of produced Cl- during the degradation of dichloroacetic acid (DCA). a) 
Photocatalytic activity shown over the time of 3 h and b) total photocatalytic performance after 
3 h compared to the BET specific surface area determined by N2 sorption measurements. The 
values are normed on the amount of degraded DCA (produced Cl-) by P25 after 3 h 
photocatalysis test (= 100 %). 
The first guess for a reason explaining this surprising observation could be that the amount of 
organic groups on the particle surface could have manipulated the PC performance of the 
samples. As the photocatalysis is a surface process, the coverage by organic molecules 
decreases the performance. If the smaller particles which are synthesized with lower treatment 
times and/or temperatures, exhibited significantly more surface moieties than the larger 
particles, the lower PC activity could be explained. As already shown in II.2.2, the presence of 
organic surface groups on the anatase particles was confirmed and these may certainly hinder 
their photocatalysis. However, very important to note is that no significant differences between 
the samples were found that could explain their anomalous PC performance dependence on 
the NP size.  
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Besides organic molecules covering the crystal surface, the presence of oxygen defects in the 
crystal lattice can influence the PC performance as already mentioned in Chapter I.1.2.63–65 To 
examine the possible presence of oxygen defects, the composition and the valence state of 
the synthesized samples were investigated by X-ray photoelectron spectroscopy (XPS). The 
XPS analyses (Figure II - 20 a) reveal that, as expected, Ti, O and C (as well as N from the 
atmosphere and In from the substrate) were detected within all samples. The Ti 2p3/2 and Ti 
2p1/2 XPS peaks at 459.5 eV and 465.5 eV (Figure II - 20 b) are characteristic for Ti4+-O bonds 
in TiO2.63–66 If a considerable amount of oxygen vacancies was present within the TiO2 crystal, 
a peak at the high energy side of the Ti 2p3/2 XPS peak around 457.0 eV typical for Ti3+ species 
would be expected.65,66 This peak was not found in any of the samples indicating the absence 
of bulk defects (with bulk meaning the particle interior, not surface atoms).63 
 
 
Figure II - 20. a) Spectra obtained by XPS survey of synthesized TiO2 samples and enlarged 
studies of the b) Ti 2p, c) O 1s and d) C region. 
In the O 1s region (Figure II - 20 c), the XPS peak at 530.8 eV is assigned to crystal lattice 
oxygen (O-Ti4+).63 The shoulder around 533 eV is caused by hydroxide species which belong 
to surface-bound water or MEEAA. In the C region (Figure II - 20 d), the main XPS peak (~286 
eV) is caused by contamination from air, while the second peak at the higher binding energy 
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(~290 eV) may be attributed to carboxyl species from the surface groups of the NPs. To 
conclude these analyses, the XPS results do not indicate the presence of oxygen defects. 
However, XPS analysis concerning oxygen vacancies of the investigated anatase powder 
samples was very difficult as they were synthesized ex-situ and therefore the measurement 
was negatively influenced by the air contamination and by the In substrate used. 
Hence, x-ray absorption fine structure (XAFS) spectroscopy has been carried out as XAFS 
spectra are very sensitive to differences in the local environment of a given element. The 
extended x-ray absorption fine structure (EXAFS) featured by oscillations stretching up to 1 
keV beyond the absorption edge bear information on the local symmetry of the absorbing 
element. The Fourier transform delivers a radial distribution function of the surrounding atoms. 
Such an EXAFS pattern consists usually of a sequence of peaks that are interpreted as 
coordination shells surrounding the absorber atom. The amplitude of these peaks is 
proportional to the effective coordination number, which can be affected by the surface-to-
volume ratio in the case of nanocrystallites, as well as by the presence of a significant number 
of vacancies in the given coordination shell. The obtained spectra show, as expected, different 
peak amplitudes for the different samples, while the peak positions remain the same indicating 
that the lattice parameters stay unchanged (Figure II - 21). 
 
Figure II - 21. The module of the Fourier transformed EXAFS spectra of MEEAA-TiO2 samples; 
the differences in the intensities of peak I and II are subject of the analysis.  
Peak I is contributed by single scattering events of the nearest six oxygen neighbors. Its 
amplitude of the coordination shell peak is influenced by present oxygen deficiencies. 
However, the amplitude of the coordination shell peak might be influenced by the presence of 
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vacancies as well as by the small sizes of the particles. Unfortunately, the samples have 
different particle sizes and the intensities of peak I do not show any clear relation neither with 
respect to the PC activity nor to the crystallite size.  
According to the theoretical model calculations peak II is contributed mainly by scattering off 
the Ti atoms in the second coordination shell. Since the Ti sublattice is assumed not to have a 
significant number of vacancies the intensity of the second shell peak should be proportional 
to the crystallite size. Indeed the intensities of peak II exhibit a linear dependence on the 
crystallite size obtained from XRD (Figure II - 22).  
 
Figure II - 22. The amplitude of the second coordination shell (peak II of the EXAFS pattern) 
exhibits a linear dependence on the mean crystallite size retrieved from XRD. (The functional 
relation is f(x) = 0.25 x + 2.15, R = 0.985). 
The same proportionality of the EXAFS amplitude intensity to the crystallite size found for peak 
II should also hold for peak I, if there were no oxygen vacancies. Hence, the peak intensities 
of the first coordination shell peak can be corrected for the size effect by the relation found 
from the analysis of Figure II - 22. The directly obtained values of the amplitudes are depicted 
in Figure II - 23 a) together with the values corrected for the size effect relation. The correction 
is done in relative terms with respect to the sample with the smallest crystallite size, i.e. 1 h, 
160 °C. The difference between the directly measured amplitude values and the corrected 
ones should be a measure of the surplus of oxygen deficiencies with respect to the sample 
with the smallest crystallite size. Figure II - 23 b) clearly shows that there is a linear trend in 
the relation of the amplitude difference and crystallite size. Thus, with increasing hydrothermal 
treatment time or temperature, the number of oxygen vacancies increases and presumably 
improves the PC performance: Oxygen deficiencies on the crystal surface can improve the 
adsorption of O2 molecules due to interactions with the Ti3+ sites (caused by the removal of 
oxygen atoms).63,65 As for PC reactions, the pre-adsorption of molecules on the catalyst 
surface is a determining step, the enhancement of pre-adsorption of oxygen molecules, results 
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in a higher PC performance.54,68–70 Additionally, Ti3+ sites can act as hole scavengers and 
therefore delay the charge carrier recombination which also improves the PC activity.63–65 
 
 
Figure II - 23. a) Amplitudes of the first coordination shell as “measured” (after FEFF967 fit) and 
corrected for the size effect. b) The difference between the measured EXAFS amplitude of the 
first coordination shell and the size-effect corrected one is a direct measure of the anion 
deficiency in the oxygen lattice.  
Additionally, high resolution TEM studies and XRD analyses (II.2.1) showed an elongation of 
the synthesized crystals (along [011] direction) forming rod-like morphologies with increasing 
autoclaving temperature (or time). Especially in the case of spherical nanocrystals around  
10 nm, an increased electron-hole recombination at surface trapping sites is expected which 
reduces their PC performance.50 However, the crystal anisotropy of nanorods is assumed to 
lead to a lower charge recombination due to the spontaneous charge carrier separation 
towards the different crystal facets and to an increased delocalization of the carrier as they can 
freely move throughout the whole crystal lenghts.49,50,68 This could partly compensate the 
presence of surface trap states resulting in a higher PC activity of the rod-like crystal samples.  
In conclusion, the synergy of both the increase in oxygen deficiencies and the elongation of 
the nanocrystals must be responsible for a higher PC activity and overrules the expected 
dependence on the specific surface area.  
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II.3. Luminescent TiO2 based core/shell structured nanoparticles 
After the successful synthesis and characterization of PC anatase NPs, the incorporation of 
luminescence properties into these systems was a main goal of this work. This is due to the 
fact that luminescence on the one hand is very helpful to analyse the particle behaviour within 
cell culture studies: The particle uptake can easily be quantified by luminescence 
measurements and their position within cells can be detected e. g. via confocal fluorescence 
microscopy. On the other hand, luminescence enables the use of PC particles not only as 
therapeutic agents but also possibly as diagnostics: If a targeting surface molecule of the 
particles specifically binds to tumour cells, these could be visualized due to the luminescence 
of the particles. This could facilitate the detection of the tumour location and the surgical 
elimination of tumour tissue. Different strategies to synthesize luminescent TiO2 based NP 
systems have been presented in Chapter I.1.4. A common and rather straight forward strategy, 
is the doping of metal oxide particles with rare earth ions. This usually results in bright 
luminescence in a colour depending of the nature of the rare earth ion. Nevertheless, this 
strategy is most often only efficient when the material is heated in the presence of oxygen 
(calcination).71,72 This heat treatment is an eminent disadvantage as it usually leads to 
aggregation of the particles and disintegration of functional surface groups. Furthermore the 
doping can also negatively influence the PC activity of the particles as it manipulates the band 
gap and can therefore enhance recombination of electrons and holes.64,73 Another drawback 
is that first several rare earth ions are classified as carcinogens and second also their supply 
is limited.74–77 Therefore, the current trend is to find substitutes for these elements. Due to 
these reasons, two different approaches were carried out for the synthesis of luminescent TiO2 
based particle systems avoiding the doping of TiO2 with rare earth elements.  
 
II.3.1. Luminescent TiO2/SiO2 core/shell nanoparticles 
The synthesis of luminescent NP systems by doping a silica matrix with organic dyes is well-
known and may be transferrable to other NP materials as well.78,79 As the TiO2 NPs were 
synthesized by heat treatment in an autoclave which would destroy organic dyes, an 
incorporation of a dye during synthesis was no option. This is why the addition of a silica shell, 
containing the organic luminescent agent, after the anatase crystal synthesis was chosen as 
a strategy to obtain a fluorescent particle system. The formation of a well-defined silica shell 
around TiO2 NPs has already been carried out various times in literature 22,23,80–84, but particles 
with organic surface groups have not been utilized for this before. This is why the synthesis of 
a silica shell (without any dye incorporation) was proved first. For this TiO2 NPs (AA-TiO2 – 
160 °C 4 h which was chosen for the proof of concept in all reactions in this chapter) were 
coated with a silica shell via a typical Stoeber synthesis: tetraorthosilicate was hydrolysed in a 
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water/ethanol mixture in the presence of ammonium hydroxide as base. The hydrolysed silica 
precursor condensates onto the present TiO2 particles, acting as seeds, resulting in Ti-O-Si 
bonding between the particle surface and TEOS. Scheme II - 1 showing the simplified reactions 
that take place during the shell formation, can be found below. Further hydrolysis and 
condensation reactions result in three-dimensional siloxane networks and finally a 
homogeneous silica shell.23,82,83,85 These reactions leading to a particle growth rather occur by 
addition of monomers to the surface than by aggregation of the small nuclei particles (which 
would be pure silica particles as side products).86 The final particle size and composition can 
be manipulated by the initial alkoxysilane, water and ammonia concentration.86,87 The present 
base favours condensation over hydrolysis reactions resulting in spherically expanding 
particles rather than in linear chain structures that could form a gel.88 
 
Scheme II - 1. Simplified (and idealized) mechanism of the formation of Si-O-Ti bonds leading 
to a shell formation around the TiO2 nanoparticle.  
To prove the successful shell formation, the synthesized particle system was analysed via 
TEM, zeta potential and DLS measurements. Zeta potential measurements showed that the 
IEP of the coated particle system was at pH = 4.6. If compared to the uncoated TiO2 with an 
IEP at the pH of 6.58 and the IEP of pure silica NPs at pH = 2.8-3.5,89,90 the IEP of the 
measured sample lay in between these materials. This also indicates the successful silica shell 
formation80,81 as the properties of the silica shell superimposes the surface properties of the 
TiO2. Furthermore, the IEP lying in between the characteristic values of the uncoated TiO2 and 
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silica NPs, can also indicate an incomplete shell formation or a shell of high porosity which 
would in both cases be advantageous for the accessibility of the TiO2 core allowing 
photocatalytic reactions.91 TEM images (Figure II - 24) showed that the coated particles were 
still sphere-like and only slightly larger than the TiO2. It is possible to distinguish the silica shell 
from the titanium dioxide core due to different material densities. According to the TEM images 
the particle samples seem to be agglomerated which is only due to the preparation method for 
TEM. DLS measurements on the contrary, show agglomerate sizes of 256.4 ± 5.5 nm with a 
PDI of 0.27 ± 0.01 for the TiO2/SiO2 system in acidic water which indicates a good dispersion 
state.  
 
Figure II - 24. TEM images of a) TiO2 (AA-TiO2) and b) silica-coated TiO2 nanoparticles. 
After having proved the silica shell formation around the TiO2 particles, the synthesis of silica 
shells doped with an organic dye and varying shell thicknesses was carried out. First the 
commercially available Rhodamine B isothiocyanate (RhBitc) was coupled to 
aminopropyltriethoxy silane (AMEO) to enable a covalent incorporation of the dye into the silica 
shell. This was to make sure that the dye cannot leak out of the particle systems after synthesis. 
The reaction is shown in Scheme II - 2.  
 
Scheme II - 2. Reaction of Rhodamine B isothiocyanate (RhBitc) with aminopropyltriethoxy 
silane (AMEO). 
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The silica shell synthesis was carried out as described above but now the silanized dye was 
mixed with the TEOS before addition. The amount of TEOS was varied (Table II - 4, theoretical 
molar ratio) to obtain 3 samples (TiO2/SiO2_1 to TiO2/SiO2_3) with different silica shell 
thicknesses and the amount of dye was always 0.5 weight-% of the added amount of TEOS. 
This amount of dye was chosen according to literature92,93 as the occurrence of self-quenching 
of the dye with too high concentrations of dye in a silica matrix is a well-known problem. To 
evaluate the synthesized luminescent particle systems DRIFT, X-ray fluorescence 
spectroscopy (XRF), zeta potential, photoluminescence (PL) and PC measurements were 
carried out. 
Table II - 4. Theoretical and experimental molar ratios (obtained by XRF) of Ti and Si in 
TiO2/SiO2 core/shell nanoparticles with increasing shell thicknesses (_1 to _3) doped with 
Rhodamine dye. Additionally, the reaction yield calculated from the experimental molar ratios 
is displayed. 
sample Theoretical molar 
ratio Ti : Si 
Experimental molar 
ratio Ti : Si (XRF) 
Yield (%) 
TiO2/SiO2_1 1 : 0.07 1 : 0.04 60.0 
TiO2/SiO2_2 1 : 0.14 1 : 0.11 76.4 
TiO2/SiO2_3 1 : 0.29 1 : 0.19 64.8 
 
The DRIFT spectra of the synthesized particles and the uncoated TiO2 particle (AA-TiO2 – 
DRIFT discussed in II.1.2) as reference are shown in Figure II - 25. They affirmed the formation 
of a silica shell around the titanium dioxide core: a strong signal at 1066 cm-1 and the shoulder 
at about 1180 cm-1 were attributed to asymmetric Si-O-Si bending and stretching vibrations. 23 
Vibration of covalent Si-O-Ti bonds between the titanium dioxide core and the silica shell 
caused a weak signal between 910 cm-1 and 960 cm-1.85 The weakness of it can be explained 
by the overlap of the Ti-O-Ti vibration band and the possible existence of only a few Ti-O-Si 
bonds due to the other organic surface moieties obstructing this binding. Signals at  
2927 cm-1, 2856 cm-1 and 1400 cm-1 corresponded to C-H vibrations of TEOS intermediate 
reaction products ((OCH2CH3)xSi(OH)4-x).23 The band at 1628 cm-1 was assigned to O-H 
bending vibration of Si-O-H groups on the surface of the shell.23 Depending on the increase of 
silica shell thickness the IR bands are more pronounced and the organic surface groups of the 
uncoated particle do almost completely disappear due to their coverage by silica. XRF analysis 
of the samples showing the experimental molar ratio of Ti to Si, suggested yields of the shell 
syntheses between 60 % and 76 % (Table II - 4). The IEPs at the pH of 6.3, 5.4 and 4.9 of 
TiO2/SiO2_1 to TiO2/SiO2_3 were received by zeta potential measurements. With higher silica 
content and therefore growing shell thickness the pH values shift closer to the IEP of silica 
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(2.8-3.5). This can be explained by the increasing overlay of the surface potential of TiO2 by 
the shell. 
 
Figure II - 25. IR (DRIFT) spectra of TiO2/SiO2 core/shell particles with increasing shell 
thicknesses (_1 to _3) compared to the uncoated TiO2 sample (AA-TiO2). 
The measurements of the fluorescence intensity of TiO2/SiO2_1 to TiO2/SiO2_3 at an excitation 
wavelength of 555 nm are shown Figure II - 26. As expected the fluorescence intensity rose 
with increasing shell thickness because the RhBitc content is proportional to the Si content if 
one assumes a homogeneous placement of RhBitc-AMEO into the shell without preferences. 
 
Figure II - 26. Fluorescence spectra of TiO2/SiO2 core/shell particles with increasing shell 
thicknesses (_1 to _3) compared to the uncoated TiO2 sample (AA-TiO2) excited at 555 nm. 
For investigating the influence of the silica shell thickness on the PC activity of the TiO2 core, 
the decomposition of DCA was utilized (as already described in II.1.3). The PC activity tests 
(Figure II - 27) reveal that an increasing shell thickness depresses the PC activity.  
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Figure II - 27. Photocatalytic activity of TiO2/SiO2 core/shell particles with increasing shell 
thicknesses (_1 to _3) compared to the uncoated TiO2 sample (AA-TiO2); determined by 
measurement of produced Cl- during the degradation of dichloroacetic acid (DCA). The values 
are normed on the amount of degraded DCA (produced Cl-) by TiO2 after 3 h photocatalysis 
test (= 100 %). 
This is logically as the shell impedes the interaction of the TiO2 surface with surrounding water 
or oxygen. Taking into consideration the PL and PC examinations, it becomes evident that a 
good PL activity is always on the cost of the PC activity of the NPs. This is due to fact that the 
amount of dye cannot be increased due to occurring self-quenching and therefore, the higher 
the wished PC activity, the higher the silica shell has to be and the lower is the PC efficiency. 
To sum up, this developed particle system can fulfil the requirement of the application as 
luminescent PC particle system but does not ideally combine both of these properties. 
 
II.3.2. ZnO/TiO2 core/shell nanoparticles§ 
Another approach to introduce luminescence into a particle system is to synthesize a 
luminescent core of another appropriate material while the shell still remains to be anatase 
with the desired properties. In the past, particle setups with a luminescent core were mainly 
used for quantum dots such as CdS, CdSe and CdTe which are highly luminescent, but most 
often toxic.94,95 This is why they were coated with a silica shell, preventing the toxic substance 
from leaking and offering a non-toxic surface for functionalization. In our case, it was important 
to achieve a TiO2 surface that is highly PC active, while the core provides the PL. As quantum 
                                               
§
 A part of this chapter has been published and is reused in this work by courtesy of The Royal Society 
of Chemistry, Original article: S. Koch et al., J. Mater. Chem. C, 2015, 3, 12430-2435. 
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dots (synthesized in nonpolar organic solvents) are most often not easily transferrable into 
aqueous solutions and toxic,96 in this work the synthesis of ZnO NPs was chosen. These 
undoped ZnO quantum dots can exhibit PL in the visible wavelength range.97–100 The visible 
emission is supposed to be caused by electron transitions from the conduction band to a deep-
level hole defect.101,102 These deep-level defects were identified as doubly charged oxygen 
vacancies originating from the charging of an oxygen vacancy with a photogenerated hole. To 
ensure the formation of these defects, adsorbed surface groups such as bridging acetates or 
hydroxyls, scavenging the photoexcited electrons, have to be present.100,102 For small particles, 
due to quantum confinement, the width of the bandgap and therefore also the difference 
between the conduction band and defect states increases.103 Consequently, the emitted 
(visible) colours that depend on that width are directly related to the NP size.101,102 Due to their 
adjustable colour emission and non-toxicity, these undoped ZnO quantum dots seemed to be 
good candidates as luminescent cores. For the synthesis the most common sol–gel 
synthesis99,104–108 was chosen using zinc acetate precursors and KOH or LiOH as base in 
ethanol as solvent. In this study it was possible to determine the accessibility of air during 
synthesis as yield and synthesis speed driving factor. To visualize this, the particle synthesis 
was carried out under 3 different conditions: in a closed flask versus an opened flask which 
allowed air circulation, and a nitrogen flooded flask. Particle growth was only observed in the 
case of air circulation, which can be seen in Figure II - 28. It shows the PL (Figure II - 28 a) 
and absorbance (Figure II - 28 b) spectra of the three differently treated samples.  
 
Figure II - 28. a) Luminescence and b) absorbance spectra of ZnO nanoparticles after 4 h of 
reaction time, synthesized in flasks closed with a lid (dotted line), without a lid allowing air 
circulation (solid line) or under a nitrogen atmosphere (dashed line). As precursors, low 
concentrated Zn(CH3CO2)2 and LiOH in ethanol were chosen. 
Only the sample reacted under air circulation shows a significant PL and absorbance for the 
wavelength ranges that are expected from what has been described in the literature for ZnO 
NPs.101,104 While a slight PL of the other samples (closed flask, respectively nitrogen flooded) 
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indicates a minor particle formation. The slightly higher PL intensity of the nitrogen flooded in 
comparison to the closed reaction batch can be explained by the enhanced formation of 
oxygen vacancies in a nitrogen atmosphere.98 Negative absorbance values in the case of the 
nitrogen atmosphere are due to the measurement method in well plates. Small variations of 
the measured sample volumes result in less absorbance and due to the subtraction of ethanol 
as reference negative values can be obtained. Therefore it can be concluded that accessibility 
of air is the driving force for an enhanced particle formation. Most possibly the oxygen in the 
air is the responsible component109 and enables upscaling due to inlet of air bubbles into the 
reaction batch. 
The successful particle synthesis was not only proved by PL measurements but also via XRD 
and TEM which is shown in Figure II - 29 (of an upscaled synthesis batch with KOH as base 
and 100 l/h compressed air inlet).  
 
Figure II - 29. a) PL spectra exc. at 350 nm, b) XRD patterns and c) TEM images and the 
determined particle size distributions of zinc oxide nanoparticles synthesized for 6 h with 100 
l/h compressed air flow. 
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XRD confirms the ZnO crystal structure with a crystallite size of about 6 nm calculated applying 
Scherrer's formula, which is in agreement with the size determination of the TEM image (6.0 
nm ± 0.9 nm).  
In the next step the synthesis of 4 different visible luminescence colours as described in 
literature101,110–112 was also proved (Figure II - 30). Due to variation of the Base LiOH, the 
particle size and therefore the luminescence wavelength is manipulated resulting in colours 
from red to green.  
 
Figure II - 30. PL intensities of ZnO nanoparticles synthesized with Zn(CH3CO2)2 and LiOH with 
the ratios 1:7.5, 1:3, 1:2 and 1:1.5; all spectra are normalized as the NP concentration and 
therefore the PL intensity of each sample differed due to the ratio of starting materials. (All 
samples were excited at a wavelength of 290 nm.) 
During the synthesis and characterization of all synthesized ZnO NPs, it became evident that 
these particles easily lose their luminescence behaviour and even dissolve under aqueous 
acidic conditions. The TiO2 shell synthesis which is described in the following paragraph, is 
carried out under these conditions (similar to the synthesis of TiO2 NPs of II.1 and II.2). Due to 
this fact, the synthesis of ZnO/TiO2 core/shell particles is not possible with the synthesized 
ZnO NPs and the planned synthesis protocol for TiO2 cores. Even if most of the literature does 
not mention the drawback of water sensibility,110,112,113 some references tried to improve the 
water stability of ZnO particles. One possibility is the coating of these particles with polymers 
made out of triethylene glycol, oleic acid, polyethylene glycol derivatives and/or 
diethanolamine.114–118 These syntheses result in an efficient protection of the ZnO core of acidic 
water but are not adequate for the coating with TiO2 as the polymer surfaces are very different 
from inorganic metal oxide surfaces and therefore a successful TiO2 condensation onto them 
it is not guaranteed. Furthermore, one tried to synthesize core/shell particles with silica as 
shell.110–112 While silica would provide similar inorganic metal oxide surface properties for 
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further reactions, the stability of this system against acids is only slightly enhanced as the shell 
is too porous to efficiently protect the labile ZnO.119 
Simultaneous to the synthesis of a luminescent core, it was examined if the shell formation of 
TiO2 around another inorganic metal oxide NP is feasible. For this proof of concept, magnetic 
iron oxide NPs were chosen as they are easy to synthesize and the washing of these particles 
is very fast due to their magnetic properties. Additionally, these particles offer hydroxyl groups 
on their surface which is a condition for coating them with the TiO2 shell by sol-gel synthesis. 
For this, magnetic NPs were synthesized via the precipitation method; Fe(II)Cl2 * 4 H2O and 
Fe(III)Cl3 * 6 H2O were dissolved in water, then ammonium hydroxide was added resulting in 
particle precipitation.120,121 After washing the particles with water and ethanol, they were added 
to the TiO2 precursors (MEEAA and titanium (IV) butoxide). The reaction mixture was then 
hydrolysed overnight. The most probable reactions during synthesis are shown in Scheme II - 
3.  
 
Scheme II - 3. Covalent integration of iron oxide nanoparticles during the preparation of the 
TiO2 precursor sol via hydrolysis and condensation reactions (- a simplified reaction 
mechanism is proposed). 
First, the titanium butoxide precursor was partly complexed by the MEEAA under release of 
butanol. In the scheme only a complex with one acid is shown to avoid any unnecessary over-
sophistication but it is possible that the titanium ion is in some cases complexed twice122,123 by 
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the acid as almost 2 equivalents of MEEAA were added to the titanium (IV) butoxide. After 
addition of the core particles, water was added and hydrolysis of residual butoxide groups was 
initiated. Subsequently, condensation between Ti-OH and Ti-OH or Ti-OBu, but also between 
Ti-OH and Fe-OH groups, took place forming a complex Ti-O-Ti, Ti-O-Fe and Ti-O-MEEAA 
network providing an amorphous TiO2 precursor sol. The covalent integration of the core 
particles into the titanium dioxide precursor sol was crucial for the later shell formation; if the 
magnetic particles were added after the hydrolysis and condensation reactions into the already 
prepared TiO2 precursor sol, no shell formation occurred. During hydrothermal treatment 
formed TiO2 particles did grow beside the magnetic particles and it was possible to eliminate 
all traces of TiO2 from the magnetic sample via washing with magnetic separation.  
After hydrothermal synthesis, the coated iron oxide NPs were magnetically separated from 
single TiO2 NPs that were formed as side products (Figure II - 31 a) and washed several times 
with slightly basic water. For successful magnetic separation, it was necessary to maintain a 
slightly basic environment to keep the particles destabilised as due to the heat treatment, the 
magnetisation of the iron oxide was significantly decreased (Figure II - 31 b). This was already 
expected as the amount of TiO2 in the shell were calculated to be 60 weight-% and it is well-
known that magnetite and/or maghemite age under heat. For this proof of concept the residual 
magnetism only had to be strong enough for the washing procedure. 
 
Figure II - 31. a) Schematic presentation (on the top) and photographs (on the bottom) of the 
magnetic separation of synthesized iron oxide/TiO2 core/shell particles (depicted with a black 
core as iron oxide and a yellow shell as TiO2) from TiO2 particles (depicted as yellow particles) 
which were formed as side products. b) Vibrating sample magnetometer measurements 
(carried out at 293 K) on dried powders of pure iron oxide nanoparticles and the synthesized 
iron oxide/TiO2 core/shell particles. 
The successful shell formation was proved via zeta potential measurements (Table II - 5); the 
isoelectric point shifted from 7.3 to approximately 6.2 which is the same isoelectric point 
exhibited by pure MEEAA-TiO2 NPs (II.1.2). This indicates the complete formation of a 
relatively dense TiO2 shell around the iron oxide as partly covered particles91 or particles with 
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porous shells often show their IEP between that of the core and the shell material (II.3.1). In 
the case of the addition of the core particles after the precursor sol formation, the isoelectric 
point was still the same as of pure iron oxide particles which indicates (as mentioned before) 
no successful shell formation.  
Table II - 5. The pHs at IEPs of iron oxide, TiO2 and iron oxide/TiO2 NPs determined by zeta 
potential titrations. 
Sample pH(IEP) [-] 
Pure iron oxide
 
NPs 7.3 
Iron oxide /TiO2 NPs  
(iron oxide added after hydrolysis and condensation of the TiO2 precursor) 
7.1-7.4 
Iron oxide /TiO2 NPs  
(iron oxide added before hydrolysis and condensation of the TiO2 precursor) 
6.1-6.3 
Pure TiO2 NPs 6.3 
 
Furthermore, XRD measurements confirmed the presence of both anatase and 
magnetite/maghemite phases (Figure II - 32 a). As one can see on the TEM image (Figure II - 
32 b), the sample looks homogenous and the particles are about the same or slightly larger 
than pure iron oxide particles with a diameter around 10 nm.91,120 At acidic pH (1-4), the 
hydrodynamic diameter of the stably dispersed core/shell samples was around 50 nm (with a 
PDI of roughly 0.3) while that of iron oxide is in the range of 10–20 nm.121 A final proof that the 
formed titanium dioxide is in close surface contact with the core particles, is the complete loss 
of PC activity of the samples. This phenomenon is due to the heterojunction of both phases, 
enabling the photogenerated electrons and holes to transfer from TiO2 to the lower lying 
conduction band of the iron oxide instead of migrating to the particle surface.124–126 
 
Figure II - 32.a) XRD pattern and b) TEM of synthesized iron oxide/TiO2 core/shell 
nanoparticles. 
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II.4. Conclusion 
Given the results obtained during inorganic syntheses of titanium dioxide NPs and related 
attempts of core-and-shell particle syntheses to introduce luminescence properties into the 
systems, one can sum up that two different TiO2 NPs were successfully synthesized. They 
were thoroughly analyzed via XRD, TEM, zeta potential measurements, DLS, TGA, nitrogen 
sorption and DRIFT. While the morphology (oval shape) and size (between 5 nm and 6 nm) of 
both anatase crystals seem to be very similar, they mainly differ in the surface functions 
introduced during the synthesis. While the AA-TiO2 bears acetyl acetonate and PTSA groups, 
the MEEAA-TiO2 features MEEAA on its surface. The higher PC activity of the MEEAA-TiO2 
compared to the AA-TiO2 is therefore mainly related to the different surface groups or more 
precisely the higher amount of functional groups on the AA-TiO2. Due to these results, the 
experiments into the influence of the hydrothermal treatment conditions on the NP properties 
were conducted with the more promising MEEAA-TiO2 system. If the autoclaving time or 
temperature during the synthesis is increased, the crystallite size increases from 4.8 nm to 7.7 
nm (1h, 160 °C to 4h, 200 °C). This was verified by XRD, TEM, DLS and nitrogen sorption 
measurements. While the properties of the surface groups are only marginally influenced by 
changes in the treatment time and/or duration (as shown via DRIFT, TGA and zeta potential 
measurements), the PC activity of the sample is significantly improved with increasing particle 
size. This was in contrast to the initial expectation that PC activity of the samples decreases 
with increasing size as the specific surface area in the sample is diminished. Their increasing 
PC performance with decreasing specific surface area were found to be caused by a change 
in crystal morphology. While small crystallites show the typical equilibrium state truncated 
tetragonal bipyramidal morphology, crystal growth leads to the formation of rod-like crystals 
with oxygen vacancies provoked by oriented attachment of single particles (as shown by 
XAFS, XRD and HR-TEM analyses). Both the more anisotropic crystal shape and the increase 
in oxygen vacancies improve the photocatalytic activity of the samples - most probably due to 
a more efficient charge carrier separation. The crystal growth via oriented attachment of {011} 
facets is presumably caused by the acidic aqueous hydrothermal treatment conditions and the 
preferential adsorption of the utilized carboxylic acid (MEEAA) onto the high energy {001} 
facets.  
After having successfully synthesized and characterized the stably dispersed, 
photocatalytically active TiO2 NPs with sizes smaller than 10 nm, that can even compete with 
the benchmark material P25, the incorporation of luminescence properties (see below) and the 
transfer into cell culture applications (Chapter IV) were then investigated. To introduce 
luminescence properties into the obtained TiO2 particles, the synthesis of luminescent 
Rhodamine B doped TiO2/SiO2 core/shell NPs was successfully carried out; the homogeneous 
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formation of a silica shell around TiO2 was proved via TEM, DLS and zeta potential 
measurements. The incorporation of Rhodamine B into the shell was evident due to the 
luminescence of the final particle system. Unfortunately, the PC activity of the particle system 
is progressively decreased with increasing silica shell thickness. For the doping of the silica 
shell with Rhodamine B, the dye concentration is limited due to self-quenching of the dye within 
the shell. This means, the higher the wished PL, the thicker the silica shell and the lower the 
PC activity of the TiO2/SiO2 particle system. The synthesis of a ZnO/TiO2 system still remained 
challenging; while luminescent ZnO NPs were successfully synthesized, their stability in acidic 
water was not sufficient for the synthesis of a TiO2 shell. Nevertheless, it was possible to prove 
the feasibility of a TiO2 shell formation around inorganic NPs such as iron oxide NPs. This 
means, if a sufficiently acid-stable luminescent inorganic particle system is found, the TiO2 
shell formation around it can be realized. For this, it has to be taken into consideration that the 
excitation of the core material must be above the absorption wavelengths of the TiO2 shell to 
ensure the arrival of the excitation wavelength to the core. Additionally, one has to bear in mind 
that the PC activity of the shell could be negatively influenced by the core. To conclude the 
attempts of luminescent core/shell particle synthesis, it can be stated that both systems were 
not deemed sophisticated enough for the use as highly photocatalytically active, luminescent 
NPs. This is the reason why another way had to be found to integrate the luminescence 
properties into the NP system. The integration of an organic dye into the coupling agents was 
identified as most promising pathway (treated in detail in Chapter III). It does not heavily 
influence the PC activity and the addition is carried out after the particle synthesis which avoids 
heat treatments of the organic components. Moreover, the excitation and emission 
wavelengths of the luminescent agent can be selected out of the range of all commercially 
available dyes and its concentration can most probably be significantly increased compared to 
a dye doped into a silica shell. 
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III.  Synthesis of organic coupling agents and their grafting onto 
TiO2 nanoparticles  
After the successful design of photocatalytic anatase nanocrystals, their surface 
functionalization was an essential objective to adapt the particle systems to the demands of 
their later applications in photodynamic cancer therapy. The elaborate design of organic 
coupling agents allows the fine tuning of molecular properties such as hydrophilicity, charge, 
geometry, luminescence or functional groups and the transfer of these characteristics to the 
entire particle system.  
III.1. Synthesis of functional coupling agents 
For the design of coupling agents, it was important to define the requirements they had to fulfil 
as functional surface groups of the nanoparticles. The first objective was to mediate the cellular 
uptake of the particles using these functional groups. It is well-known that the surface charge 
of particles has a great influence on their cellular uptake and that the surface potential can be 
easily modified by functional surface groups.1–14 Wise selection of functional groups can 
therefore optimize the cellular NP uptake. Furthermore, they can be used for the coupling of 
biological molecules onto the particle for example for targeted tumour treatment.15–19 A second 
objective was the introduction of luminescence properties into the particle system. This can be 
achieved by the incorporation of an organic dye into the coupling agent.20–24 Luminescence 
enables the detection of the particle systems in cell culture studies for better analysis and 
examination of the particle interaction with the cells.25 It also gives the opportunity for their 
imaging in human tissue when they are for example used as anti-tumour agents. The final task 
for the coupling agent was to improve or at least not decrease the solubility and dispersibility 
of the particles in physiological solutions. These objectives have driven the design of 
fluorescent and non-fluorescent molecules, which are presented in the following in more detail 
(Figure III - 1; 1st generation dendritic coupling agents as examples). 
 
Figure III - 1. Structure of the a) fluorescent and b) non-fluorescent 1st generation dendritic 
coupling agents. 
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First, the functional terminal groups of the coupling agents were chosen to be amines as in 
general positive surface charge at physiological pH leads to a better cellular uptake of the 
particles.3–6,10–12,14 Additionally, by fine tuning of the surface potential it may even be possible 
to enhance the particle uptake by cancer cells while healthy cells do not show an increased 
uptake.26 This behaviour is especially preferred for nanoparticles that are used for cancer 
treatment. To be able to finely tune the positive particle surface potential, we not only relied on 
linear coupling agents but dendritic structures were also used. By increasing the number of 
branches and therefore of functional terminal groups of the molecules, the positive charge of 
the particle surface is step-wise increased while maintaining the number of coupling agents 
per nanoparticle. This was of the utmost importance for this study as the functionalized TiO2 
nanoparticles were meant to be used as photocatalytic cancer treatment agent. By covering 
the surface with more coupling agents, the free TiO2 surface is decreased and as the 
photocatalysis is a surface process, its efficiency is strongly diminished. By using dendritic 
structures, one can most probably incline the surface charge while not decreasing the 
photocatalytic activity. Furthermore, the steric hindrance of dendritic surface agents during 
grafting is expected to lead to a less dense surface functionalization and therefore “non-
passivated” TiO2 surface is available for catalytic reactions.27 It also has to be mentioned, that 
amino groups are suitable for couplings with biological molecules that bear succinimidyl esters 
or carboxylic groups.15,17,18 This could enable the coupling of targeting agents like epithelial 
growth factors receptor antibodies,28 aptamers19 or folates29 onto the particles for active 
targeting of cancer cells resulting in a more efficient cancer treatment.  
The dendritic structures were chosen to be polyamidoamine (PAMAM) based as these 
structures are one of the most common structures used in materials science as well as in 
biotechnology due to their architecture and functionalities.30 These can be easily modified and 
therefore adapted for various fields of application.31–33 PAMAM are said to be in general non-
toxic (if low generation dendrons are used) and show a good solubility in physiological solutions 
due to their hydrophilic properties.31,34–36 
Another essential part of the coupling agent was the anchoring site that allows the binding of 
the organic molecule onto the inorganic particle. For this, silanes like organofunctional 
ethoxysilanes (RSi(OEt)3) were the most preferred reagents as silanol groups can covalently 
bind on titanium surfaces, which exhibit hydroxyl moieties.37–39 The subsequent grafting can 
be carried out under mild conditions e.g. in hydroalcoholic medium by hydrolysis of the ethoxy 
groups and subsequent condensation with the TiO2 hydroxyls.40,41 The formed Si-O-Ti bond is 
expected to be stable in water under mild acidic and basic conditions, which is suitable for 
biomedical applications. 
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In order to optionally add luminescence properties to the particle system, a dye had to be 
incorporated into the coupling agent. For this approach, commercial rhodamine derivatives 
were selected because of their high photostability and quantum yield (especially in aqueous 
solutions) as well as their good chemical and thermal stability.42,43 Furthermore, the 
luminescence and absorption of the dye had to be over 450 nm as TiO2 strongly absorbs light 
up to these wavelengths.44,45 This is the case for example for rhodamine B (λabs= 554 nm, λpl= 
576 nm).46 The dyes also show a satisfying solubility in water and were proved to be non-toxic, 
which is both very important for later biomedical applications.42,47 Additionally, an efficient 
coupling of the dye to the rest of the organic coupling agent was of great importance. This is 
why Rhodamine B isothiocyanate was the first choice as it is an affordable model dye that 
easily reacts with amines of the coupling agent. For later applications the use of dyes with 
absorption and luminescence in higher wavelength ranges would be preferred in order to be 
able to operate within the optical “window” (600-1300 nm)48,49 and reach higher light 
penetration in human tissue. For the incorporation of the luminescent agent into the molecule, 
a connection is needed between the anchoring site, the luminescent agent and the functional 
groups (including the dendritic structures). For this the amino acid lysine was chosen as it 
offers three reactive sites: 2 amino groups and one carboxyl group. The hydrophilic lysine can 
also improve the solubility of the coupling agent in water. It has the appearance of a T section, 
which allows a linear connection between the anchoring site and the functional groups (and 
dendritic structures), while providing a lateral reaction side for the dye.50 This was an important 
requirement as the dye should not be in the periphery of the dendron to not influence the 
efficiency of the functional terminal groups in their task to modify the surface charge and couple 
organic molecules. It was also an option to integrate the dye linearly into the molecule between 
the functional groups and the anchoring site but organic dyes that show two reactive sites in a 
linear arrangement are commonly not commercially available.  
Additionally, we decided to introduce a spacer or linker moiety between the anchoring site and 
the lysine or in the case of non-fluorescent coupling agents - where no T section is needed - 
between the anchor and the dendritic structure. This spacer should provide a certain flexibility 
for a higher grafting efficiency of the coupling agent as it increases the distance between the 
anchoring site and the large, rather inflexible structures of the dye and the dendritic branches. 
It should also enhance the colloidal stability of the functionalized particle in water. This is why 
a polyethylene glycol (PEG)-like spacer has been selected as PEG is nontoxic and provides 
high colloidal stability of functionalized particles in physiologic media due to its hydrophilic 
character.51–53  
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After having defined the targeted structure of the grafting agents, the planned synthesis routes 
are described in the following sections: First, the synthesis of the linear and dendritic 
fluorescent coupling agents is discussed (III.1.1) before moving forward to the non-fluorescent 
grafting agents (III.1.2). 
 
III.1.1. Synthesis of linear and dendritic fluorescent coupling agents  
III.1.1.a. Coupling agent I (compound 4) 
The first strategy was to synthesize a linear, rather simple molecule that features the same 
modules as the following more complex fluorescent coupling agents with anchoring site, 
spacer and dye but was obtained after only 4 reaction steps. It was mainly meant to test the 
feasibility of the synthesis route, in particular the incorporation of the commercial dye 
rhodamine B isothiocyanate into the molecule. This coupling agent should help to investigate 
if the dye survives all reaction conditions for the molecule synthesis and the grafting onto 
particles (including acidic and basic conditions as well as heat). The synthetic pathway of this 
so called compound 4 or coupling agent I is described in Scheme III - 1. 
The starting material 2,2-(ethylenedioxy)bis(ethylamine) provides on each side a terminal 
amine. As it was intended to react each side with two different highly reactive molecules, one 
first had to be protected. Di-tert-butyl dicarbonate (Boc anhydride) was chosen as reagent 
because its related Boc protection is very resistant against basic conditions, heat (up to 185 
°C) and nucleophilic attacks.54,55 This was important as the protected starting compound had 
to survive all following reaction and washing steps with basic treatments. Furthermore, with 
this protecting group high yields in mono-protected product can be obtained if the molecule 
that is to be protected is taken in excess and reaction conditions are optimized.56,57 During the 
amine protection carbon dioxide and t-butanol are formed as side products, which is shown in 
Scheme III - 2. The solvent and the volatile side products were removed under vacuum and 
the excess 2,2-(ethylenedioxy)bis(ethylamine) was removed by washing the organic phase 
(CH2Cl2) with water. The mono-protected product (compound 1) was obtained in 97 % yield 
containing only traces of di-protected compound not visible in NMR. These traces visualized 
by thin layer chromatography (TLC) did not take part in the following reaction and were then 
easily removed by washing. 
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Scheme III - 2. Mechanism of the protection of a primary amine with di-tert-butyl dicarbonate. 
In the next step, Rhodamine B isothiocyanate (RhBitc) was reacted with the free amine of 
compound 1. The reaction was carried out under basic conditions with the addition of 
triethylamine (TEA). This ensured that the free amine was not protonated and therefore 
provided a free electron pair for the nucleophilic attack of the isothiocyanate carbon. The 
reaction mechanism is shown in Scheme III - 3. As solvents, a mixture of CH2Cl2 and 
dimethylformamide (DMF) was chosen to achieve the solubility of RhBitc salt while minimizing 
the amount of high boiling point solvent. The reaction was carried out overnight and after 
evaporation of all volatile components, the crude powder was extensively washed with diethyl 
ether to remove unreacted compound 1 (as it had been added in slight excess) as well as 
traces of di-protected 2,2-(ethylenedioxy)bis(ethylamine) produced during the synthesis of 
compound 1. In order to remove the TEA•HCl salt resulting from the reaction of TEA with the 
chloride of RhBitc, a wash with basic water was carried out in order to free the TEA. After 
evaporation of the free TEA, compound 2 was obtained with a yield of 94 %. 
 
Scheme III - 3. Reaction mechanism of a primary amine with an isothiocyanate. 
Now the Boc protecting group of compound 2 was cleaved by bubbling anhydrous HCl in the 
CH2Cl2 solution. The cleavage takes place through an SN1 pathway forming the tert-butyl 
cation. With Cl- as a weak nucleophile, the cation can be slowly converted into tert-butyl 
chloride or rearranges into isobutene both of which can easily be eliminated out of the reaction 
batch by evaporation.58,59 The reaction mechanism is shown in Scheme III - 4. After 
evaporation of all volatile components, no further purification was necessary and compound 
3 was obtained as an ammonium salt, in quantitative yield.  
For the grafting of the organic molecule, the silane moiety had to be introduced into the 
compound 3. For this the deprotected amine, which was obtained as an ammonium salt was 
dissolved in CH2Cl2 with the help of a large excess of TEA (15 eq - otherwise it was not soluble). 
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Then it was reacted with a slight excess of triethoxy(3-isocyanatopropyl)silane (1.2 eq). 
Afterwards, the solvent and excess TEA were evaporated. The residue was thoroughly washed 
with pentane to remove the unreacted silane.  
 
Scheme III - 4. Mechanism of the cleavage of the Boc protecting group from an amine with 
gaseous HCl.  
After evaporation of all traces of pentane, the compound 4 was obtained in about 90 % yield. 
It has to be mentioned that traces of TEA•HCl were still present in the compound. Therefore 
the yield was calculated with the help of the 1H-NMR integrals. No further purification was 
needed as the salt was not supposed to interfere with the grafting reactions. Compound 4, 
also called coupling agent I, is later on used for the grafting onto TiO2 nanoparticles. It has to 
be mentioned that the commercial RhBitc contained impurities, mainly visible in mass 
spectroscopy (MS). Most of them did not take part into the reactions and were removed during 
washing procedures. Nevertheless small amounts of rhodamine B amine (identified via MS) 
were not removed during all reaction steps and therefore reacted with the triethoxy(3-
isocyanatopropyl)silane forming a side product to the desired compound 4. The amount of 
this side product is expected to be considerably low as NMR analysis does not show signals 
that can be assigned to it. 
III.1.1.b. Coupling agent II 
The second linear molecule was synthesized as a reference to the planned dendritic coupling 
agent III (treated later on in this chapter); it has the same basic components but does not 
contain a dendritic structure. The synthesis procedure of this linear coupling agent, is described 
in Scheme III - 5. For the design of this molecule, the most crucial point was to use three 
different protecting groups for amines (contained in the coupling agent) and to place them most 
ideally to avoid the unwanted deprotection during a reaction or during the cleavage of another 
protecting group. As a result, benzyloxycarbonyl (Z), tert-butoxycarbonyl (Boc) and 9-
Fluorenylmethoxycarbonyl (Fmoc) were chosen as protecting groups. They are shortly 
introduced now, while more precise descriptions of their coupling and cleavage reactions will 
be provided later. The Z protecting group is the most popular protecting group in peptide 
synthesis due to its facile introduction and removal conditions.  
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It can be easily cleaved by catalytic hydrogenation or by acidolysis and is stable to most of the 
coupling reactions.54,55,58 Boc was the first urethane-type protection found that was stable to 
catalytic hydrogenation (used for Z cleavage) while labile under mild acidic conditions (as 
already mentioned before).54,55,58 The Fmoc group was found to be the perfect completion for 
Boc and Z as it is completely stable against acids and to a large extent to catalytic 
hydrogenation while it can be removed with bases such as alkyl amines.54,55,58 Comparing the 
cleavage conditions of all three protecting groups, the Fmoc protecting group was found to be 
the most labile group as it may be cleaved during prolonged catalytic hydrogenation (used for 
Z removal).58 Additionally, this protecting group could be involuntarily removed during several 
coupling reactions needed for the synthesis of the coupling agents. For example, the reaction 
of isocyanates and isothiocyanates with amines had to be carried out under basic conditions 
and would most probably result in Fmoc cleavage. This is why Fmoc was always cleaved first. 
One of the two other protecting groups was also planned to be cleaved during the synthesis 
route, while the last protecting group was meant to be removed after grafting of the final 
coupling agent onto the nanoparticles. 
The starting materials for the linear coupling agent II were compound 1 and the commercially 
available Fmoc-lysine-Z-OH (Scheme III - 6). The amines of this lysine are already Fmoc and 
Z protected; the epsilon amine is Z protected and the alpha amine is Fmoc protected. 
 
Scheme III - 6. Fmoc-lysine-Z-OH. 
The carboxylic group is the only unprotected reactive group and can form an amide with the 
unprotected amine of compound 1. The coupling between compound 1 and Fmoc-lysine-Z-
OH was carried out by activating the carboxylic acid with N-hydroxysuccinimide (NHS) and 
N,N'-dicyclohexylcarbodiimide (DCC). First, the carboxylic acid is added to DCC leading to O-
acylurea. Then NHS reacts with the O-acylurea to form a second, more stable activated ester. 
This avoids the formation of N-acylurea as a side product60,61 as NHS reacts with the DCC-
activated compound faster than the reaction forming the side product can take place (Scheme 
III - 7).61 The activated ester reacts with the amine forming an amide and dicyclohexylurea 
(DCU).60,61 For this reaction Fmoc-lysine-Z-OH was dissolved in CH2Cl2 and reacted with DCC 
and NHS. The formed DCU, which was insoluble in CH2Cl2, was filtered off and compound 1 
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was added. The activated carboxyl group reacted with the free amine resulting in an amide 
bond (releasing the NHS) and the formation of compound 5. In order to purify this product, 
first the organic reaction phase was washed with acidic water to quench unreacted DCC 
converting it in dicyclourea (which was removed by filtration). Then, washing with basic water 
removed the main part of NHS and drying and subsequent washing of the powder with 
diethylether eliminated unreacted starting materials. To withdraw any remaining traces of NHS 
a silica column was run and pure compound 5 was obtained with a yield of 61 %. 
 
Scheme III - 7. Amide formation with the help of DCC and NHS. 
In order to go on with further reactions, the Fmoc protected amine had to be deprotected under 
basic conditions.58,62,63 For this, a treatment with diethylamine in tetrahydrofuran (THF) was 
chosen. The cleavage mechanism is shown in Scheme III - 8. In contrast to other nonhydrolytic 
bases used for the cleavage like piperidine or morpholine, it does not form adducts with the 
produced dibenzofulvene. This is on one side a risk, as dibenzofulvene can polymerize, 
forming an insoluble mass or can irreversibly react with the deblocked amine. On the other 
hand, scavenging this compound by the base is a reversible equilibrium dependent reaction 
and often incomplete, which results in mixture that is even more difficult to separate.58,63  
 
Scheme III - 8. Mechanism of the Fmoc protecting group cleavage with diethylamine. 
The produced CO2 and the diethylamine were easily removed after the reaction. Nevertheless 
the obtained side product dibenzofulvene had to be separated from the product by washing. 
This was achieved by dissolving the crude material in acetonitrile followed by the addition of 
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water (with a ratio of 1:9). Now the dibenzofulvene was eliminated from this very polar phase 
by washing with pentane while the product stayed in the water phase and was then extracted 
with CH2Cl2 after basification of the water phase to yield compound 6 (98 %). Eventually 
polymerized dibenzofulvene was not extracted with pentane but also stayed in the water phase 
as a white mass during extraction of the compound with CH2Cl2. 
Now, similar to the synthesis of compound 2 the free amine of compound 6 was coupled to 
the luminescent agent (RhBitc) to yield compound 7 (91 %).  
Then two different routes were investigated; either the cleavage of the Boc (Scheme III - 5; 
route A) or of the Z protecting group (Scheme III - 5; route B). Both reactions were supposed 
to lead to a free amine that can be reacted with the triethoxy(3-isocyanatopropyl)silane to 
obtain a final coupling agent, while the remaining protecting group has to be removed after 
grafting onto the nanoparticles. For the Boc deprotection, a treatment with HCl similar to the 
one used for compound 3 was conducted. While the Boc protecting group was entirely 
removed, compound 8 was not obtained but fragments of it. If the Boc cleavage was carried 
out treating compound 7 with trifluoroacetic acid (TFA, with the same reaction mechanism as 
the cleavage with HCl), the Boc protecting group was not successfully cleaved and fragments 
of compound 7 were obtained. In both cases, MS revealed the amide bond hydrolysis on the 
alpha position of the lysine with the neighbouring thiourea group participation.64  
The proposed mechanism for this reaction is shown in Scheme III - 9 in the case of weak acids 
(i.e. without parallel Boc group cleavage). This reaction has only been documented by Lang et 
al.64 who studied the stability of glutamic acid linked to peptides and e. g. a phenyl. The 
breakage of the amine bond because of the neighbouring thiourea group was observed at pH 
= 4 in aqueous conditions and at elevated temperatures (80 - 100°C). In the case of coupling 
agent II, no heat was applied but stronger acids (HCl, TFA) were used either under anhydrous 
(HCl treatment) conditions or in the presence of water traces (TFA treatment).  
The same fragmentation of compound 7 was obtained while carrying out the Z deprotection 
to obtain compound 9. For this deprotection a hydrogenation with the catalyst Pd on carbon 
was chosen. The proposed mechanism of this reaction is described in Scheme III - 10. It has 
to be mentioned that while in the case of homogenous catalysis the depicted mechanism 
seems to be the most probable one, for heterogeneous one (which has been used in this study) 
it may be different as dissociative adsorption of the reactant onto the Pd particles would be 
necessary for the catalysis.  
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Scheme III - 9. Proposed mechanism of amide bond hydrolysis under the participation of the 
neighboring thiourea group at room temperature and acidic conditions (without additional Boc-
cleavage).64  
 
Scheme III - 10. Proposed mechanism of the Z protecting group cleavage with the help of 
catalytic hydrogenation (Pd/C, H2).  
With this treatment the Z protecting group can be cleaved in general while not affecting the 
Boc protecting group, which is also present in compound 7.54,55 Following literature, methanol 
was chosen as the solvent and additionally a small amount of HCl was added to promote the 
Z group cleavage thanks to protonation of the nitrogen atom.65–71 During this deprotection 
procedure, only the amide bond hydrolysis at the lysine alpha position of compound 7 was 
achieved while not cleaving the Z protecting group.  
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Thus, this specific amide bond is less stable than both carbamates of the Z and Boc protecting 
groups and it is not possible to complete this synthesis route to obtain coupling agent II. It 
also has to be mentioned that a separation of the dye from the rest of compound 7 by rupture 
of the thiourea was detected in MS analysis of the synthesis attempts of compound 8 and 
compound 9. Nevertheless, this bond breakage is assumed to be caused by the electrospray 
ionization for MS. In order to avoid the amide bond hydrolysis on the alpha position of the 
lysine with the neighbouring thiourea group participation, the most evident solution was to 
change the function connecting the dye with the lysine. In the case of an amide bond instead 
of a thiourea at this position, this reaction was reported not to take place.64 This approach was 
attempted for coupling agent III and will be described later on. 
III.1.1.c. Coupling agent III (compound 22) 
In parallel to the synthesis of coupling agent II, the preparation of its dendritic version, named 
coupling agent III was investigated. The first planned synthetic pathway of this 1st generation 
dendritic coupling agent is described in Scheme III - 11. This molecule contains two dendritic 
branches with phthalimide-protected amines as end groups. These protecting groups were 
meant to be cleaved after successful grafting of the coupling agent onto the particles while 
preventing the reaction of the terminal amines during synthesis.  
Due to the design of this molecule the location or cleavage order of the protecting groups had 
to be slightly changed according to their stability and cleavage mechanisms as mentioned 
before. As Z-lysine-Fmoc-OH was not commercially affordable, it was first synthesized by the 
protection of the commercial Z-lysine-OH. 
The free epsilon amine was protected by the reaction with 9-Fluorenylmethoxycarbonyl 
chloride (Fmoc-Cl) as shown in Scheme III - 12. When carrying out Fmoc protection of amino 
acids, it always has to be considered that di-peptide formation can occur as a side reaction. 
Especially during protection procedures of the alpha amine detectable amounts of dipeptide 
acids or even tripeptide acids have been reported when chloroformates like Fmoc-Cl were 
utilized.58 The carboxy group of amino acids can be activated by the reaction with a 
chloroformate forming an anhydride. These intermediates are sufficiently stable in aqueous-
organic reaction media to then undergo aminolysis and form a peptide with another amino 
acid. They are usually difficult to detect and to separate from the product and therefore a major 
concern for the Fmoc protection of amino acids. These side products were obtained even 
under Schotten–Baumann conditions (mixture of aqueous and organic solvent and reaction at 
0 °C).58  
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Scheme III - 12. Reaction mechanism of Fmoc protection of an amine with FmocCl. 
Nevertheless, dipeptide formation during the Fmoc protection of Z-lysine-OH or lysine-Z-OH 
has in general not been mentioned before.67,72,73 Following the reaction protocols from 
literature,67,72,73 Z-lysine-OH was reacted with Fmoc-Cl in a mixture of Na2CO3-water solution 
and an organic solvent. In contrast to former publications, dipeptide formation was detected by 
TLC and even visible in NMR. The probable reaction mechanism for the formation of dipeptides 
is shown in Scheme III - 13.  
 
Scheme III - 13. Probable mechanisms of dipeptide formation during Fmoc protection of Z-
lysine-OH with FmocCl. 
With the help of several washing procedures the Z-lysine-Fmoc-OH was purified; after 
complete reaction of Fmoc-Cl (controlled by TLC), the crude compound was precipitated by 
addition of 1 M potassium hydrogenosulfate solution. Then the precipitate was washed with 
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water to remove all salts and with toluene to remove the Fmoc-OH that was generated due to 
the dipeptide side reaction. Afterwards, the precipitate was washed with diethylether to 
separate the Z-lysine-Fmoc-OH from the dipeptide. This was possible due to different solubility; 
the dipeptide was insoluble in this solvent while the product was. Depending on the organic 
solvent used for synthesis the yield of compound 10 greatly varied due to the amount of 
dipeptide that was formed as a side reaction (Table III - 1). 
Table III - 1. Obtained yields of compound 10 depending on the organic solvent used for 
synthesis. 
organic solvent yield 
THF 30 % 
dioxane 11 % 
DMF 68 % 
 
Then compound 10 was reacted with compound 1 to obtain compound 11. This compound 
was obtained with a yield of 80 %.  
In order to obtain compound 12 with a yield of 93 %, the Fmoc protecting group was cleaved.  
To begin the growth of the dendritic structure, the acrylate (compound 13) as reactant had 
first to be synthesized; N-(2-hydroxyethyl)phthalimide was reacted with acryloylchloride in the 
presence of TEA to scavenge the HCl formed.74–78 The reaction mechanism is the same as for 
the reaction of an amine with an acylchloride, which was explained in Scheme III - 12 for the 
Fmoc protection of an amine with FmocCl. The product was easily purified as it stayed in the 
organic phase (CH2Cl2) while the unreacted reactants were extracted with water. Compound 
13 was obtained with a yield of 59 %.  
Now the creation of the 1st generation dendritic branches was carried out by stirring compound 
13 and compound 12 in THF for 6 days at 65 °C. During this time the acrylate reacted with 
the free amine through a double Michael addition as shown in Scheme III - 14.79  
 
Scheme III - 14. Mechanism of the double Michael addition. 
With the help of column chromatography, the excess compound 13 was separated from the 
obtained compound 14 (91 %). As well as THF, dioxane and DMF were tested as possible 
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reaction solvents that solubilized the reactants sufficiently. Nevertheless, in these solvents only 
the formation of one branch was achieved.  
For the subsequent deprotection of the Z-protected amine of compound 14 the hydrogenation 
with Pd on carbon was carried out as described for the attempt to obtain compound 9. This 
treatment does usually not affect the Boc and phthalimide protecting groups present in 
compound 14.54,55 During analysis of the expected Z-deprotected compound 15, NMR and 
MS analyses indicated a decomposition of the compound; parts of the dendritic branches were 
removed by transesterification reactions with the methanol solvent. The base and acid 
catalysed transesterification mechanism is shown in Scheme III - 15.  
 
Scheme III - 15. The a) base and b) acid catalysed transesterification mechanism with B 
representing a base.84 
In this specific case R1 would be the methanol solvent, R2 the coupling agent and R3 the benzyl 
group of Z. How the Pd/H2 catalyses the transesterification has not been studied in detail yet 
as acidic or basic catalysis seems to be handier and very few publications can be found that 
mention such transesterifications using similar catalysts.80–83 
In order to further determine which reaction conditions are leading to a transesterification 
reaction, several stability tests were carried out on compound 14. The results of these 
examinations are shown in Table III - 2. As this mechanism is an equilibrium driven reaction 
with an alcohol, it is logical that the presence of methanol or ethanol favoured 
transesterifications. Additionally, a base or Pd and H2 had to be present to catalyse this 
reaction, while acidic conditions did not promote the reaction in this case. If the catalytic 
III. Synthesis of organic coupling agents and their grafting onto TiO2 nanoparticles 
 
 
- 108 - 
hydrogenation would be carried out in THF no side reactions are supposed to occur and the 
reaction product would be compound 15 as expected (given that the Z cleavage is 
successful).  
Table III - 2. Stability tests with compound 14 over 24 h (except for the last case: 12 h). 
solvent catalyst stability (proved by NMR and/or MS) 
methanol HCl in water stable 
methanol KOH in water transesterification 
methanol  Pd/C, H2 transesterification 
THF Pd/C, H2 stable 
THF KOH in water hydrolysis 
ethanol/water NH3 in water transesterification 
 
Nevertheless, in the following planned reaction steps, washings with basic water were 
necessary, which also seemed to affect the stability of the compound (like in Table III - 2; THF 
and KOH) even without the presence of an alcohol. In this case a small percentage of 
compound 14 appeared to be hydrolysed under base catalysis resulting in the carboxylic acid 
and the alcohol. The reaction mechanism of this reaction is similar to Scheme III - 15 a) while 
R1 would be a proton. This was the first argument against the use of compound 14 for the 
synthesis as a coupling agent but even more crucial was the planned grafting of the final 
coupling agent onto the particle. This reaction had to be carried out in a hydroalcoholic solvent 
and in the presence of a base (like in Table III - 2 ethanol/water and NH3), which both are 
indispensable for the hydrolysis and condensation reactions of the coupling agent (as 
discussed in III.2.). Under these conditions, the coupling agent would definitely be destroyed. 
This is why a modification of the structure of the dendritic branches was necessary; the ester 
groups were replaced by amide groups, which are more stable and should withstand the 
subsequent reaction steps.  
The alternative synthesis route for the 1st generation dendritic coupling agent III is shown in 
Scheme III - 16. The acrylate was substituted by an acrylamide for the creation of the branches. 
In order to obtain this reactant, two synthetic steps were required.85 First, 2-chloropropylamine 
hydrochloride was reacted with acryloylchloride in CH2Cl2 and in the presence of TEA to 
scavenge the HCl formed. The reaction mechanism is the same as for the reaction of an amine 
with an acylchloride, which was explained in Scheme III - 12. The TEA•HCl salt was filtered off 
and the unreacted reactants were washed away with basic water to obtain pure compound 
16 (88 %).  
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Afterwards, potassium phthalimide was reacted with compound 16 in DMF (75 °C, 24 h) via 
Gabriel synthesis to yield compound 17, following a SN2 mechanism. The reaction results in 
a phthalimide-protected primary amine. The formed KCl as a side product was filtered off and 
the compound was purified via column chromatography to yield pure compound 17 (55 %). 
During this reaction, polymerization of the reactant compound 16 led to various side products 
lowering the yield. 
In order to obtain compound 18, compound 12 and compound 17 were reacted in methanol 
via double Michael addition as described in Scheme III - 14.86,87 For this reaction to take place, 
the reactants had to be heated to 75 °C and stirred for 7 days. In contrast to the acrylate, the 
acrylamide showed a lower reactivity towards the free amine while easily polymerizing, which 
led to lower yields of compound 18 (57 %). The pure desired product was obtained after 
purification by column chromatography.  
Subsequent Z deprotection was carried out via hydrogenation with Pd on carbon as described 
for the synthesis attempt of compound 9. Our findings confirmed other publications that - in 
the case of lysine - the Z cleavage was only possible with the addition of an acid protonating 
the heteroatom to facilitate the reaction while strongly acidic conditions led to a parallel Boc 
deprotection.65–71 In the presence of 4 eq acetic acid the Boc protecting group was not affected 
while an addition of 2 eq HCl already resulted in Boc cleavage. Due to the present acid, 
compound 19 was first obtained as a salt and it was possible to extract it with water from the 
organic phase that contained the unreacted compound 18. After basification of the aqueous 
phase, the pure product as free amine was recovered with dichloromethane (54 % yield). 
In order to introduce the dye into the coupling agent, compound 19 was reacted with 5-/6-
carboxytetramethylrhodamine, succinimidyl ester (NHS-Rhodamine) in presence of TEA. DMF 
was used as solvent to guarantee the solubility of all reactants. After 15 h of reaction, all volatile 
compounds were removed and the obtained crude product was dissolved in CH2Cl2. The 
desired product was separated from deactivated NHS-Rhodamine (due to hydrolysis), the side 
product NHS and unreacted compound 19 by washing with basic and acidic water. This 
procedure resulted in compound 20 (85 %).  
For Boc protecting group cleavage, similar to the second synthesis attempt of compound 8, 
compound 20 was dissolved in CH2Cl2 and TFA was added to obtain compound 21 after 
reaction overnight in quantitative yield. Finally, the silane moiety was added to the compound 
21. In order to do so, the deprotected amine, which was obtained as an ammonium salt, was 
dissolved in CH2Cl2 with the help of an excess of TEA. Then it was reacted with triethoxy(3-
isocyanatopropyl)silane overnight. Afterwards, the solvent and excess TEA were evaporated 
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to obtain compound 22, also called coupling agent III, in quantitative yield. It has to be 
mentioned that the side product TEA•TFA was still present in the compound. This small 
quantity of salt was not supposed to interfere in subsequent grafting reactions.  
The feasibility to introduce rhodamine into the coupling agent via amide bond formation and to 
finalize the coupling agent III has been herein proved. Nevertheless, the commercial NHS-
rhodamine was only available in small quantities. Consequently, the coupling agent III was 
obtained in quantities too limited to be used for grafting approaches. In general, the NHS-
activated as well as the non-activated 5-/6-carboxytetramethylrhodamine are both 
commercially not available with a reasonable price and quantity. This is why for future studies, 
the synthesis of carboxytetramethylrhodamine and its subsequent activation for amide 
formation would be advisable and has already been proved to be feasible in literature.88 
 
III.1.2. Synthesis of dendritic non-fluorescent coupling agents  
The approach to synthesize non-fluorescent coupling agents emerged out of the problems 
occurring during the synthesis of the coupling agents II and III. Non-fluorescent dendritic 
coupling agents are useful to study the charge-dependent cellular uptake as they can finely 
manipulate the particle surface charge. They will also be a suitable tool to study the dendritic 
effect of the positively charged terminal groups without having to consider charge effects of an 
incorporated dye. Analysis techniques that do not rely on fluorescence, can be used to detect 
the functionalized nanoparticles; for example confocal Raman microscopy. This is why the 
synthesis of non-fluorescent coupling agents is valuable to gain more insights into the 
behaviour of functionalized NP systems. 
 
III.1.2.a. Coupling agent IV (compound 25) 
The first non-fluorescent coupling agent is a 1st generation dendron showing a similar structure 
to coupling agent III while not containing the lysine and the rhodamine B components. Its 
synthesis route is described in Scheme III - 17. 
In order to obtain compound 23, compound 1 and compound 17 were reacted under the 
same conditions as used for compound 18. In the same way, the yield (46 %) of the purified 
compound 23 (after column chromatography) was considerably low due to polymerization 
reactions of the acrylamide. Subsequent Boc deprotection was carried out with the help of a 
TFA treatment, similar to the second synthesis attempt of compound 8. The resulting 
compound 24 was obtained as a TFA salt in quantitative yield and not transformed into a salt- 
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free compound as this free amine acts as a strong base, reacting with the phthalimide 
protecting group during storage. The proposed mechanism for this reaction is described in 
Scheme III - 18 and may lead mainly to a cyclisation of the molecule (or to a smaller extent in 
a polymerization, which was not detectable in MS). The cyclisation of compound 24 was 
concluded as MS showed the same mass but NMR indicated the shift of the protons whose 
environment changed due to the reaction. Additionally, the subsequent urea formation did not 
take place due to no available primary amine. 
 
Scheme III - 18. Proposed mechanism for the phthalimide ring opening by a primary amine. 
For the synthesis of compound 25, compound 24 was reacted with triethoxy(3-
isocyanatopropyl)silane in presence of TEA similar to the synthesis of compound 4. TEA 
withdrew the TFA from the primary amine of compound 24 making it accessible for a reaction 
with the isocyanate. The isourea formation proceeded faster than the before described reaction 
of the amine with the phthalimide group resulting in compound 25 in quantitative yield. This 
coupling agent IV, is later on used for the grafting onto TiO2 nanoparticles.  
The synthesis of 2nd generation dendritic coupling agent V and coupling agent VI (Scheme 
III - 19) with a similar structure either to coupling agent III or to coupling agent IV was started 
but as the coupling agents were not completed, these synthesis routes are not discussed here. 
Nevertheless, the synthesis protocols can be found in the experimental part of this manuscript 
(compound 26 to compound 30). 
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Scheme III - 19. 2nd generation dendritic coupling agents. 
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III.2. Grafting of functional coupling agents onto particles 
After the synthesis of the organic coupling agents, their grafting onto TiO2 nanoparticles was 
carried out. The surface modification of TiO2 groups was realized via the reaction of the surface 
hydroxyl groups of the particles with the silanol group of the grafting agents resulting in 
covalent bonds. As grafting agents, organo-silanes were chosen as their reactive silane groups 
can typically covalently react onto inorganic substrates (like silica, gold or metal oxides)89 while 
they do not react with organic molecules. The chosen trimethoxy- or triethoxy-organo-silanes 
were preferred to trichloro-organo-silanes as these are less reactive (R–Si(OC2H5)3 < R–
Si(OCH3)3 < R–SiCl3) and may lead to a more uniform grafting due to less self-condensation 
before or during grafting. 
As the particles were obtained in aqueous solution during synthesis and mainly showed 
hydrophilic properties, the grafting conditions had to be in aqueous solutions. Furthermore, the 
presence of water is favourable for the silanization, since it promotes the hydrolysis of the 
alkoxy-organo-silanes. Hydrolysis has first to take place before further condensation reactions 
can proceed - as already shown in Chapter II.3.1. Additionally, the reaction medium was 
chosen to be hydroalcoholic as hydrophilic and protic solvents usually accelerate the 
hydrolysis of silanes increasing the reaction kinetics.90,91 In the case of silanization, the amount 
of free hydroxyl groups on a surfaces is often too low to form more than one siloxane group on 
it, which may be the case for the TiO2 particles used, bearing additional organic groups on their 
surface (as discussed in Chapter II.1. and II.2.). This is the reason why cross-linking reactions 
between the coupling agents also occur leading to a densification of the siloxane layer and 
thus to an even stronger attachment of the layer around the particle surface.92 Nevertheless, 
the already present organic surface moieties may also impede the cross-linking reactions 
between the coupling agents. 
In addition to the silanization, an unwanted polycondensation of the organo-silane can also 
take place leading to the formation of silane aggregates. If these aggregates condensate onto 
the particle surfaces the homogeneity of the surface layer can be greatly diminished.93 The 
preferential reaction of silanes can be mediated by the addition of an acid or a base as 
catalysts. Acids tend to promote the formation of net like structures (due to slower hydrolysis) 
while bases promote particle like structures (due to faster hydrolysis).94,95 The functionalization 
of a material works with both catalysts but under acidic conditions oligomerization is more 
probable.96 This is why a base is usually chosen to promote the surface functionalization of 
nanoparticles. Most often ammonia is used as the base but also other amines with 
exchangeable protons like ethylamine or diethylamine are an option.95,97,98 Even if base 
catalysed functionalization is preferred, the acidic catalysis approach also had to be taken into 
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consideration as the synthesized TiO2 nanoparticles are nicely dispersed only under acidic 
conditions, which is important for the accessibility of hydroxyl surface groups. The stabilisation 
of the nanoparticles under basic conditions with the help of an stabilising agent is an option 
that has been chosen before.99–101 However, the stabiliser can also impede the surface 
accessibility of the particles and the removal of it after grafting cannot be guaranteed. This 
influences the final surface properties and can have negative effects on the later cell culture 
application. Due to this, the stabilisation of particles with stabilising agents was not chosen for 
the graftings carried out in this work. 
Furthermore, the reaction of organo-silanes can also be influenced by the experimental 
parameters like the reaction time, temperature and solvent or water concentration chosen for 
the surface functionalisation. Raising the temperature for example accelerates the reaction 
kinetics and therefore decrease the reaction time, which is mainly dependent on the reactivity 
of the silane and can vary from several minutes to hours.102 Additionally, the slower the silane 
addition is, the more efficient the surface coverage.103 The concentration of particles in the 
reaction solution should also be relatively low, to avoid cross-linking between the particles 
through siloxane bridges. 
 
III.2.1. Optimization of grafting protocols with commercial silanes 
Due to the before mentioned factors influencing the successful grafting of organo-silanes onto 
particle surfaces, the commercial silane [3-(2-aminoethylamino)propyl]trimethoxysilane 
(Scheme III - 20) was used to first determine an optimized grafting protocol. This molecule was 
chosen as a model as it also shows hydrophilic properties and an amine end group similar to 
the synthesized coupling agents (III.1). Grafting conditions104 such as ethanol to water 
concentration, were chosen according to the results of the silica shell formation around the 
synthesized TiO2 particles as discussed in Chapter II.3.1. In order to determine the most 
suitable catalyst, graftings were carried out first with the addition of ammonia as a catalyst 
(improving the functionalization of the particles by the silane). A second reaction protocol 
included the addition of nitric acid for the silane addition as it provides good particle stability 
and later ammonia to complete the grafting reaction, in an attempt to combine both advantages 
of the catalysts. 
 
Scheme III - 20. [3-(2-Aminoethylamino)propyl]trimethoxysilane. 
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In order to determine the minimum of silane needed for the grafting reactions, the theoretical 
amount of silanes needed to obtain a monolayer on the particles was calculated. The following 
assumptions were made: the surface area of the particle samples that is available for grafting 
is the BET surface area determined by N2 sorption and the restricting factor for the monolayer 
density on a surface is the distance between uncoupled hydrolysed silanes.89 As the maximal 
length of a Si-OH…HO-Si sequence is d = 0.6 nm,89 this is the diameter of the assumed 
covered circular area A =  ቀdଶቁଶ ∗  π of a single hydrolysed organo-silane (N = 1). The surface 
coverage c by an organo-silane is therefore:  
c = nA = NNA ∗ A = ͳNA ∗  ቆቀdʹቁଶ ∗  πቇ = ͷ.ͺ͹Ͷ ∗ ͳͲ−6 molm²  
with NA as Avogadro’s constant (͸.Ͳʹʹ ∗ ͳͲଶଷ ଵ୫o୪) and the chemical amount n = NNA. The 
calculated amount of silane for each of the particle samples utilized for grafting in this chapter 
are shown in Table III - 3. 
Table III - 3. Calculation of the theoretic amount of silane needed depending on the specific 
surface area of the particle sample. 
particle samples specific surface area S 
(N2 sorption) [m²/g] 
theoretic amount a of required 
silane per mg particles: 𝐚 = 𝐜 ∗ 𝐒 
[µmol/mg] 
AA-TiO2 207.5 1.22 
MEEAA-TiO2 (200 °C 4 h) 185.2 1.09 
 
Following this, concentrations from 50 µmol to 0.5 µmol [3-(2-aminoethylamino)propyl]-
trimethoxysilane per mg nanoparticle were used. The AA-TiO2 particles (160 °C, 4 h) were 
chosen as model particles for both the basic and acidic (to later basic) grafting protocols. After 
grafting the silane onto them, the samples were characterized via zeta potential, DLS, as well 
as DRIFT measurements. The results are shown in Table III - 4 (zeta potential and DLS 
analyses) and in Figure III - 2 (DRIFT). DLS measurements have been carried out in ethanol, 
to visualize a successful functionalization of the nanoparticles as the non-functionalized 
particles are not stably dispersed in ethanol resulting in large agglomerate sizes. The organo-
silane mediates a stabilisation in ethanol; this means if the agglomerate size is significantly 
decreased, the functionalization has been successful and the particle surface is sufficiently 
modified to ensure a tuning of the surface properties of the particles by the organic grafting 
agent. The results of DLS measurements all indicate a successful functionalization as the 
agglomerate size of the (former not stably dispersed) particles in ethanol is smaller than 50 nm 
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after the silane grafting. It appears that the agglomerate size can be decreased with increasing 
amounts of silanes due to a larger number of functional groups on the particle system that 
enhance the dispersibility in ethanol. If the amount of grafting agent is increased further, the 
diameter of the entire particle sample is also increased, which results in slightly larger 
agglomerate sizes. Nevertheless, the difference in agglomerate sizes should not be 
considered too important as the small variations in agglomerate size can also be due to varying 
dispersion efficiency by ultrasonic treatment.  
Table III - 4. Analysis (zeta potential and DLS) of AA-TiO2 functionalized with [3-(2-
aminoethylamino)propyl]trimethoxysilane under basic or acidic (to later basic) conditions. 
Sample 
prepared 
under basic 
conditions, 
ratio of silane 
to NP 
[µmol/mg] 
pH(IEP) 
determined 
by zeta 
potential 
titration 
Agglomerate 
size [nm]  
(PDI [-]) 
in ethanol 
Sample 
prepared first 
under acid 
(to later 
basic) 
conditions, 
ratio of silane 
to NP 
[µmol/mg] 
pH(IEP) 
determined 
by zeta 
potential 
titration 
Agglomerate 
size [nm]  
(PDI [-]) 
in ethanol 
50 8.5 42.9 ± 0.4 
(0.29 ± 0.01) 
50 7.3 34.8 ± 0.3 
(0.29 ± 0.03) 
10 8.0 36.3 ± 0.1 
(0.31 ± 0.01) 
10 7.0 32.3 ± 0.2 
(0.22 ± 0.01) 
5 8.0 37.7 ± 0.2 
(0.29 ± 0.01) 
5 7.2 22.4 ± 0.1 
(0.21 ± 0.01) 
1 7.9 42.0 ± 0.4 
(0.27 ± 0.01) 
1 6.9 24.3 ± 0.2 
(0.23 ± 0.01) 
0.5 7.8 49.8 ± 0.2 
(0.49 ± 0.01) 
0.5 6.9 30.8 ± 0.9 
(0.28 ± 0.01) 
0 (AA-TiO2 as 
reference) 
6.9 1325.3 ± 36.5 
(0.04 ± 0.03) 
0 (AA-TiO2 as 
reference) 
6.9 1325.3 ± 36.5 
(0.04 ± 0.03) 
 
This is why the determined pHs of the IEPs (Table III - 4) and DRIFT (Figure III - 2) spectra 
were taken to decide on the most efficient grafting protocol. The IEPs of the samples shift 
towards more basic pHs with increasing amounts of organosilane added during the grafting. 
This indicates that the more reactant is present, the more silane is grafted onto the TiO2 NPs, 
i.e. the more amines are present on the surface overlaying the original surface potential of the 
TiO2 particles. Comparing both grafting protocols, it is evident that the pHs of the IEPs of the 
samples synthesized with the basic protocol are in all cases more basic than in the case of the 
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protocol starting under acidic conditions. This indicates a more efficient grafting under basic 
conditions. 
The DRIFT spectra show an increase in the relative intensities of the characteristic absorption 
bands of the grafted organo-silane. The intensities of the bending vibrations of CH2 and NH at 
1450 cm-1 and 1590 cm-1 incline with higher amounts of added grafting agent for both grafting 
conditions. This becomes evident if one compares these maxima for example with the local 
absorption minima close to 1500 cm-1. However, it has to be mentioned that these spectra 
cannot be quantitatively analysed as firstly the baseline corrections are rather difficult due to 
the high absorption of TiO2 (below ~ 1000 cm-1) and secondly no specific vibration band was 
found without intensity changes for all measured samples. Already with the smallest organo-
silane addition, the vibration bands of the organic moieties (acetylacetonate and p-toluene 
sulfonic acid) resting from TiO2 synthesis seem to be drastically decreased. This can be 
explained by the surface sensitivity of DRIFT measurements; the grafted silane present on the 
surface may overlay the signals of the other present molecules. 
 
Figure III - 2. IR (DRIFT) spectra of AA-TiO2 functionalized with [3-(2-
aminoethylamino)propyl]trimethoxysilane under a) basic or b) acidic (to later basic) 
conditions.(*adsorbed HNO3 of the grafting procedure) 
In this context it is also not clear, if the grafted silane layer substitutes the organic surface 
moieties (Scheme III - 21 a), leaves space for them (Scheme III - 21 b), covers for them 
(Scheme III - 21 c) or does a combination of all these possibilities. Comparing the samples of 
both grafting protocols modified with 0.5 or 0 µmol/mg organo-silane, the basic protocol seems 
to be slightly more efficient as the vibration bands of the organic surface groups from NP 
synthesis are less intense compared to the vibration bands of the grafted [3-(2-
aminoethylamino)propyl]trimethoxysilane, i.e. the CH2 and NH vibrations. 
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Scheme III - 21. Possible interactions between the grafted silanes and surface moieties of TiO2 
particles (R, R1 = organic groups): silanes a) substitute the surface group, b) leave space for 
it or c) enclose it. 
Thus, the results obtained by DRIFT measurements seem to confirm the outcomes of zeta 
potential analyses and the basic protocol is considered to be the more suitable protocol as the 
grafting of silane onto the particles is more efficient. This is important as it means that less side 
products caused by oligomerization are formed and the total amount of silane needed for the 
grafting is lower. As the basic protocol was therefore chosen for future graftings, the 
photocatalytic activity of the samples (functionalized via the basic protocol) with the smallest 
amounts of silane (1 and 0.5 µmol/mg), was examined to determine the influences of the 
surface functionalization on the photocatalytic activity. The results are shown in Figure III - 3. 
The activity of AA-TiO2 functionalized with 1 µmol/mg and 0.5 µmol/mg [3-(2-
aminoethylamino)propyl]trimethoxysilane is reduced to 56 % and 64 % compared to the 
unmodified particles. 
 
Figure III - 3. Photocatalytic activity of AA-TiO2 functionalized with 1 µmol/mg or 0.5 µmol/mg 
[3-(2-aminoethylamino)propyl]trimethoxysilane in comparison to the unmodified AA-TiO2. The 
values are normed on the amount of degraded dichloroacetic acid (DCA, i.e. produced Cl-) by 
AA-TiO2 after 3 h photocatalysis test (= 100%). 
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In order to study if a further decrease in the amount of grafting agent still results in an efficient 
functionalization but a higher preserved photocatalytic activity, (3-trimethoxysilylpropyl)-
diethylenetriamine was utilized as a model organo-silane (Scheme III - 22).  
 
Scheme III - 22. (3-Trimethoxysilylpropyl)-diethylenetriamine. 
This molecule bears more CH2 and NH groups and therefore the shift of the IEPs of the 
functionalized particles was expected to be more pronounced. Additionally, it has a higher 
molecular weight, which is more similar to the synthesized organo-silanes and might impede 
the photocatalytic activity more significantly. The results obtained from grafting AA-TiO2 with 
N1-(3-trimethoxysilylpropyl)diethylenetriamine in concentrations from 1 to 0.05 µmol/mg 
particle are summarized in Table III - 5. 
Table III - 5. Analysis (zeta potential, DLS and photocatalytic efficiency) of AA-TiO2 
functionalized with N1-(3-trimethoxysilylpropyl)diethylenetriamine under basic conditions. 
Sample 
prepared under 
basic 
conditions, ratio 
of silane to NP 
[µmol/mg] 
pH(IEP) 
determined 
by zeta 
potential 
titration 
Agglomerate size [nm] 
(PDI [-]) 
in ethanol 
Photocatalytic 
efficiency compared 
to the unmodified 
particle samples 
after 3 h 
photocatalysis test 
1 8.7 59.0 ± 19.0 (0.48 ± 0.24) 64 % 
0.5 8.5 62.1 ± 5.7 (0.64 ± 0.20) 73 % 
0.1 7.7 1200 ± 145 (0.38 ± 0.05) 67 % 
0.05 7.3 932 ± 178 (0.17 ± 0.05) 82 % 
0 (AA-TiO2 as 
reference) 
6.9 1325.3 ± 36.5 (0.04 ± 0.03) 100 % 
 
In comparison to the 1 and 0.5 µmol/mg [3-(2-aminoethylamino)propyl]-trimethoxysilane 
grafted under basic conditions (Table III - 4), the pHs of the IEPs of N1-(3-
trimethoxysilylpropyl)diethylenetriamine are as expected more basic (8.7 and 8.5 compared to 
7.9 and 7.8 for 1 and 0.5 µmol/mg, respectively). Additionally, the slightly higher hydrodynamic 
diameters of the samples (around 60 nm instead of around 45 nm for both 1 and 0.5 µmol/mg) 
are supposed to be mainly caused by the longer organic chain of the silane. Surprisingly, the 
larger silane reduces the PC performance slightly less (64 % and 73 % compared to 56 % and 
64 % for 1 and 0.5 µmol/mg, respectively). Possible explanations can be a better dispersion 
state and higher positive surface charge at the acidic pH of the DCA degradation test. This 
results in more accessible NP surface area and favours molecular adsorption, which is 
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supposed to lead to a more efficient catalytic degradation of DCA. Concerning the smaller 
concentration of silane per mg NP (0.1 and 0.05 µmol/mg), one can conclude from DLS (large 
agglomerate sizes) and zeta potential analyses (only small shifts of the pHs of the IEPs) that 
these quantities are not sufficient to significantly influence the surface properties of the 
particles. Therefore, these quantities are considered too low to provide an efficient surface 
functionalization of the NPs. 
Due to these results a concentration of 0.5 to 1 µmol silane per mg AA-TiO2 seems to be 
optimal to obtain a significant change in the surface properties of the particles. These 
concentrations are slightly smaller than the calculated one (1.22 µmol/mg), which could 
indicate that the formed silane layer is not completely closed around the NP. This should 
therefore provide a sufficient surface availability for PC reactions. However, the decrease in 
the PC activity of 30 to 40 % cannot be avoided if one intends to manipulate the surface 
properties via functionalization with organo-silanes. 
After having proved the feasibility of modifying the AA-TiO2 nanoparticles with organo-silanes 
and having determined the most efficient grafting conditions, the photocatalytically most active 
particle sample MEEAA-TiO2 synthesized at 200 °C for 4 h was also functionalized with N1-(3-
trimethoxysilylpropyl)diethylenetriamine to determine the most appropriate silane 
concentration for this system. This system was also chosen to be functionalized later on with 
the synthesized coupling agents (III.2.2). The obtained results are summarized in Table III - 6. 
Table III - 6. Analysis (zeta potential, DLS and photocatalytic efficiency) of MEEAA-TiO2 
functionalized with N1-(3-trimethoxysilylpropyl)diethylenetriamine under basic conditions. The 
values obtained during the photocatalysis tests are normed on the amount of degraded DCA 
(produced Cl-) by MEEAA-TiO2 after 3 h photocatalysis test (= 100%). 
ratio of 
silane to NP 
[µmol/mg] 
pH(IEP) 
determined 
by zeta 
potential 
titration 
Agglomerate size [nm] 
(PDI [-]) 
in EtOH 
Photocatalytic efficiency 
compared to the 
unmodified particle 
samples after 3 h 
photocatalysis test 
 
4 7.1 41.3 ± 0.6 (0.23 ± 0.01) 78 % 
2 7.3 41.6 ± 0.6 (0.24 ± 0.02) 67 % 
1 7.1 36.1 ± 0.6 (0.23 ± 0.03) 62 % 
0.5 7.3 62.8 ± 0.5 (0.37 ± 0.01) 81 % 
0 (MEEAA-
TiO2 as 
reference) 
6.6 1672 ± 520.4 (0.18 ± 0.12) 100 % 
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While the grafting with 0.5 µmol/mg seems to form a less dense layer, which is expressed by 
a larger agglomerate size, all other concentrations show no significant differences in 
agglomerate size or PC activity. It is assumed that with the amount of 1 µmol/mg a monolayer 
is formed on the NP surfaces and therefore further condensation onto the surfaces is hindered 
by the organic chains of the silanes. For increasing the silane layer on the particles, 
significantly more grafting agent is needed. This assumption is supported by the theoretic 
calculations, which indicated exactly a concentration of 1 µmol/mg for a monolayer on the 
chosen MEEAA-TiO2 (200 °C 4 h). In comparison to the functionalized AA-TiO2 the IEP of the 
MEEAA-TiO2 samples are slightly less shifted which could indicate either a less efficient 
grafting or a higher influence of the organic surface groups that are already present on the 
particle samples after synthesis.  
Based on the obtained results, the concentration of 2 µmol/mg silane per NP was chosen as 
ideal concentration for the future graftings (of synthesized coupling agents, discussed in 
III.2.2). This concentration seemed to be a good equilibrium between a sufficient amount of 
silane to guarantee a successful grafting even with larger, bulkier silanes and the probable 
waste of excess silane.  
 
III.2.2. Grafting of synthesized coupling agents onto MEEAA-TiO2 (200 °C, 4 h) 
After having optimized the grafting protocol and determined suitable concentrations for the 
functionalization of the most efficient photocatalytic nanoparticles, namely MEEAA-TiO2 
synthesized at 200 °C for 4 h, the graftings of the synthesized coupling agents I and IV were 
carried out with the chosen concentration of 2 µmol silane per mg NP. 
III.2.2.a. Grafting of coupling agent I 
The successful grafting of coupling agent I (Scheme III - 23) onto MEEAA-TiO2 was examined 
with the help of zeta potential, DLS, IR and PL measurements.  
 
Scheme III - 23. Coupling agent I. 
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The obtained IEP and the agglomerate size for the functionalized NP system are shown in 
Table III - 7 and compared to the unmodified system as reference.  
Table III - 7. pH of IEP (zeta potential) and agglomerate size (DLS) of MEEAA-TiO2 
functionalized with coupling agent I compared to the unmodified NP system. 
ratio of coupling agent I to 
MEEAA-TiO2 NP [µmol/mg] 
pH(IEP) determined 
by zeta potential 
titration 
Agglomerate size [nm]  
(PDI [-]) 
in water pH = 10 
2 5.4 461 ± 26 (0.45) 
0 (= reference) 6.6 10.000 ± 2.000 
 
The pH of the IEP shifts significantly, indicating a successful surface modification. Keeping in 
mind the structure of coupling agent I, it is evident that the surface potential of the modified 
particle is mainly dominated by the functional groups of rhodamine B, i.e. the carboxyl and the 
tertiary amines. As the pKa value of rhodamine B is reported to be 3.0 to 3.7,105,106 it is not 
surprising that the IEP shifts towards more acidic pH values. According to the measurements, 
the highest zeta potential of the functionalized sample was reached using basic pHs. This is 
why the DLS measurements were carried out at the pH of 10 to ensure the best electrostatic 
stabilisation of the particle dispersion. In contrast to this, the dispersibility of the unmodified 
TiO2 NPs was very low at this pH. This is why the modified NPs show significantly smaller 
agglomerate sizes. Nevertheless, the measured hydrodynamic diameter is still very large 
compared to well-dispersed particle samples without modification or modified with the 
commercial amino-silanes. This is most probably caused by the low solubility of rhodamine in 
water107 which is not favoring a good dispersion state of the functionalized NPs. 
A further confirmation of the successful NP functionalization are the obtained IR spectra 
(Figure III - 4) of the unmodified particles (exposed to grafting conditions to obtain a reliable 
reference), the coupling agent I before grafting and the particle system functionalized with 
the coupling agent I. Characteristic absorption bands of the coupling agent I can also be 
identified on the functionalized particles (marked in Figure III - 4 with arrows). The absorption 
bands with wave numbers from 2980 to 2870 cm-1 are caused by asymmetric stretching of CH3 
(2978 cm-1) and CH2 (2927 cm-1) as well as symmetric stretching of CH2 (2870 cm-1) of the 
coupling agent I. The signals between 1750 and 1000 cm-1 are dominated by vibrations of 
the Rhodamine B component which cover signals of the rest of the molecule and were 
assigned based on literature:108–110 The stretching of the xanthene ring (ν CC, ν CO, ν COC) 
causes signals at 1645 and 1272 cm-1. Bending and stretching vibrations of the aromatic rings 
(CCH, CC) absorb at 1334 and 1176 cm-1. The vibrations of the carboxyl group cause signals 
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at 1583 cm-1 (νas COO-), 1409 cm-1 (νs COO-) and 1243 cm-1 (ν CO), while the absorption band 
at 1468 cm-1 may be attributed to vibrations of the ethylamino groups (ν CN). 
 
Figure III - 4. IR (DRIFT or ATR) spectra of the MEEAA-TiO2 functionalized with coupling 
agent I (black) compared to the coupling agent I (red) and the unmodified MEEAA-TiO2 
(blue). 
The last evidence of a successful particle modification is the measured PL spectrum and the 
strong pink colour of the samples visible by eye (Figure III - 5). The absorption and PL maxima 
lie in the expected wavelength ranges, outside the absorption range of the TiO2 nanoparticles. 
In order to finalize the examinations of the NP system functionalized with coupling agent I, 
its photocatalytic (PC) activity was assessed and compared to the unmodified NPs reference. 
The outcomes are shown in Figure III - 6. Based on the results obtained for the particles 
modified with commercial silanes (III.2.1), it was expected that the PC performance is going to 
be decreased after the grafting of coupling agent I. Nevertheless, the PC activity was 
significantly increased which is surprising as the grafting of the silane reduced the TiO2 surface 
area available for photocatalysis. There are two possible explanations for this behaviour; either 
the rhodamine acts as photosensitizer or the modified surface charge enhances molecular 
adsorption.  
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Figure III - 5. PL spectrum of unmodified (blue) and functionalized (black) MEEAA-TiO2 (with 
coupling agent I); excited at 556 nm (i.e. at the absorption maximum of the functionalized 
particle system). Additionally, photographs of both particle samples as dispersions in water at 
pH = 10 are shown. 
 
Figure III - 6. PC activity of MEEAA-TiO2 functionalized with coupling agent I (black) 
compared to the unmodified MEEAA-TiO2 (blue). The values are normed on the amount of 
degraded DCA (produced Cl-) by MEEAA-TiO2 (4 h, 200 °C) after 3 h photocatalysis test (= 
100 %). 
It is well-known, that dyes that are in contact with semiconductor surfaces can transfer 
absorbed energy.111 As rhodamine B absorbs light of a different wavelength range compared 
to TiO2, the energy transfer of the dye onto the NP would increase the PC performance as 
more light is absorbed in total, i.e. more electron-hole pairs are created that can take part in 
PC reactions. Rhodamine B seems suitable for this approach112 but it is questionable if this is 
really happening or/and having a significant influence on the PC performance of the sample 
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as the applied UV-light for the PC test should only lie between 300 and 400 nm and the main 
absorbance of rhodamine B takes place over 460 nm.113 It is considered as more probable that 
the modified surface charge (significant shift of the pH of the IEP) or the properties of the 
surface moieties may either favour the adsorption of the dichloroacetic acid used as 
degradable substance or of the water or oxygen molecules. This would also lead to a more 
efficient photocatalysis as every photocatalytic reaction demands pre-adsorption of the 
participating molecules.114 
To sum up, while a PL nanoparticle system with a good PC activity was successfully obtained, 
its surface charge and agglomerate size is not adequate for the use as positively charged anti-
tumour agent. This is why the introduction of amines as functional terminal groups within the 
surface agent has to be achieved. 
III.2.2.b. Grafting of coupling agent IV 
Concerning this matter, the successfully synthesized coupling agent IV (Scheme III - 24) was 
grafted onto MEEAA-TiO2 (4 h, 200 °C). The obtained modified NP system was again analysed 
with zeta potential and DLS (Table III - 8). 
 
Scheme III - 24. Coupling agent IV. 
Table III - 8. IEP (zeta potential) and agglomerate size (DLS) of MEEAA-TiO2 functionalized 
with coupling agent IV compared to the unmodified NP system. 
ratio of coupling agent IV to 
MEEAA-TiO2 NP [µmol/mg] 
pH(IEP) determined 
by zeta potential 
titration 
Agglomerate size [nm]  
(PDI [-]) 
in water pH = 3 
2 6.2 658.1 ± 21.2 (0.8) 
0 (= reference) 6.6 32.8 ± 0.8 (0.1) 
 
Considering the structure of coupling agent IV, the only marginal shift of the IEP of the 
functionalized NPs in comparison to the NPs before grafting is no surprise as the organic 
molecule does not bear any ionic groups and should therefore not influence the surface charge 
of the NPs. This is why the zeta potential measurements are not appropriate to prove the 
grafting in this particular case. The agglomerate size of the samples was considerably 
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augmented after the functionalization which may be explained by a less efficient electrostatic 
stabilisation of the samples due to the uncharged coupling agent. However, it could also point 
out that the functionalization led to the formation of NP clusters resulting in the aggregation of 
particles. IR measurements (Figure III - 7) were able to finally prove the grafting of the 
coupling agent IV onto MEEAA-TiO2.  
 
Figure III - 7. IR (DRIFT or ATR) spectra of the MEEAA-TiO2 functionalized with coupling 
agent IV (black) compared to the coupling agent IV (red – compound 24) and the unmodified 
MEEAA-TiO2 (blue) in the region a) 3750-2500 cm-1 and b) 1800-1250 cm-1. 
For these measurements compound 24 (Scheme III - 17) instead of compound 25 (Scheme 
III - 17) was used as it was more stable and therefore easier to handle during the analysis 
while already providing the most important molecular functions of the coupling agent. Its IR 
spectrum is compared to the spectra of the unmodified NPs and of the coupling agent IV 
grafted onto the NPs. Characteristic absorption bands of the compound 24 can also be 
identified on the functionalized particles (marked in Figure III - 7 with arrows). Symmetric 
stretching of NH in amides absorbs at 2285 cm-1 and symmetric stretching of CH in the 
aromatic rings of the phthalimide at 3085 cm-1. The absorption bands with wave numbers from 
2955 to 2850 cm-1 are caused by asymmetric and symmetric stretching of CH2. The signals at 
1770 and 1706 cm-1 are dominated by asymmetric and symmetric stretching vibrations of the 
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C=O in the imides and the C=C deformation of the aromatic rings cause a band around 1669 
cm-1.115 The vibrations of the amide groups (amide I: ν C=O, amide II: ν CN, δ NH) of coupling 
agent IV cause signals at 1669 and 1555 cm-1.104 It has to be admitted that not all of the 
characteristic bands can be found on the functionalized NP sample and the ones that can be 
identified are less intense compared to the samples modified with coupling agent I. This could 
indicate a less efficient grafting in the case of coupling agent IV. 
In order to further analyse the obtained sample and to evaluate its suitability for future 
applications as anti-tumour agent, it is of utter importance to remove the phthalimide protecting 
groups to obtain terminal primary amines and therefore positively charged particle surfaces at 
physiological pH. The deprotection of phthalimide protected amines is usually carried out with 
bases containing a primary amine such as methylamine or hydrazine.55,116–121 The reaction 
mechanism for the phthalimide cleavage with hydrazine is shown in Scheme III - 25.  
 
Scheme III - 25. Mechanism of the phthalimide protecting group cleavage with the help of 
hydrazine. 
In this study, 3, 10, 100 or 1000 molar equivalents of amine of the base (either methylamine 
or hydryzine) per phthalimide group of the coupling agent IV and a reaction time of 16 h at 
room temperature were chosen. Because of the nature of the NP dispersion, water was used 
as solvent for this reaction. The theoretic amount of coupling agent IV per mg NP (which was 
used for the grafting) was used as basis for these calculations. The concentration rows of the 
bases were supposed to allow the determination of the most appropriate amount of base, 
which guarantees an efficient phthalimide cleavage while not destroying the Si-O-Ti bonds via 
basic hydrolysis. The planned deprotection of the grafted coupling agent IV is shown in 
Scheme III - 26. A successful deprotection should result in the disappearance of the absorption 
bands in IR of the phthalimide groups (especially the stretching vibrations of C=O in the imide). 
However, for the sample examined in this study, these changes may be very difficult to detect 
due to the low intensity of the absorption bands of coupling agent IV grafted onto MEEAA-
TiO2. Furthermore, the pHs of the IEPs of the samples should show a significant basic shift 
and the dispersion state of the NPs was expected to be improved because of better 
electrostatic stabilisation.  
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Scheme III - 26. Phthalimide protecting group cleavage of the grafted coupling agent IV. 
All IEPs of the obtained samples lay in the pH range of 5.8 to 6.1 (for more details see Appendix 
II) which clearly is no significant shift towards basic pH and rather resembles the IEP of the 
unmodified MEEAA-TiO2. Also, the hydrodynamic diameters of the samples were not 
significantly decreased (for more details see Appendix II). While the shift in the pH of the IEP 
could indicate that the entire coupling agent is removed from the particle surface instead of a 
phthalimide group cleavage, the DLS measurements do not confirm this assumption as the 
agglomerate sizes were not decreased (which is expected for a “cleaned” MEEAA-TiO2 
surface). For more insights, DRIFT measurements were conducted. Independent of the type 
(methylamine or hydrazine) or concentration of base used, there was no difference in the 
obtained DRIFT spectra between all base-treated samples. This is why the spectrum of the 
sample (coupling agent IV-MEEAA-TiO2) treated with 10 eq methylamine is shown as 
representative example in Figure III - 8 and compared to the unmodified MEEAA-TiO2, the 
unmodified MEEAA-TiO2 treated with methylamine and the coupling agent IV-MEEAA-TiO2. 
Comparing the unmodified MEEAA-TiO2 to the unmodified MEEAA-TiO2 treated with 
methylamine, it is evident that the base treatment does not change the nature of MEEAA 
surface groups. Small variances in the spectra such as between 1700 and 1600 cm-1 are most 
probably caused by a varying amount of adsorbed water in the samples. The characteristic 
absorption bands of coupling agent IV-MEEAA-TiO2 are partly maintained during the base 
treatment (indicated with arrows in Figure III - 8).  
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Figure III - 8. IR (DRIFT) spectra of the coupling agent IV-MEEAA-TiO2 treated with 10 eq 
methylamine (orange) compared to the unmodified MEEAA-TiO2 (blue), the unmodified 
MEEAA-TiO2 treated with methylamine (green) and the coupling agent IV-MEEAA-TiO2 
(black) in the region a) 3800-2500 cm-1 and b) 1800-1250 cm-1. 
The most evident signals are the asymmetric and symmetric stretching of CH2 (from 2955 to 
2850 cm-1) which prove the presence of organic coupling agent components on the particles. 
Other signals (marked with * in Figure III - 8) such as the symmetric stretching of CH in the 
aromatic rings of the phthalimide (3085 cm-1) or asymmetric and symmetric stretching 
vibrations of the C=O in the imides (1770 and 1706 cm-1) seem to be no longer detectable. 
Due to the low intensity of the before mentioned absorption bands, it is not clear if they 
disappeared because of phthalimide cleavage or destruction of parts of the coupling agent or 
if they are just partly covered for example by vibrations of higher amounts of adsorbed water.  
Based on these not very conclusive results, one can deduce that possibly no cleavage of the 
phthalimide group occurred, while a destruction of parts of the coupling agent or the partial 
removal of the entire coupling agent by Si-O-Ti cleavage seem to be an option. While there 
are still a lot of options to improve the deprotection procedure such as the use of temperature 
or decrease in present water along with the use of other solvents, the evaluation of the 
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deprotection success will always remain challenging with this functionalized NP sample. One 
obstacle is the difficulty to first determine the grafting success as the characteristic vibration 
bands in DRIFT of the grafted coupling agent IV are weak and IEP does only shift minimally. 
This means it is not possible to distinguish between the unsuccessful cleavage with the 
coupling agent remaining intact and the removal of parts of the coupling agent during the 
phthalimide cleavage procedure. For more meaningful investigations, the use of other NPs 
with less absorptive material (such as silica) and no organic groups (such as P25 TiO2 or silica) 
would be advisable to obtain more significant changes in the DRIFT spectra. However, this 
was not the aim of this work and is therefore not treated herein. 
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III.3. Conclusion 
In this chapter the synthesis of organic coupling agents and their subsequent grafting onto the 
before synthesized TiO2 NPs was investigated. Concerning the organic syntheses, four either 
luminescent or non-luminescent dendritic or linear structures were aimed at as shown in 
Scheme III - 27. The first three coupling agents all contain a rhodamine dye. The coupling 
agent I as linear molecule without terminal amine group was successfully obtained and proved 
the stability of the luminescence agent during all synthesis and washing steps. The coupling 
agent II was supposed to combine the incorporation of the dye with a terminal functional group. 
Several synthesis steps were successfully carried out up to the coupling of the non-
luminescent components of the coupling agent to the dye by establishing a thiourea linkage. 
However, this thiourea linkage on the alpha position of the lysine was responsible for the 
rearrangement (cycle formation) of the molecule under acidic conditions. The lability of the 
amide linkage next to the thiourea has never been reported for lysine under the reaction 
conditions used (strong acids, room temperature). In this context, the cleavage of both the Boc 
and Z protection group was not possible and the synthetic pathway was not continued. 
Nevertheless, the insights gained during the synthesis of coupling agent II helped to 
synthesize coupling agent III, a luminescent 1st generation dendritic molecule. This was by 
far the most complex synthesis route with several obstacles that had to be overcome; for 
example, the dipeptide formation during Fmoc-protection of Z-lysine was effectively reduced 
to a minimum by the use of DMF as organic solvent (instead of THF or dioxane). The instability 
of the ester bond of the first established dendron under hydrogenation due to transesterification 
reactions (in presence of an alcohol) was rather surprising as well and initiated further 
examinations of the stability of this bond. It became evident, that these ester bonds will partly 
be transformed by transesterification reactions due to the basic hydroalcoholic milieu used. 
Using an amide instead of the ester function, provided a stable molecule up to the final reaction 
step. Thanks to the experiences made during the synthesis of coupling agent II, instead of 
rhodamine isothiocyanate, the NHS-rhodamine was used. This guaranteed the stability of the 
compound during the subsequent reaction steps. Coupling agent III was therefore 
successfully obtained. Coupling agent IV, a dendritic non-luminescent coupling agent bears 
the same dendritic branches as coupling agent III while not containing the lysine moiety or a 
dye. This compound was also successfully obtained. The synthesis of 2nd generation dendritic 
coupling agent V and coupling agent VI with a similar structure either to coupling agent III 
or to coupling agent IV was started but is still in progress. While the quantity of the 
successfully synthesized coupling agent III was too low to proceed with the grafting reaction, 
both coupling agent I and IV were available for it. 
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Scheme III - 27. Organic coupling agents synthesized in this chapter. 
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For the grafting, first the most adequate grafting procedure was successfully determined with 
commercial silanes ([3-(2-aminoethylamino)propyl]-trimethoxysilane, N1-(3-trimethoxysilyl-
propyl)diethylenetriamine). Basic hydroalcoholic grafting conditions seemed to be superior to 
a protocol starting under acidic conditions while both procedures led to a successful particle 
modification. The surface charge of the particles was effectively manipulated as shown by zeta 
potential measurements, while the PC activity of the TiO2 particles was slightly reduced (a 
reduction of 20 – 40 % was generally determined). In the case of MEEAA-TiO2 (4 h, 200 °C), 
an amount of 1 to 4 µmol of added silane per mg NPs resulted in similar results concerning 
the surface charge and PC activity. This indicates that a monolayer is formed that impedes 
further condensation of silane molecules because of the steric hindrance of the organic groups 
of the grafting agent. The amount of 1 µmol/mg as minimal amount of silanes needed to obtain 
a monolayer on the particles is in good agreement with the calculated amount of 1.09 µmol/mg 
(for MEEAA-TiO2). The addition of considerably higher amounts of silane (as tested with AA-
TiO2) presumably leads to the growth of further molecular layers around the NPs. 
This is why 2 µmol silane per mg NP was chosen as optimal amount for the grafting of the 
synthesized coupling agents I and IV onto MEEAA-TiO2 (4 h, 200 °C). The successful grafting 
of coupling agent I was confirmed by all used analysis methods (IR, DLS, zeta potential 
measurements). The surface potential of the NPs was significantly modified by the 
functionalisation which led to a considerably negative surface charge at physiological pH. In 
the context of the planned later applications in cell culture tests, a positive surface charge is 
desired and therefore, this result stressed the need of basic groups such as primary amines in 
the coupling agents. Also the dispersion state of the modified particles in water was not 
satisfying which is not surprising as rhodamine is known to have a low solubility in it. An 
integration of terminal amine groups into the coupling agent would therefore also certainly 
improve the dispersibility of the sample. Nevertheless, the obtained modified NPs showed a 
very high PL and an excellent PC activity even outreaching the results of unmodified samples. 
This surprising PC performance was supposed to be caused by the significantly changed 
surface charge which may favour the adsorption of molecules taking part into the photocatalytic 
reactions. The successful grafting of coupling agent IV was confirmed by IR even though the 
detected characteristic absorption bands were of low intensity. The IEP of the sample was not 
significantly changed which may be owed to the absence of ionic components in the coupling 
agent. The attempts which were carried out in order to cleave the phthalimide protection group 
of the grafted coupling agents IV, were not conclusive and have not yet been successful.  
Summing up, the feasibility to synthesize luminescent and non-luminescent dendritic coupling 
agents as well as their grafting onto the before synthesized TiO2 NPs was successfully shown 
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(while the complete synthesis of all planned coupling agents is still under progress). The 
potentials as well as obstacles of the organic synthesis routes and grafting procedures of these 
coupling agents were clearly shown. For future studies the synthesis of luminescent coupling 
agents (in particular) should be further investigated and optimized. Also, the phthalimide 
protecting group cleavage of grafted coupling agents still has to be developed. Additionally, it 
could be considered to use the phthalimide protected coupling agents as obtained because of 
the probable anti-tumour activity of phthalimide groups.122 
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IV.  Cell culture examinations of synthesized TiO2 particle systems 
The first step for future applications of TiO2 nanoparticles in the biomedical field is the 
examination of their in vitro cytotoxicity. A compound is considered to be cytotoxic in vitro if it 
interferes with the cells, which includes cellular attachment, significant morphology alterations, 
an adverse cell growth rate or cell death.1 Nevertheless, the most common and reliable method 
for the evaluation of cytotoxicity is the evaluation of the relative number of dead cells compared 
to viable cells. The cytotoxicity of the synthesized nanoparticles (NPs) towards malignant and 
non-malignant cell types has to be examined as this is very important for later applications as 
tumour treatment agent; the particles should be non-toxic (in their inactivated form) towards all 
cell types to provide a specific photocatalytic (PC) tumour treatment when ultraviolet (UV) light 
is applied.  
FaDu cells and primary human mesenchymal stem cells have been selected as representative 
cell systems for all in vitro tests in this chapter. FaDu is a well-established cell line of head and 
neck squamous cell carcinoma (HNSCC). Previously, cancer cell elimination of HNSCC by 
photoactivated NPs has been described.2 In the current investigation, FaDu cells were used 
for the cytotoxicity tests with respect to possible applications of TiO2 NPs as a photosensitising 
agent in experimental cancer therapy in future. Furthermore, human bone marrow-derived 
mesenchymal stem cells (BMSC) were applied in order to examine toxicity in non-malignant 
cells. Due to their phenotypic and cellular plasticity, stem cells are considered a promising test 
system for cytotoxicity evaluations.3 For further cytotoxicity assessments also HLaC78 cells as 
another tumour cell line and primary human fibroblasts as a non-malignant cell type, which are 
present in the tissue of interest, were selected.  
The duration of NP incubation with the cells before cytotoxicity assessment was chosen to be 
24 h as the particle uptake is said to start as early as one hour after NP addition and proceeds 
at least for 24 hours.4 The chosen 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium 
bromide (MTT) assay detects the viability of cells; only viable cells bearing intact mitochondria 
are able to metabolise the applied yellow tetrazolium MTT salt into a purple formazan crystal 
(Scheme IV - 1).5–7 This colour change can be easily detected using an automated 
spectrophotometric microplate reader. It is a well-established method used for various 
categories of malignant and non-malignant cells and cell lines in vitro in immunological 
investigations, cancer research and material biocompatibility evaluations.1,8–10 The advantage 
of this assay is that it only needs a small amount of cells and is quite sensitive towards cytotoxic 
events, which allows the miniaturization of the test into 96-well plate formats.1,9,11 The assay 
protocol is considerably simple and rapid, reproducible and economic.9,10 As the water-
insoluble formazan requires the addition of DMSO, the assay is a lytic end point assay, giving 
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for example no opportunity for additional spectrophotometric readings.1 Also the pH 
dependence of the absorption spectrum of reduced MTT has to be considered for obtaining 
reliable results.7 
 
Scheme IV - 1. Reduction of tetrazolium salt into formazan.12 
The use of MTT assays to determine the cytotoxicity of particles such as TiO2 NPs is already 
well established.7 Using this method it has to be kept in mind that the metal ions derived from 
the particle samples (like Zn2+ in the case of ZnO NPs) can inhibit the MTT reduction reaction. 
Furthermore, NPs can also deplete free MTT by interactions and therefore cause false 
negative results. Concerning the readout, present NPs can increase the light absorption and 
therefore also falsify the outcomes.7 This is why for every NP sample blind tests with only the 
NPs and MTT have to be carried out to ensure reliable measurements. 
Prior to the toxicity determinations, the particles had to be transferred into cell culture medium 
(and stabilised). This procedure is discussed in the following chapter (IV.1). Subsequently the 
cytotoxicity of both stabilised and not-stabilised particles was examined (IV.2). Finally, an 
observed tumour treatment effect of the examined particle samples is described in IV.3. 
IV.1. Stabilisation of TiO2 nanoparticles in cell culture media* 
For the use of nanoparticles in in vitro or in vivo tests the particles have to be transferred into 
physiological solutions. Doing this, a problem arises: without appropriate surface modification, 
NPs tend to agglomerate and sediment in these solutions due to their pH and salt  
content.13–15 This was also the case for the synthesized AA-TiO2 and MEEAA-TiO2 standard 
particles that were used for these examinations. The particles already lost their dispersion state 
                                               
*
 Parts of this chapter have been published and are reused in this work by courtesy of Elsevier, original 
article: S. Koch et al., Colloids Surf., B, 2016, 143, 7–14. 
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if they were brought to neutral pH, which was necessary for the transfer into cell culture media. 
Agglomerate sizes of several µm were observed (Figure IV - 1).  
 
Figure IV - 1. Average hydrodynamic diameter (Z-average) of AA-TiO2 and MEEAA-TiO2 after 
synthesis and ultrasonic treatment (US), after neutralisation and after transfer into DMEM, 
BEGM or RPMI. *Standard deviations of these values may not be reliable as DLS 
measurements were impeded by sedimentation of the NPs. 
In  aqueous solutions the colloids are mainly stabilised by electrostatic repulsion between 
equally charged particles16. This electrostatic stabilisation is always limited to a certain pH 
range as at a particular concentration of OH−or H3O+, these ions may neutralize the surface 
charge of the particles up to their isoelectric point resulting in flocculation.17,18 In the same way, 
an increase of ionic strength of the solution, for example due to dissolved salts, results in 
destabilisation of colloidal dispersions, which is well described by the DLVO (Derjaguin-
Landau-Verwey-Overbeek) theory.19 This is why, after transfer into cell culture media (DMEM, 
BEGM or RPMI), the agglomerate sizes of the samples had not been significantly reduced and 
sedimentation of the particles occurred immediately. In order to ensure a consistent 
assessment of the therapeutic and diagnostic potential of NPs in cell culture experiments or 
animal testing, this issue needs to be addressed: studies concerning particle concentrations 
are only reliable when carried out with stable dispersions that guarantee an accurate dosing. 
The effect of different sized particles on cells can only be studied if the particles do not form 
large agglomerates.13,20,21 In the case of PC NPs, agglomeration also leads to an unwanted 
reduction of surface area and therefore lower PC efficiency.13,22  
Thus, a suitable stabilising agent had to be found to achieve stable, non-agglomerated NP 
dispersions in cell culture media. In order to do so, several stabilising agent have been 
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screened: fetal bovine serum (FBS) and bovine serum albumin (BSA) were used as biological 
stabilising agents since they have been previously applied for this purpose,13–15,20 and thus 
serve as reference systems. BSA can be found abundantly in bovine blood plasma14,15,20 and 
FBS is commonly added as a growth supplement to cell culture media.13,14 They both form a 
protein corona around particles through ionic interactions and therefore act as stabilisers23,24 
due to mainly electrostatic but also to a certain extent weak steric effects.14 Furthermore, 
polycarboxylate ethers (like Melflux®4930 F, Melpers®V4343 and Sika®ViscoCrete®-
10110178) as combined ionic and steric surfactants have been chosen as stabilising agent. 
Their great potential for various NPs in solutions has been demonstrated recently.18,25,26 
Polycarboxylate ethers have been commonly used in the cement industry as superplasticisers 
that adsorb onto silicate particles, improving the particle mobility and flow behaviour of cement. 
The polycarboxylate ether comb-polymers consist of a polycarboxylate backbone and 
polyethylene oxide side chains bound to the backbone as esters. They adsorb onto the 
nanoparticle surface via coulombic attractions between the negatively charged backbone and 
the positively charged particle surface.27 Due to the charge of the backbone and steric effects 
of the comb-polymer side chains, the particles are electrosterically stabilised.18 Although this 
property means they are promising candidates for particle stabilisation in environments with 
high ionic strength, to the best of our knowledge, these stabilising agents have never been 
applied in cell culture experiments so far.  
The particles were stabilised following the protocol described in literature.15,20 The surface-
active agents (FBS, BSA, Melflux, Melpers or Sika ViscoCrete) were added to the US treated 
samples at pH 2–3 where the particles are ideally dispersed, as this ensures that the complete 
surface of each individual NP is accessible by the stabiliser molecules for adsorption. When 
the dispersions were then neutralised, the stabilisers prevented particle agglomeration. In 
order to quantitatively evaluate the stabilisation efficiency, DLS and sedimentation studies 
were carried out. The agglomerate size of the stabilised particles was only measured 
immediately after the transfer to cell culture media as the hydrodynamic diameter stayed the 
same over 24 h, which has been proved by Ji et al.14 The sedimentation of the stabilised NPs 
in cell culture media was examined by measuring the absorbance (at 490 nm) of the 
supernatant (= upper 10 %) of the samples immediately and at 24 h after NP transfer. Due to 
light scattering by the particles, the absorbance decreased with lower particle concentration in 
the supernatant when the particles sedimented. The absorbance directly after particle transfer 
was taken as 100 % stably dispersed particles and the measured reference (medium with 
stabiliser but without particles) was considered as 0 % stably dispersed particles. Taking these 
numbers into account the percentage of particles that were still stably dispersed after 24 h was 
calculated. The results for AA-TiO2 are shown in Figure IV - 2. The results for MEEAA-TiO2 
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can be found in the Appendix III. Slight differences between these results are due to different 
surface groups and varied surface charges, however, the results are overall very similar.  
 
Figure IV - 2. AA-TiO2 (0.5 mg/ml) in different cell culture media (DMEM, BEGM, RPMI) 
stabilised with 1 mg, 10 mg, 50 mg or 100 mg BSA, FBS, Melflux, Melpers or Sika ViscoCrete 
per 1 mg NP. a) Percentage of particles still stably dispersed after 24 h with decreasing 
dispersion stability from A: 100% (dark green) to E: <25 % (dark red). b) Agglomerate size (Z-
average) with increasing hydrodynamic diameter from a: <100 nm (dark green) to f: >700 nm 
(dark red).  
The commonly used stabilisers BSA and FBS (in the chosen concentration range) only show 
stabilising effects in the FBS-containing DMEM (and RPMI). This indicates that for these 
biological stabilisers a high amount of cell culture supplement, FBS, is additionally needed to 
build up a larger protein corona that is sufficient to stabilise the particles. BSA does not seem 
to be an adequate stabilising agent for the examined NPs as BSA only adsorbs at strong 
negatively charged oxide surfaces14,15,28 and the examined particles only exhibit a low negative 
charge at physiological pH (∼7.4). A cell culture medium can be seen as an electrolytic solution 
with high ionic strength14 comparable to a 0.12 M NaCl solution.13 As the zeta potential of BSA 
itself decreases in salt solutions29 due to interactions with the salts, the electrostatic 
stabilisation of particles by BSA is less efficient in cell culture media. In contrast to BSA, FBS 
stabilises the NPs independent of their surface charge due to a synergistic effect of its 
components such as globulin, BSA and transferrin.14 Therefore, it seems to be more suitable 
as a stabilising agent for the examined only slightly charged TiO2 NPs. Additionally, several 
studies have already indicated that even if FBS contains a large amount of BSA, the albumin 
that is initially adsorbed onto the NP surfaces is usually replaced within several minutes up to 
a few hours by other less abundant but more specific proteins like apolipoproteins.30–32 This 
may also be an explanation for the higher stabilisation efficiency of FBS compared to BSA. 
The stabilisation of AA-TiO2 and MEEAA-TiO2 by polycarboxylate ethers (Melflux, Melpers and 
Sika ViscoCrete) seems to be independent of the addition of FBS as a supplement. This may 
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be due to the mainly steric stabilisation of polycarboxylate ethers (see below) not favouring 
ionic interactions with FBS. 
As suggested by Mandel et al.,18 polycarboxylate ethers develop hydrogen bridging bonds 
between their carboxylic groups and the hydroxyl groups on the particle surface, when added 
at acidic pH to the particle dispersion (Figure IV - 3 a). This means that with this procedure, 
surfactants are not only weakly adsorbed but to a certain extent sufficiently anchored onto the 
particles. Thus they chemically functionalize the particles so that they show the surface 
characteristics of the polymer. Therefore, the measured isoelectric points of the functionalized 
particles were found at acidic pH values depending on the composition of the polycarboxylate 
ether (Melflux and Sika-ViscoCrete around pH 2 and Melpers around pH 3; these values are 
also confirmed in other works).18,33 The surfactant sterically stabilises the particles via the bulky 
polyethylene oxide side chains. With increased pH (>2) the unbound carboxylic acid groups of 
the polymer backbone start to deprotonate, resulting in an electrostatic stabilisation that adds 
to the steric stabilisation. At neutral pH, these systems exhibit both the electrostatic and steric 
repulsion mechanisms, known as electrosteric stabilisation (Figure IV - 3 b). For this reason 
this class of polycarboxylate ethers are ideally suited for NP stabilisation in cell culture media 
as the charged groups render the polymers (respective to functionalized particles) dispersible 
in water. However, even if the electrostatic stabilisation efficiency is very low in cell culture 
media, due to the prevailing high ionic strength, the steric repulsion keeps the particles 
separated. In summary, the stabilisation of the particles with polycarboxylate ethers is not 
influenced by the pH, ionic strength or chemical composition of the media. This has also been 
shown for other well-anchored polyethylene oxide moieties in literature.34  
As a result, the efficiency of polycarboxylate ethers as stabilisers mainly depends on their 
anchoring strength onto the particles, the particle surface coverage and the polymer 
composition (e.g. chain lengths). From the experiments shown in Figure IV - 2 it can be 
concluded that the most efficient stabilising agent is Melflux. It provides a stable dispersion for 
both particle systems in all media with 1 mg stabiliser per mg nanoparticle. Agglomerate sizes 
smaller than 100 nm are obtained in all three cell culture media. In comparison to the other 
polycarboxylate ethers (Sika ViscoCrete with 2000 g/mol side chain and Melpers with 500 
g/mol side chain) this polymer has the longest polyethylene side chains (3000 g/mol), providing 
the best steric stabilisation. Due to its side chain lengths, Sika ViscoCrete is the second best 
of the tested polycarboxylate ethers.  
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Figure IV - 3. Schemes of particles stabilised with a polycarboxylate ether at physiological pH 
showing a) the binding of the polymer onto the particle surface and b) one polymer chain 
adsorbed onto the particle surface, stabilising the particle electrosterically. 
For further examinations (in RPMI medium) Melflux, the most efficient stabiliser, and FBS, as 
a control from the literature, have been selected. The best stabilising agent concentrations 
were chosen with the help of DLS measurements (Figure IV - 4).The agglomerate sizes of the 
particles first decreased with increasing stabilising agent concentrations and then finally 
started to increase again. This can be explained as with a low concentration there are not 
enough stabiliser molecules to completely cover the surface of every single particle and, due 
to their partly uncovered surface, particles still form agglomerates. With increasing stabiliser 
concentration, there are enough surface-active molecules to stabilise smaller agglomerates. 
When an ideal concentration is reached, each NP is surrounded with a monolayer of stabilising 
agent; this results in a perfectly stabilised dispersion. With increasing stabiliser concentration, 
further stabilising agent layers are formed around each particle.15  
 
Figure IV - 4. Average hydrodynamic diameter of AA-TiO2 and MEEAA-TiO2 (0.5 mg/ml) in 
RPMI stabilised with a) FBS or b) Melflux. 
Due to this and possible bridging effects of the stabiliser between particles, resulting in a 
connection of particles, the agglomerate size starts to increase again. The smallest stabiliser 
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concentration required to achieve a stable NP dispersion was 100 mg and 0.4 mg per 1 mg 
NP for FBS and Melflux, respectively. Both stabilisers prevented the formation of agglomerates 
larger than 200 nm, which is promising with respect to a facilitated cellular uptake effect.35 
The sedimentation study over 24 h confirmed the successful stabilisation of the dispersions 
with these stabiliser concentrations; Figure IV - 5 shows the absorbance measurements over 
time a) and photographs b) at 0 h and 24 h after NP transfer into RPMI.  
 
Figure IV - 5. Sedimentation study of AA-TiO2 (0.5 mg/ml) in RPMI stabilised with FBS (1 mg 
NP:100 mg FBS) or Melflux (1 mg NP:0.4 mg Melflux) and not stabilised: a) percentage of not-
sedimented particles determined via absorbance measurements and b) photograph of 
samples at 0 h and 24 h after addition of the stabiliser to the NP dispersion (*sedimented 
particles). 
The pure NPs sedimented almost completely within one day while FBS- and Melflux-stabilised 
NPs did not show any sedimentation during this time range. Comparing both stabilisers it is 
worth noting that the amount of Melflux that is needed to stabilise the NPs is small. This 
indicates a very efficient stabilisation. For cell culture tests stabiliser concentrations as small 
as possible are desired in order to reduce potential influences regarding the particle toxicity 
and the uptake by the cells. 
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IV.2. Cytotoxicity of TiO2 nanoparticles†
Prior to the cytotoxicity evaluation of stabilised and not-stabilised particles, the novel stabiliser 
Melflux had to prove its biocompatibility. This characteristic was assessed in cell culture 
studies; FaDu cells were treated with different Melflux concentrations for 24 h and examined 
via MTT assay. RPMI was chosen as cell culture medium for all viability tests as this medium 
was proved to be very suitable for PC tumour treatment experiments.36 The viability of FaDu 
after incubation with Melflux is shown in Figure IV - 6. The stabiliser can be considered as non-
toxic up to 500 µg/ml as the statistical analysis (Wilcoxon Test) showed no significant decrease 
in viability for all tested concentrations. For the cytotoxicity assay with TiO2, nanoparticle 
concentrations up to 300 µg/ml were chosen and so the highest necessary Melflux 
concentration was 120 µg/ml. Therefore, with respect to the results of the MTT assay with 
Melflux alone, the stabiliser should not influence the toxicity of the particles. 
 
Figure IV - 6. Viability of FaDu cells treated with Melflux for 24 h compared to the viability of 
non-treated cells. No significance (n.s.) with p < 0.05 was found in all tested NP concentrations 
in comparison to the negative control. 
After approval of Melflux as biocompatible stabilising agent, the cytotoxicity of AA-TiO2 and 
MEEAA-TiO2 with and without FBS or Melflux towards FaDu and stem cells was examined. 
The obtained viability results are shown in Figure IV - 7 and Figure IV - 8. Both particle systems 
were non-toxic up to 300 µg/ml for both stem cells and cancer cells: the not-stabilised particle 
agglomerates as well as the two differently stabilised agglomerates with diameters under 200 
                                               
†
 Parts of this chapter have been published and are reused in this work by courtesy of Elsevier, original 
article: S. Koch et al., Colloids Surf., B, 2016, 143, 7–14. 
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nm. This indicates that both agglomerates as well as single particles are non-toxic towards 
malignant and non-malignant cells. Although cell viability of both cell types was decreased 
after exposure to high concentrations (such as 300 µg/ml) of AA-TiO2, the results were not 
significant. Nevertheless, MEEAA-TiO2 seems to be slightly more biocompatible in comparison 
to AA-TiO2, which may be due to differences in the surface moieties of both particle systems: 
the MEEAA derivative has a polyethylene glycol-like structure and this polymer is known to be 
non-toxic and is therefore used for medical applications. As a result, MEEAA bearing MEEAA-
TiO2 may be slightly less toxic towards cells than AA-TiO2. The addition of Melflux and FBS 
did not significantly influence the toxicity of the NPs. However, cell viability tended to increase 
in samples treated with MEEAA-TiO2 and FBS (Figure IV - 7 b). A possible explanation for this 
is that with increasing NP concentration, the FBS concentration also increases, which may 
lead to enhanced cell viability. This is due to growth factors contained in FBS, which stimulate 
cell growth. The addition of FBS as a stabiliser can therefore significantly influence studies on 
particle toxicity. Furthermore in cell culture experiments addition of FBS varies the medium 
composition leading to less well-defined chemical conditions, notwithstanding any ethical 
implications.37 For these reasons the use of Melflux as non-toxic stabiliser is a very promising 
alternative to commonly used stabilisers. 
 
Figure IV - 7. Viability of tumour cells (FaDu) treated with a) AA-TiO2 and b) MEEAA-TiO2 
without stabiliser and stabilised with FBS (1 mg NP:100 mg FBS) or Melflux (1 mg NP:0.4 mg 
Melflux). The values are normalised with respect to the vitality of no particle treated cells. No 
significance (n.s.) with p < 0.05 was found in all tested NP concentrations in comparison to the 
negative control. 
IV. Cell culture examinations of synthesized TiO2 particle systems 
 
- 153 - 
 
 
Figure IV - 8. Viability of stem cells (BMSC) treated with a) AA-TiO2 and b) MEEAA-TiO2 without 
stabiliser and stabilised with FBS (1 mg NP:100 mg FBS) or Melflux (1 mg NP:0.4 mg Melflux). 
The values are normalised with respect to the vitality of no particle treated cells. No significance 
(n.s.) with p < 0.05 was found in all tested NP concentrations in comparison to the negative 
control.  
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IV.3. Tumour treatment effect of MEEAA-TiO2 particles 
After successful stabilisation of the synthesized TiO2 NPs in cell culture media and proof of 
their non-toxicity, the next logical step towards an application as PC anti-tumour agent is the 
assessment of their cytotoxicity after/during UVA-1 light application in vitro. The state of the art 
approach to determine the anti-tumour activity of PC NPs is shown in Figure IV - 9 a).38–43  
 
Figure IV - 9. a) State of the art photocatalytic tumour treatment including the direct UVA-1 
light application onto cells after NP uptake compared to b) a new approach avoiding it. 
For this examination, the NPs are exposed to the cells (Figure IV - 9 a), step 1) and incubated 
for 24 h to allow cellular uptake of the NPs before applying the UVA-1 (340-400 nm wavelength 
range) light (Figure IV - 9 a), step 2). During UVA-1 light application, the NPs are activated to 
do photocatalysis, which leads to cellular damages and apoptosis ((Figure IV - 9 a), step 3) as 
e. g. shown by a MTT assay. However, even if the NPs are exclusively taken up by malignant 
cells or their toxicity is specific towards malignant cells, the damage of non-malignant cells 
caused by UVA-1 light can never be avoided. Regarding our experimental approach, we tried 
to exclude direct UVA light application to cells and we found that MEEAA-TiO2 (4 h, 160 °C) 
samples were anti-tumour active after a UVA (315-400 nm wavelength range) light pre-
activation for 24 h (Figure IV - 9 b). Within this setting, the NPs were first pre-activated with 
UVA light (Figure IV - 9 b), step 1) for 24 h, then added to the cells and incubated for another 
24 h (Figure IV - 9 b), step 2) before evaluating the cell viability (Figure IV - 9 b), step 3). This 
procedure was carried out with two malignant (FaDu, HLaC78) and two non-malignant (BMSC, 
fibroblasts) cell types and compared to the exposure of non-irradiated and therefore inactive 
MEEAA-TiO2 samples to the cells. For all cell culture tests described in this chapter, NP 
samples without any stabilising agent were utilized to not further complicate the toxicity 
evaluations. The subsequent MTT test after incubation revealed that while the inactive NPs 
were as expected non-toxic to all cell types (Figure IV - 10 a), the pre-activated NPs showed 
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specific toxicity towards the cancer cells while affecting the non-malignant ones only at higher 
concentrations (Figure IV - 10 b). 
 
Figure IV - 10. Viability of non-malignant cells (BMSC, fibroblasts) and malignant cells 
(HLaC78, FaDu) treated with a) MEEAA-TiO2 (160 °C, 4 h) without UVA light pre-activation 
and b) MEEAA-TiO2 (160 °C, 4 h) pre-activated with UVA light for 24 h. The values are 
normalised with respect to the vitality of no particle treated cells. Significance compared to the 
control with a P-value < 0.05 is indicated by asterisks. 
To further examine this result and to determine, which component of the samples may be 
responsible for the anti-tumour effect, four different samples were prepared and toxicologically 
evaluated (Figure IV - 11). The sample 1) was MEEAA as commercially obtained, which was 
UVA light pre-activated for 24 h and the sample 2) was pure TiO2 as the present MEEAA was 
removed by washing steps with diluted HNO3 and then UVA light pre-activated for 24 h. The 
sample 3) was MEEAA-TiO2 as synthesized, which was first UVA light pre-activated for 24 h 
and then the NPs were removed via centrifugation and only the supernatant containing pre-
activated MEEAA was utilized. The sample 4) consisted of MEEAA-TiO2 as synthesized and 
was just treated with UVA light for 24 h exactly like the standard sample used before (Figure 
IV - 10). While sample 1) and 2) showed no anti-tumour activity, sample 3) was as toxic to 
cancer cells as the reference sample 4). These results lead to the conclusion that both 
components MEEAA and TiO2 NPs are needed for the activation of the samples. The MEEAA 
is “activated” by the PC activity of the TiO2 NPs and subsequently acts anti-tumour active even 
if no particles are present in the cell culture. 
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Figure IV - 11. Viability of tumour cells (FaDu) treated with UVA light (24 h) pre-activated 
samples: 1) pure MEEAA, 2) TiO2 NPs (160 °C, 4 h) without MEEAA (realized with the help of 
washing steps), 3) MEEAA, which was separated from the TiO2 NPs after pre-activation via 
centrifugation and 4) MEEAA-TiO2 NPs (standard sample). The values are normalised with 
respect to the vitality of no particle treated cells. Significance compared to the control with a 
P-value < 0.05 is indicated by asterisks. 
While reactive oxygen species (•O2−, •OH) generated by photocatalysis are short-lived entities 
(less than 70–200 ns),44,45 it is well-known that the photocatalysed degradation of an organic 
molecule usually does not result in instantaneous formation of carbon dioxide but long-lived 
intermediate species such as long-lived radicals are formed.46,47 Therefore, the long term 
activity of the samples were tested to investigate the possible creation of long-lived species, 
which could act toxic towards malignant cells either because of their properties or due to 
continuing degradation into carbon dioxide during cell culture incubation. If the photocatalysis 
by TiO2 led to long-lasting but unstable intermediate species in the MEEAA sample, the probe 
would lose its anti-tumour activity during storage. As shown in Figure IV - 12 a), the samples 
do not change their toxic behaviour even after 5 days storage time and therefore, the acid must 
be irreversibly and long-term modified by the TiO2 photocatalysis during UVA light treatment.  
In order to study a possible degradation of the MEEAA during UVA light activation, HPLC and 
NMR analysis were planned to be carried out before and after UVA treatment. However, as 
the commercial MEEAA used for synthesis showed a low purity (70 %), the first analyses of 
the samples were not conclusive because of too high contamination by other unidentified 
organic compounds. Based on these findings, a purer commercial MEEAA sample (> 95 %) 
was purchased and compared to the standard compound. For this examination, the acids were 
intermixed with commercial P25 TiO2 NPs as this procedure is less time consuming than the 
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hydrothermal synthesis approach for MEEAA-TiO2 and gives the same results concerning PC 
UVA light activation of the MEEAA samples. The MTT tests depicted in Figure IV - 12 b) clearly 
show that the anti-tumour effect is caused by the impurities of the sample and not by the 
MEEAA as the purer commercial MEEAA does not induce any significant toxicity.  
 
Figure IV - 12. Viability of tumour cells (FaDu) treated with UVA light (24 h) pre-activated 
samples: a) MEEAA-TiO2 NPs (standard sample) after storage for 0, 1 or 5 days and b) P25 
TiO2 NP dispersions prepared with standard MEEAA (purity = 70 %) or MEEAA with a higher 
purity (> 95 %). The values are normalised with respect to the vitality of no particle treated 
cells. Significance compared to the control with a P-value < 0.05 is indicated by asterisks. 
In order to further investigate, which is the compound responsible for the anti-tumour effect in 
the commercial MEEAA sample (70 %), it was divided into several fractions via distillation 
(heating up to 250 °C under dynamic vacuum – further information in the experimental part). 
The aim was to divide possible non-toxic from toxic components. After distillation, all samples 
were intermixed with P25 colloids, UVA light pre-activated and subsequently tested for their 
cytotoxicity towards cancer cells. The results are summarized in Figure IV - 13 and compared 
to the undistilled MEEAA. It is evident that fraction II did not show any significant anti-tumour 
effect up to 150 µg/ml NP concentration (included) while fraction IV exhibited the highest anti-
tumour activity with significant toxicity already at a concentration of 100 µg/ml. This is why 
these two fractions were analysed in more detail; fraction II appeared to be the purified MEEAA 
(verified by NMR and MS), which explains the low cytotoxicity of this fraction. It is therefore 
also logical that the viability values of FaDu cells treated with this fraction II resemble the ones 
treated with commercial MEEAA with a higher purity (> 95 %, Figure IV - 12). Fraction IV could 
first not be identified as it was a mixture out of at least 2 compounds, which was mainly 
indicated by the detection of several molecular masses by MS and impossible integral ratios 
of the signals in the 1H-NMR. This is why fraction IV was separated via column 
chromatography, obtaining two fractions, denoted as IV-a and IV-b. Fraction IV-a consists of 
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one single pure compound IV-a. This compound IV-a is the main component of fraction IV by 
weight (76 %) and its structure (Scheme IV - 2) was identified with the help of 2D NMR analysis 
and MS. 
 
Figure IV - 13. Viability of tumour cells (FaDu) treated with UVA light (24 h) pre-activated P25 
TiO2 dispersions prepared with commercial MEEAA sample before distillation and fractions I 
to IV obtained during its distillation. Significance compared to the control with a P-value < 0.05 
is indicated by asterisks. 
 
Scheme IV - 2. Identified compound IV-a of fraction IV-a. 
This compound IV-a did not show any anti-tumour activity after UVA light activation in presence 
of P25 TiO2 NPs (Figure IV - 14) and also NMR analysis did not show any changes in molecular 
structure (such as signal shifts or changes in integral value). Thus, this compound seems to 
be not affected by the UVA light treatment and can be taken as internal standard for 
subsequent NMR analyses of the fraction IV.  
In contrast to the fraction IV-a, the fraction IV-b is highly anti-tumour active after the pre-
activation. The NMR measurements of this fraction showed pure spectra of MEEAA and also 
MS analysis indicated the presence of pure MEEAA. These results were rather surprising as 
it was shown before that the pure MEEAA does not possess any anti-tumour activity. This is 
why the presence of further undetectable impurities was expected. Organic impurities in the 
sample must be existent in concentrations lower than the detection limit of NMR while inorganic 
impurities such as salts can be present in higher concentrations as they are usually not 
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visualized by NMR or MS. This is why X-ray fluorescence spectroscopy (XRF) was carried out 
(Table – EP – 5, Experimental part) in order to detect all elements heavier than sodium. 
Ultimately, these measurements showed the presence of chloride as impurity. 
 
Figure IV - 14. Viability of tumour cells (FaDu) treated with UVA light (24 h) pre-activated P25 
TiO2 dispersions prepared with fractions IV obtained during distillation of the commercial 
MEEAA sample and with fraction IV-a and by IV-b obtained after column chromatography of 
fraction IV. Significance compared to the control with a P-value < 0.05 is indicated by asterisks. 
The probability that the chloride substitutes a proton of the MEEAA (under formation of a 
covalent bond) is seen as quite low as this would result in shifts in the NMR spectra. The 
formation of a complex out of chloride and MEEAA also seems very unlikely given the acidic 
nature of both components (Cl- and COO-). Thus, the detected chloride is possibly available 
as salt with elements that cannot be detected by XRF such as for example Li, Be or Na. The 
presence of this undetermined chloride compound could strongly influence the PC degradation 
of the MEEAA and result in an enhanced decomposition or in a modified degradation pathway 
resulting in molecular fragments different from those of pure MEEAA samples. It has already 
been shown in the current literature that the PC degradation of an organic molecule by TiO2 
can be significantly enhanced by the presence of other organic compounds or metal ions.48,49 
In order to further examine the processes caused by the UVA light activation, NMR analysis 
and high pressure liquid chromatography (HPLC) coupled to MS were carried out for the 
fraction IV before and after UVA light treatment. The 1H-NMR spectra (Figure IV - 15) of fraction 
IV logically show signals caused by both MEEAA (fraction IV-b) and compound VI-a (fraction 
IV-b), which have been identified before thanks to their separation via column chromatography. 
No new signals were detected in the 13C- and 1H-NMR spectra after UVA light treatment. 
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However, taking into account the integrals of the characteristic 1H-NMR signals of compound 
IV-a as internal standards (marked in green) and comparing them to the signal, which is only 
caused by MEEAA (marked in red), it becomes evident that the integral of this signal is 
decreased (from 1.4 to 0.8) during UVA light treatment. Consequently, one can conclude that 
either only the CH2 of the acetic acid moiety of MEEAA is removed during the pre-activation or 
the entire MEEAA is fragmented into small, highly volatile and therefore not measurable 
organic compounds such as CO2. Furthermore, the degradation into smaller fragments in 
concentrations lower than the detection limit of NMR is conceivable. However, the possible 
decrease in the other MEEAA signals (C15-C19) cannot easily be determined by NMR as the 
signals lie in the same range as the ones caused by compound IV-a. 
 
Figure IV - 15. 1H-NMR spectra of fraction IV in D2O before (on the top) and after 24 h UVA 
pre-activation (on the bottom). The carbon atoms of both the molecules are numbered and 
the numbers are related to the specific signals in the spectra. 
HPLC analysis indicated that the amount of MEEAA was lowered by 10 % during UVA light 
treatment and the appearance of two new mass fragments was detected. The measured m/z 
and probable structures with their calculated molecular masses are depicted in Table IV - 1. 
IV. Cell culture examinations of synthesized TiO2 particle systems 
 
- 161 - 
 
The proposed structures were selected based on the reactant MEEAA and possible 
degradation pathways of the methyl ethers and carboxylic acids found in literature.48–53 
However, it must be admitted that PC decomposition reactions are very complex and therefore, 
other possible structures may not have been identified. Also the proton abstractions of ethoxy 
groups could take place and lead to other degradation pathways not considered in this work. 
The degradation could occur similarly to the degradation of butanoic acid via the H abstraction 
from a methylene group.54 
Table IV - 1. New fragments (m/z) after UVA light treatment detected by HPLC-MS and 
belonging possible molecular structures and their calculated m/z.   
measured m/z, 
negative mode probable structure, name 
calculated m/z of  
[M-H]- 
117.07 
compound MS117 
117.06 
 
163.15 
compound MS163 
163.06 
 
 
The detected compound MS163 is most probably obtained during the PC degradation of the 
methyl ether group (Scheme IV - 3, highlighted in green colour). The proposed possible 
degradation pathway of the methyl ether group of MEEAA was deduced from the PC 
decomposition of methyl-tert-butyl ether or methyl perfluoroalkyl ethers.52,53 The detected 
compound MS117 must most probably be produced by both the removal of the methoxy group 
(Scheme IV - 3, highlighted in green colour) and the degradation of the carboxylic acid via the 
proton abstraction from the α-carbon by hydroxyl radicals and further reaction with the 
surrounding oxygen resulting in a formate ester. Possible degradation pathways of the 
carboxylic acid are depicted in Scheme IV - 4 deduced from the PC decompositions of 
carboxylic acids such as propanoic and octanoic acids.48–51 In both schemes the red arrows 
indicate reaction steps that are considered very probable but could not be confirmed by the 
literature.  
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Scheme IV - 3. Proposed possible degradation pathway of the methyl ether group of MEEAA 
deduced from the photocatalytic decomposition of methyl-tert-butyl ether or methyl 
perfluoroalkyl ethers.52,53 (red arrows: assumed reaction steps not confirmed by literature, 
green labelled compounds: possible degradation products detected by MS) 
 
 
Scheme IV - 4. Proposed possible degradation pathway of the carboxyl group of MEEAA 
deduced from the photocatalytic decomposition of R-COOH (R= alkylchain).48–51(red arrows: 
assumed reaction steps not confirmed by literature, green labelled compound: possible 
degradation products detected by MS) 
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The potential cytotoxicity of the identified compounds has not been evaluated yet. While pure 
MEEAA (shown in this study) and (2-methoxyethoxy)acetic acid55 are considered as non-toxic, 
the toxicity by alkoxyacetic acids has been proved to increase with decreasing chain length (e. 
g. in the case of testicular toxicity in rats).56 Shorter alkoxyacetic acids such as methoxyacetic 
acid, ethoxyacetic acid or butoxyacetic acid have for example been confirmed to be 
embryotoxic.57 They lead to an intracellular acidification of cells inhibiting their cell 
differentiation.57 Studying the hematotoxicity of alkoxyacetic and -propionic acids, it was shown 
that the presence and location of the ether bond plays a determining role in the toxicity of the 
compound.58 A cytotoxic behaviour of formates such as commercially available ethyl formate 
has not been reported.59 Taking into account all the before mentioned insights, the cytotoxicity 
(e.g. towards malignant cells) of the two identified compounds seems probable and should 
therefore be studied in future.  
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IV.4. Conclusion 
For the transfer of the samples into cell culture media, the synthesized unmodified AA- and 
MEEAA-TiO2 NPs were stabilised to avoid agglomeration and sedimentation. Stabilising the 
NPs with BSA, FBS, Melpers® V4343 or Sika® ViscoCrete®-10110178 improved the NP 
dispersion in various cell culture media. Melflux® 4930 F appeared to be the most suitable 
stabilising agent in this study, stabilising the particles against agglomeration and subsequent 
sedimentation over 24 h in all three tested cell culture media. The stabilisation assures an 
accurate dosing of particles for cell culture tests and reliable concentration-dependent particle 
uptake studies as the particles do not sediment. In contrast to FBS, which is commonly used 
as a stabiliser in the literature, Melflux does not influence the cytotoxicity of the particles. 
Therefore, it is suitable as a stabilising agent of TiO2 NPs and may be of special interest for 
studies on the toxicity or therapeutic potential of these NPs.  
In addition and essential for this research work, the tested synthesized NP systems AA-TiO2 
and MEEAA-TiO2 were both proved to be non-toxic towards both malignant and non-malignant 
cells in their inactive state, at least within the applied concentrations - both as well-stabilised 
single particles or not-stabilised agglomerates. This paves the way towards their application 
as tumour treatment agent as their non-toxicity may enable UVA light activated specific tumour 
treatment. Furthermore, these tests provide the basis for subsequent cytotoxicity tests of 
functionalized TiO2 particles, enabling studies on the influence of modified surface properties 
on their toxicity. 
The detected anti-tumour activity of 24 h UVA light pre-activated MEEAA-TiO2 samples is most 
probably caused by the PC degradation of MEEAA into cytotoxic compounds enhanced by the 
presence of chloride impurities in the commercially obtained acid. This work on the one hand 
provided impressive results concerning a specific tumour treatment, on the other hand it 
stressed that the transfer of commercial and chemical compounds into biomedical applications 
can provoke unexpected obstacles concerning the toxicity of unidentified impurities. However, 
for the organically modified NPs synthesized in this work (Chapter III), this toxicity is of no 
relevance as the particles are purified during the functionalization procedure.  
Future works should include the cytotoxicity assessment of the functionalized MEEAA-TiO2 
samples as well as the development of the state of the art PC tumour treatment via the UVA 
light application onto cells exposed to PC NPs (as shown in Figure IV - 9).  
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Head and neck cancer is one of the ten most common cancers globally and typically shows 
difficult-to-treat field cancerization, which means that the tumour is not situated in a well-
defined location but widely spread over the tissue. Usually these formations are a mixture of 
pre-malignant and malignant superficial manifestations with some regions having deeply 
invasive tumour fractions. This unclear extent of the tumour makes a surgical removal very 
difficult and also radiation or chemotherapy are often meeting their limits raising the desire for 
novel therapy strategies.  
Photocatalytic nanoparticles (PC NPs), such as titanium dioxide, with their unique physical and 
chemical properties due to their dimensions below 100 nm have a great potential as 
photodynamic tumour treatment agent and could therefore enhance the current standard 
treatments. Additionally, these NPs combine their function as a therapeutic agent with surfaces 
that can be functionalized to mediate cellular uptake or carry molecules for diagnostic. Thus, 
the key points this research has sought to address were the synthesis of anatase NPs, their 
functionalization with dendritic and non-dendritic surface agents and the transfer of the 
developed NPs into cell culture studies.  
The first part of this work was therefore dedicated to the synthesis and thorough 
characterization (XRD, TEM, zeta potential, DLS, TGA, nitrogen sorption, DRIFT and PC 
degradation) of two anatase NP systems AA-TiO2 and MEEAA-TiO2 mainly differing in their 
surface groups (acetonate – AA plus para-toluene sulfonic acid and 2-[2-(2-
methoxyethoxy)ethoxy]acetic acid - MEEAA) from the hydrothermal synthesis. The higher PC 
activity of the MEEAA-TiO2 compared to the AA-TiO2 was therefore mainly related to the 
different surface groups or more precisely the higher amount of organic groups on the AA-
TiO2. With increasing autoclaving time or temperature during the synthesis, the crystallite size 
of the synthesized systems was increased (from ~5 to ~8 nm) while the properties of the 
surface groups were not significantly influenced. Surprisingly, the photocatalytic performance 
of the samples augmented with increasing particle size, which is reverse to basic knowledge 
and was found to be caused by a change in crystal morphology at longer hydrothermal 
treatment times or higher temperatures. While small crystallites show the typical equilibrium 
state truncated tetragonal bipyramidal morphology, crystal growth leads to the formation of 
rod-like crystals with oxygen vacancies provoked by oriented attachment of single particles 
(XAFS, XRD and HR-TEM analyses). Both the more anisotropic crystal shape and the increase 
in oxygen vacancies improve the charge carrier separation and thus the photocatalytic activity 
of the samples. 
For the next approach, the synthesized anatase NPs were prepared for cell culture 
examinations, which included their stabilisation in cell culture media. The polycarboxylate ether 
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Melflux® 4930 F, which has never been used for cell culture studies before, was shown to be 
the most suitable stabilising agent, stabilising the particles against agglomeration and 
subsequent sedimentation over 24 h in cell culture media. The non-toxicity of this stabiliser 
was demonstrated as well as its superiority (in stabiliser concentration and influence on the 
cytotoxicity) over foetal bovine serum, which is commonly used as a stabiliser in the literature. 
In addition both stabilised and not-stabilised NP systems AA-TiO2 and MEEAA-TiO2 were 
proved to be non-toxic towards both malignant and non-malignant cells in their inactive state, 
which paves the way towards their therapeutic application enabling ultraviolet (UV) light 
triggered specific tumour treatment.  
With the help of commercial silanes ([3-(2-aminoethylamino)propyl]-trimethoxysilane, N1-(3-
trimethoxysilyl-propyl)diethylenetriamine) the feasibility of grafting onto the developed TiO2 
NPs was proved. The grafting procedure and the concentration of coupling agents for an 
efficient grafting of the NPs was optimized guaranteeing a strongly modified particle surface 
while maintaining the photocatalytic activity of the samples. These results were the basis for 
the functionalization of NPs with self-synthesized well-tailored and well-characterized surface 
agents. The synthesis routes for four either luminescent or non-luminescent dendritic or linear 
structures for the particle functionalization via silanization were planned, carried out and 
critically examined. Three of the synthesized coupling agents contained a rhodamine dye; 
while the first coupling agent was as linear molecule without terminal amine group, the second 
linear coupling agent combined the dye with a terminal functional group. The luminescent 1st 
generation dendritic molecule united the two terminal amine groups thanks to the dendritic 
branches with an off-centred dye. The last coupling agent also bore a dendritic structure with 
two terminal amine groups but no dye. Two of the mentioned coupling agents were grafted 
onto MEEAA-TiO2 and the successful surface modification was shown via IR, DLS and zeta 
potential measurements. First studies on the PC activity of one of the modified samples were 
also carried out and indicated the surprising increase in its performance probably caused by 
the properties of the rhodamine dye-containing coupling agent that also resulted in a strong 
luminescence of the NPs.  
This is why, one can state that the synthesis of luminescent NPs by grafting a dye-containing 
coupling agent was successfully carried out. Another approach to introduce luminescence 
properties into the TiO2 particle systems via the synthesis of luminescent Rhodamine B doped 
TiO2/SiO2 core/shell NPs was shown to be feasible. However, this modification always resulted 
in a drastically reduced PC activity due to the silica shell that covers the photocatalytically 
active surface. Thus, the development of NPs consisting of a luminescent core and a 
photocatalytically active shell would be advantageous as it would ideally not influence the 
General conclusion 
 
- 170 - 
 
photocatalytic performance of the sample while possessing luminescence properties. As a side 
effect, the synthesis of the coupling agents would be facilitated as there would be no more 
need for the integration of a dye into the molecule structure. While the feasibility to form a TiO2 
shell around inorganic NPs such as iron oxide NPs has been already shown in this work, future 
studies should search for a luminescent inorganic particle, which is sufficiently stable under 
the hydrothermal synthesis conditions of TiO2. 
Concerning the synthesis of luminescent, dendritic coupling agents, first synthesis routes have 
successfully been established. However, further research might well be conducted on these 
coupling agents in order to optimize the design and reaction pathway for example of the dye- 
and terminal amine-containing linear organosilane. Furthermore, the use of phthalimide as 
protecting group of the terminal amines and its cleavage after grafting should be rethought; 
either a more efficient cleavage procedure not affecting the Ti-O-Si bonds should be found or 
the phthalimide could be substituted by another protecting group, which can be cleaved under 
milder conditions.  
Subsequently, future works should focus on the cytotoxicity assessment of the functionalized 
TiO2 samples as well as the development of the state of the art PC tumour treatment via the 
UV light application onto cells exposed to PC NPs. Regarding the detected anti-tumour activity 
of 24 h UV light pre-activated MEEAA-TiO2 samples, this work pointed out that the transfer of 
commercial and chemical compounds into biomedical applications can provoke unexpected 
obstacles concerning the toxicity of unidentified impurities. Nevertheless, the discovered 
specific anti-tumour activity is quite impressive and surely it would be interesting to evaluate it 
in more detail for the use of this compound as possible future tumour drug. 
One unique characteristic of this research work has been the development of functionalized 
NP systems for biomedical applications, starting from the particle synthesis, proceeding the 
synthesis of organic coupling agents, as well as the grafting onto the particles and ending with 
the preparation of the samples for cell culture examinations and additional cytotoxicity studies. 
While most researches only focus on one step of the descriped pathway, the challenging option 
to carry out all steps in the same project allows the better understanding of the influences of 
each step on the others and the possibilty to track back problems to their routes that occure in 
the later steps of the research.  
The novel insights gained in the augmentation of PC performance of the synthesized anatase 
NPs due to a morphology change during crystal growth could benefit the perfection of the 
hydrothermal sol-gel synthesis of highly photocatalytically active TiO2 NPs.  
The stabilisation of these NPs in cell culture media with Melflux® 4930 F can surely be 
transferred to particles consisting of other materials and may therefore be of special interest 
for studies on the toxicity or therapeutic potential of NPs in general.  
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The proof of the feasibility to graft organo-silanes onto the synthesized TiO2 particles paves 
the way for their utilization in a broad range of applications as well-determined, manipulable 
surface properties are the basis for this. They could possibly be used as additives for example 
in plastics or functional coatings, as drug carriers or in solar cells.  
The development of novel luminescent dendritic coupling agents is not only of great importance 
for the functionalization of photocatalytic NPs used for tumour treatment, but also for the 
modification of for example drug-carrier particles consisting of other materials as they allow 
the combination of diagnostic with therapeutic applications and a monitoring of the applied 
substances. Also fundamental research concerning the particle uptake by cells could be 
facilitated by the functionalization of NPs with these luminescent coupling agents as they may 
allow their facile luminescence detection. 
The photocatalytic TiO2 NP systems in their functionalized or unmodified state, which were 
developed in this work, are of great interest for photodynamic tumour therapy. This therapy 
approach would consist of the particle application onto the tissue of interest and the cellular 
uptake of the NPs by cells. Subsequently, the UV light is supposed to be applied on the treated 
area to activate the NPs in order to photocatalytically destroy cellular components leading to 
cell apoptosis and tumour destruction. Due to the proved non-toxicity in their inactive state, 
areas that are not treated with UV light may not be damaged and TiO2 photocatalysis is 
expected to specifically destroy tumour cells.  
As well as photodynamic tumour treatment, the developed NP systems could also benefit 
photocatalytic water purification or the development of photonic and optoelectronic devices. In 
the case of water purification, the stably dispersed NP samples showing an excellent 
photocatalytic activity could be used to decompose organic contaminants in waste water such 
as pesticides or drugs. For the development of photonic and optoelectronic devices, the 
semiconductor properties of the anatase NPs providing a wide band-gap are ideal for the light 
energy conversion. The possibility to functionalize the surface gives the opportunity to couple 
sensitizers such as dyes on it in order to construct for example dye-sensitized solar cells. 
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Experimental part* 
1. Materials, equipment and experimental set-ups 
1.1. Solvents, reagents and materials for cell culture experiments  
Solvents and reagents for inorganic and organic syntheses 
Solvents and starting materials were purchased from Acros, Alfa Aesar, Aldrich, Fisher 
Scientific, Lehmann & Voss & Co or Bachem. All chemical compounds were reagent-grade 
(but 2-[2-(2-methoxyethoxy)ethoxy]acetic acid which was technical grade) and used without 
further purification (but triethylamine and isocyanatopropyltriethoxysilane which were purified 
by distillation over CaH2 or under dynamic vacuum). Water was deionised before use. All 
solvents for organic synthesis were anhydrous. DMF and dioxane were purchased, others 
were dried over dehydrating agents and distilled under inert atmosphere: 
- CH2Cl2: CaH2; 
- MeOH: CaH2; 
- EtOH: CaH2; 
- THF: Benzophenone, Na; 
- pentane: Benzophenone, Na; 
Solvents, media and cells for cell culture experiments 
Stabilising agents for particles in cell culture media were purchased from Sigma–Aldrich, BASF 
and Sika. The cell culture media utilised for this research were bronchial epithelial cell growth 
medium (BEGM with 1 vol-% penicillin and streptomycin (10000 µg/ml, PenStrep) and 
supplement mix C-39165), Roswell Park Memorial Institute medium (RPMI with 1 vol-% FBS, 
1 vol-% PenStrep, 1 vol-% non-essential amino acids and 1 vol-% sodium pyruvate) and 
Dulbecco’s modified eagle medium (DMEM with 10 vol-% FBS and 1 vol% PenStrep). These 
substances were ordered from PromoCell GmbH, Sigma-Aldrich, Linaris, gibcoR life 
technologiesTM and Biochrom AG. 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium 
bromide (MTT) was also ordered from Sigma-Aldrich. 
The head and neck squamous cell carcinoma cell line FaDu was established from the lymph 
node metastasis of a hypopharyngeal squamous cell carcinoma. Primary human bone marrow-
derived mesenchymal stem cells (BMSC) from human bone marrow were obtained from 
voluntary patients undergoing surgery in the Department of Orthopedics of the University Clinic 
Wuerzburg. The study was approved by the Ethics Committee of the Medical Faculty, 
University of Wuerzburg (12/06) and informed consent was obtained from all of the individuals 
included. Primary fibroblasts were obtained from voluntary patients undergoing surgery in the 
Department of Oto-Rhino-Laryngology, Plastic, Aesthetic and Reconstructive Head and Neck 
Surgery of the University Clinic Wuerzburg. The study was approved by the Ethics Committee 
of the Medical Faculty, University of Wuerzburg (16/06) and informed consent was obtained 
from all of the individuals included. The laryngeal squamous cell carcinoma cell line HLaC78 
was generated at the Department of Oto-Rhino-Laryngology, Plastic, Aesthetic and 
Reconstructive Head and Neck Surgery of the University Clinic Wuerzburg.1 
1.2. Equipment and experimental set-ups 
BET – Nitrogen sorption: Nitrogen sorption experiments were carried out on an automated 
volumetric analyser (Model Autosorb 3B). Prior to the measurement, the nanoparticle (NP) 
samples were dried at 110 °C for 16 h at reduced pressure. The specific surface area of the 
                                               
*
 Parts of this chapter have been published and are reused in this work by courtesy of:  
The Royal Society of Chemistry, original article: S. Koch et al., J. Mater. Chem. C, 2015, 3, 12430-2435, 
Elsevier, original article: S. Koch et al., Colloids Surf., B, 2016, 143, 7–14. 
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powder samples was determined according to Brunauer, Emmet and Teller by using the 
adsorption data in the relative pressure range from 0.05 to 0.3 p/p0. 
Elemental analysis (EA): The elemental compositions of the synthesized compounds were 
determined by elemental analysis, carried out on a THERMO FISHER FLASH 2000. 
Fourier transform infrared analysis: Diffuse reflectance infrared Fourier transform (DRIFT) 
measurements were conducted on a Thermo Fisher Scientific Nicolet 6700 spectrometer 
equipped with a diffuse reflection unit. The spectra were recorded via 200 scans from 4000 to 
400 cm-1 at a resolution of 4 cm-1. All powder samples (at a concentration of 1 - 4 weight-%) 
were intermixed with dried KBr and finely ground. Attenuated total reflection (ATR) spectra 
were recorded on a Nicolet iS50 spectrometer with an integrated ATR unit using 200 scans 
from 4000 to 400 cm-1 at a resolution of 4 cm-1. 
High pressure liquid chromatography (HPLC): HPLC measurements were performed on a 
Shimadzu Nexera LC-30AD liquid chromatograph with a SIL-30AC autosampler and a column-
thermostat with integrated column-switching valve. The system was coupled to a Shimadzu 
8040 triple-quadrupole mass spectrometer with an electrospray ion source. Full scan mass 
spectra were taken from 50 to 400 m/z with a scan speed of 5000 u/sec in Q1 and 15000 u/sec 
in Q3 for 1.5 minutes. The mass spectrometer was used in the negative ion mode. The ESI 
source was operated with a capillary voltage of -3.5 kV. The temperature of the heat block and 
of the desolvation line in the ion source was set to 450°C and 200 °C, respectively. The 
nebulizing and drying gas flow was 3 and 10 l/min, respectively. An isocratic elution was 
performed with water and methanol in the ratio of 30 to 70, the flow rate was 0.2000 ml/min, 
and the column oven was set to 25°C.  
Mass spectrometry (MS): Mass spectra were performed on a QStar Elite Mass Spectrometer 
equipped with an electrospray ionization (ESI) source (operated in a positive or negative ion 
mode) or on a Jeol Masse AccuToF Spectrometer with an electric ionization (EI) or field 
desorption (FD) source. All samples were dissolved in methanol for these measurements. 
Nuclear magnetic resonance (NMR): NMR spectra were performed on the Bruker Avance 300 
FT NMR spectrometer (1H: 300 MHz, 13C: 75 MHz), the Bruker DPX 400 FT NMR spectrometer 
(1H: 400 MHz, 13C: 101 MHz) and the Bruker DPX 600 FT NMR spectrometer (1H: 600 MHz, 
13C: 151 MHz). Chemical shifts of 1H NMR signals were calibrated according to the signals of 
deuterated solvents quoted to internal standard TMS (δ = 0.00). All samples were dissolved in 
an appropriate deuterated solvent prior to the measurements. Following abbreviations are 
used for the analysis of NMR spectra: s = singlet, d = doublet, dd = doublet-doublet, t = triplet, 
q = quartet, p = pentet, m = multiplet, br = broad, J = J coupling constant. 
Photocatalytic activity tests: The photocatalytic activity of the synthesized samples is 
measured by a dichloroacetic acid degradation with the set-up shown in Figure - EP - 1. The 
test is carried out in a double-jacket reactor that is cooled by water to 20 °C. In the center of 
the reactor a halogen lamp (Philips CLEO Compact 15W) with wavelengths of 300-400 nm is 
placed in a silica tube. Furthermore, a glass tube for bubbling compressed air into the testing 
solution, a temperature sensor, a chloride measuring electrode and its reference Ag/AgCl 
electrode were also placed into the vessel. For the photocatalytic activity test, 0.5 to 0.8 litre 
of solution (depending on the set-up) were filled into the reactor, consisting of water with 100 
mg/l NPs and 1 g/l dichloroacetic acid. Magnetic stirring was used during the whole test to 
guarantee a homogeneous dispersion of the particles. Before starting the UV activated 
dichloroacetic acid decomposition, the aqueous solution was stirred for 20 min in darkness to 
ensure constant reaction conditions. Then the light was switched on and after 5 min the first 
chloride concentration was recorded as zero-point.  
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Figure - EP - 1. Photocatalytic activity test set-up. 
Sedimentation studies: The sedimentation of AA-TiO2 and MEEAA-TiO2 NPs with or without 
chosen stabilising agents in cell culture media was examined by absorbance measurements; 
6 ml of NPs in cell culture media (0.5 mg/ml) was transferred into a 15 ml vial and 0.2 ml of the 
upper 10 % of the dispersion was then taken immediately and at 24 h after NP transfer. The 
absorbance at 490 nm of the withdrawn aliquots was measured and as references the 
absorbance of the pure media with stabiliser was also measured at the two time points. The 
24 h continuous sedimentation studies were carried out by monitoring the absorbance at 490 
nm as a function of time. As a reference RPMI containing the appropriate amount of water and 
stabiliser without particles was simultaneously acquired. The percentage of non-sedimented 
particles was then calculated taking the first measurement as 100 % and the reference as 0 
%. 
Thermogravimetric (TG) measurements coupled with mass spectrometry: TG coupled with MS 
analyses were performed on Netzsch STA 409 Pyrolysor coupled to a Balzers Instruments 
Thermostar quadrupolar mass spectrometer. The mass loss of the dried samples (10–20 mg) 
was monitored under argon at temperatures from 30°C to 1000°C with a heating rate of 5 
K/min.  
Transmitted electron microscopy (TEM): TEM images were obtained on a HITACHI H7650, 
(100 kV, equipped with a GATAN 11 mPx camera) or on a JEOL JSM 2010 at an acceleration 
voltage of 200 kV. High resolution TEM micrographs were obtained on a FEI Titan operating 
at 300 keV. The samples were prepared onto carbon-coated copper grids and slowly dried on 
the grid under ambient conditions.  
UV-Vis and photoluminescence analysis: UV-Vis measurements on sample solutions were 
carried out on a TECAN Multimode-Microplate-Reader Infinite® M1000 PRO, a Shimadzu UV-
3100, a Titertek Multiskan PLUS MK II from Labsystems or a Shimadzu UV-1560 PC. 
 
X-ray absorption fine structure (XAFS) analyses: The XAFS spectra were recorded at the K-
edge of titanium (4966 eV) in transmission mode at the μ-Spot beamline, at the Bessy II light 
source, Berlin, Germany. The x-ray absorption near edge spectra (XANES) were measured 
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with a step of 0.5 eV at the absorption edge and with a 2 eV step above the edge. The extended 
x-ray absorption fine structre (EXAFS) range was scanned up to k = 12 Å-1 with a constant 
step in k-space of 0.04 Å-1. The spectra underwent the standard data treatment procedure 
using the IFFEFIT software package.2,3  Cellulose pellets filled with dry powder sample with an 
absorption optimized thickness were produced for XAFS measurements. 
X-ray diffraction (XRD): The phase composition of the prepared TiO2 powder samples was 
analysed on a PANalytical Empyrean Series 2 or on a Bruker D2 PHASER employing Cu Kα 
radiation.  
X-ray fluorescence spectroscopy (XRF): The liquid samples were analysed on a PANalytical 
sequential spectrometer system AXIOS DY 1495 with an Rh-target x-ray spectrografic tube 
(60 kV, 4 kW). 
X-ray photoelectron spectra (XPS): Electronic properties were investigated by the Darmstadt 
Integrated System for MATerial research (DAISY-MAT), which combines a Physical 
Electronics PHI 5700 multitechnique surface analysis system with several deposition 
chambers via an ultrahigh vacuum sample transfer. X-ray photoelectron spectra were recorded 
using monochromatic Al Kα (1486.6 eV) radiation with an energy resolution of ≈0.4 eV as 
determined from the broadening of the Fermi edge of a sputter-cleaned Ag sample. Binding 
energies of core levels and valence band maximum can be determined with an accuracy of  
50 meV and 100 meV, respectively. Binding energies obtained by XPS were calibrated by the 
Fermi level energy of the sputter-cleaned Ag sample. Hence, all the biding energies are given 
respect to the calibrated Fermi level. TiO2 powder samples were pressed onto the Indium foil 
as a conductive substrate to avoid a charging problem and transferred into the XPS chamber 
without any pre-treatments.     
Zeta potential and dynamic light scattering (DLS): DLS and zeta potential analyses were 
carried out on the Malvern Instruments Zetasizer Nano ZS ZEN 3600 in combination with the 
Multi-Purpose Titrator MPT-2 or on Horiba Scientific NP analyzer SZ-100. The measurements 
were performed at 25°C for diluted aqueous particle dispersions. The isoelectric points were 
determined by zeta potential measurements during titration with the help of HCl and NaOH. 
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2. Inorganic nanoparticle synthesis protocols 
2.1. Synthesis of TiO2 nanoparticles 
Synthesis of acetyl acetonate (AA) coordinated TiO2-NPs (AA-TiO2) 
100.12 g acetyl acetone (1 mol, 1 eq) was dropped into 342.17 g titanium (IV) ethoxide (1.5 
mol, 1.5 eq) over 1.5 h under stirring. 90.08 g water (5 mol, 5 eq) was mixed with 9.51 g p-
toluene sulfonic acid (0.05 mol, 0.05 eq). The water solution was added dropwise over 1 h to 
the titanium precursors and stirred overnight at room temperature. The solution was then 
concentrated by rotary evaporation resulting in an orange powder (TiO2 content: 56.8 weight-
%, determined by heating up to 800 °C). The powder was subsequently dissolved in water to 
obtain a 12 weight-% (dark red, clear) amorphous titanium sol. This dispersion was 
hydrothermally treated in an autoclave (with 250 ml teflon insert filled to 75 % volume) with one 
of the following settings: 
- 1 h at 160 °C 
- 4 h at 160 °C 
- 16 h at 160 °C 
- 4 h at 180 °C 
- 4 h at 200 °C 
The obtained orange to beige gel was dissolved in water (3 weight-% TiO2 content) and 
subsequently pressure filtrated (0.8 µm membrane).  
For analysis the samples were either washed with ethanol (for TEM and DRIFT) via 
centrifugation and redispersion (3 times at 30 000 rpm for 0.5 h), dried under vacuum if 
necessary (DRIFT) or washed via dialysis (10-20 kDa molecular cut-off) against water with up 
to 6 water changes (for photocatalytic activity test, TGA, XRD, zeta potential, DLS) and dried 
via freeze drying (TGA, XRD, XPS) or re-stabilised with the addition of 1 M HNO3 (to obtain 
pH = 3, for DLS). 
Synthesis of 2-[2-(2-methoxyethoxy)ethoxy]acetic acid (MEEAA) coordinated TiO2-NPs 
(MEEAA-TiO2) 
204.19 g 2-[2-(2-methoxyethoxy)ethoxy]acetic acid (1.13 mol, 1.89 eq) was dropped into 
342.17 g titanium(IV) butoxide (0.6 mol, 1 eq) over 1 h under stirring. 36.03 g water (2 mol, 
3.33 eq) was added dropwise over 30 min to the titanium precursors and stirred overnight at 
room temperature. The solution was then concentrated by rotary evaporation resulting in an 
orange viscous liquid (TiO2 content: 18.3 weight-%. determined by heating up to 800 °C). It 
was subsequently diluted with water to obtain a 12 weight-% orange, clear amorphous titanium 
sol. This dispersion was hydrothermally treated in an autoclave (with 250 ml Teflon insert filled 
to 75 % volume) with one of the following settings: 
- 1 h at 160 °C 
- 4 h at 160 °C 
- 16 h at 160 °C 
- 4 h at 180 °C 
- 4 h at 200 °C 
The obtained orange to beige gel was dissolved in water (3 weight-% TiO2 content) and 
subsequently pressure filtrated (0.8 µm membrane).  
For analysis the samples were either washed with ethanol (for TEM and DRIFT) via 
centrifugation and redispersion (3 times at 30 000 rpm for 0.5 h), dried under vacuum if 
necessary (DRIFT) or washed via dialysis (10-20 kDa molecular cut-off) against water with up 
to 6 water changes (for photocatalytic activity test, TGA, XRD, zeta potential, DLS) and dried 
via freeze drying (TGA, XRD, XPS, XAFS) or re-stabilised with the addition of 1 M HNO3 (to 
obtain pH = 3, for DLS). 
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2.2. Synthesis of luminescent TiO2 based core/shell nanoparticles  
Synthesis of TiO2/SiO2 core/shell nanoparticles 
For the coating of TiO2 NPs with a SiO2 shell 16.67 g TiO2 NP dispersion (0.5 g titanium dioxide) 
was mixed with 2.7 ml ammonia aqueous solution (25 %) to obtain a pH of 10 and redispersed 
using ultrasonic treatment (Branson Sonifier 450, 4 min, duty cycle = 30 %, strength = 7). 60 
ml of ethanol were immediately added and 0.38 g TEOS in 20 ml ethanol were dropwise added 
within 30 min under permanent stirring. After 2 h of stirring, the reaction mixtures were 
concentrated via rotary evaporation and subsequently washed three times with ethanol via 
centrifugation. 
Synthesis of luminescent TiO2/rhodamine-doped SiO2 core/shell nanoparticles with varying 
shell thicknesses 
Before the synthesis of the silica shell doped with RhBitc, the luminescent agent was 
conjugated to AMEO. Therefore, RhBitc (5.6 µg) was dissolved in DMF (2 ml) and a fivefold 
excess of AMEO was added to the dye solution under argon atmosphere. The reaction mixture 
was stirred overnight at room temperature in darkness. The modified luminescent agent is 
denoted as RhBitc-AMEO. 
For the coating of TiO2 NPs with a dye doped SiO2 shell, 16.67 g TiO2 NP dispersion (0.5 g 
TiO2) was mixed with 2.7 ml ammonia aqueous solution (25 %) to obtain a pH of 10 and 
redispersed using ultrasonic treatment. 60 ml of ethanol were immediately added and 0.09 g, 
0.18 g or 0.38 g TEOS with 49 µl, 106 µl or 212 µl RhBitc-AMEO in 20 ml ethanol were dropwise 
added within 30 min under permanent stirring. Due to this, 0.3 mol-% of Si-atoms added to the 
reaction belonged to AMEO or RhBitc-AMEO and the theoretic molar ratio Ti/Si/RhBitc was 
1/0.07/4.11E-5, 1/0.14/8.8E-5 or 1/0.29/17.77E-5. After 2 h of stirring, the reaction mixtures 
were concentrated via rotary evaporation and subsequently washed with ethanol via 
centrifugation until a clear supernatant was obtained. The NPs were stored in ethanol or dried 
under vacuum for further characterization. The TiO2/SiO2 core/shell NPs are named as 
TiO2/SiO2_1 to TiO2/SiO2_3 (0.09 g to 0.38 g TEOS). 
Synthesis of ZnO nanoparticles with LiOH as base 
Zn(CH3CO2)2 (37 mg, 0.2 mmol) was dissolved in ethanol (20 ml) in an ultrasonic bath. LiOH 
(36 mg, 1.5 mmol) was also ultrasonically dissolved in ethanol (20 ml). Then, both solutions 
were mixed together and stirred for 4 h at room temperature. The synthesis was carried out 
under three different conditions: firstly in a lid-covered flask, secondly in an open flask (which 
allowed for air exchange) and thirdly in a flask flooded with nitrogen. 
Synthesis of ZnO nanoparticles with KOH as base  
Zn(CH3CO2)2 * H2O (8.13 g, 37 mmol) was dissolved in ethanol (700 ml) with the help of 
continuous sonication using a Branson Sonifier II Model 450 for 15 min in an ice water bath. 
Also KOH (8.31 g, 148 mmol) was dissolved in ethanol (280 ml) in an ultrasonic bath. After 
combining both solutions, compressed air was continuously bubbled into the stirred reaction 
batch at a flow rate of 100 l/h. The compressed air was introduced into the reaction vessel via 
a glass frit with holes of a diameter of 200 mm. The reaction was performed for 6 h at room 
temperature. 
Synthesis of ZnO nanoparticles with varying LiOH ratios 
Zn(CH3CO2)2 (37 mg, 0.2 mmol) was dissolved in ethanol (3.08 ml) in an ultrasonic bath. LiOH 
(in appropriate concentration – see Table - EP - 1) was also ultrasonically dissolved in ethanol. 
Then, both solutions were mixed together and stirred for 24 h in an open flask at room 
temperature.  
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Table - EP - 1. Variation of reactant ratios for ZnO synthesis. 
concentration ZnOAc:LiOH 
[mol]:[mol] 
mass [g] (quantity [mmol]) amount of ethanol as solvent 
[ml] 
1:1.15 0.0055 (0.23) 0.55 
1:2 0.0096 (0.4) 0.96 
1:3 0.0144 (0.6) 1.44 
1:7.5 0.0360 (1.5) 3.6 
 
Synthesis of Fe2O3/TiO2 core/shell nanoparticles 
First the synthesis of 3.9 g Fe2O3 NPs was carried out by a precipitation method. For this, 
Fe(II)Cl2 * 4 H2O (1 eq., 8 mmol, 1.59 g) and Fe(III)Cl3 * 6 H2O (2 eq., 16 mmol, 4.325 g) were 
dissolved in 200 ml water under strong stirring. 12 ml of 25 % ammonium hydroxide in water 
was quickly added. The obtained particles were washed twice with water and twice with ethanol 
by magnetic separation and redispersion. The ethanol was removed before the transfer of the 
particle pellet into the titanium precursor batch. 
For the shell synthesis, 33.56 g 2-[2-(2-methoxyethoxy)ethoxy]acetic acid (0.1883 mol,  
1.883 eq) was dropped into 34.03 g titanium(IV) butoxide (0.1 mol, 1 eq) over 1 h under stirring. 
This batch was added to the Fe2O3 particle pellet (3.9 g) under stirring. Then 6.01 g water (0.33 
mol, 3.33 eq) was added dropwise over 30 min to the titanium precursors and stirred overnight 
at room temperature. The solution was then concentrated by rotary evaporation resulting in a 
black viscous liquid (Fe2O3/TiO2 content: 25.2 weight-%, determined by heating up to 800 °C). 
It was subsequently diluted with water to obtain sol with 12 weight-% inorganic core/shell 
precursor. This dispersion was hydrothermally treated in an autoclave (with 100 ml Teflon 
insert filled to 75 % volume) at 160 °C for 4 h. The finally obtained brown to black gel was 
diluted with water, destabilised with NaOH (pH = 10), 5 times washed with water via magnetic 
separation and redispersion and finally stabilised with HNO3 (pH = 3-4). 
 
  
Experimental part 
 
 
- 182 - 
3. Organic coupling agent synthesis protocols 
All reactions described below were carried out under argon atmosphere. Exceptions were the 
reactions for compound 9, compound 10, compound 15, compound 19, compound 21 
and compound 24. 
Compound 1: 
 
Chemical formula: C11H24N2O4 
Molecular weight: 248.32 g/mol 
Di-tert-butyl dicarbonate (1 eq., 0.05 mmol, 10.91 g) was dissolved in 100 ml CH2Cl2 and 
dropwise added to 2,2-(ethylenedioxy)bis(ethylamine) (10 eq., 0.5 mmol, 74.10 g) under strong 
stirring at 0 °C over 8 h. The reaction batch was then stirred for 16 h at room temperature. 300 
ml water was added and the product was extracted with 3 x 50 ml CH2Cl2. The combined 
organic phases were washed with 3 x 150 ml water. The organic phase was dried over MgSO4, 
filtrated and concentrated under vacuum to yield compound 1 (97 %) as clear and pale yellow 
oil. 
1H NMR (300 MHz, DMSO, δ [ppm]): 
5.77 (s, 1H, 3-NH-4), 3.51-3.49 (m, 4H, 7, 6), 3.41-3.37 (m, 4H, 8, 5), 3.07 (dd, J = 5.97 Hz, 
2H, 4), 2.80 (s, 2H, 9-NH2), 2.68 (t, J = 5.73 Hz, 2H, 9), 1.38 (s, 9H, 1).   
13C NMR (75 MHz, DMSO, δ [ppm]): 
156.03 (1C, 3), 78.02 (1C, 2), 72.85 (2C, 8, 5), 70.01/69.94 (2C, 7, 6), 41.51 (1C, 9), ~ 40.12 
(1C, 4 in solvent signal), 29.57 (3C, 1). 
MS (ESI, m/z)  
[M+H]+ calculated: 249.18, found: 249.20 
EA† 
calculated: C, 53.21; H, 9.74; N, 11.28; O, 25.77 
found: C, 50.72; H, 9.03; N, 10.26 
 
Compound 2: 
 
Chemical formula: C40H53N5O7S 
Molecular weight: 747.95 g/mol 
Compound 1 (1.2 eq., 0.48 mmol, 0.119 g) was dissolved in 3 ml CH2Cl2, triethylamine (TEA 
– 1.5 eq., 0.6 mmol, 83.74 µl) was then added and stirred for 10 min. Rhodamine B 
isothiocyanate (RhBitc – 1 eq., 0.4 mmol, 0.214 g) was dissolved in 3 ml DMF and added to 
the reaction batch. The reaction was carried out for 16 h under stirring at room temperature in 
darkness. The crude compound as powder was obtained by complete removal of all volatile 
compounds under vacuum. It was extensively washed with diethyl ether with the aid of 
                                               
†
 The difference between calculated and found percentage of the elements is caused by traces of di-
Boc protected compound.  
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ultrasonic treatment. The product was dissolved in 5 ml CH2Cl2 and 1 ml 1 M KOH solution 
was added. The organic solvent and liberated TEA were removed under vacuum and the 
product was extracted from the water phase with 3 x 20 ml and 3 x10 ml CH2Cl2. The combined 
organic phases were dried over MgSO4, filtrated and concentrated under vacuum to yield 
compound 2 (94 %) as dark violet solid. 
1H NMR (300 MHz, DMSO, δ [ppm]): 
8.33-6.11 (m, 9H, 12, 16, 17, 20, 21, 23), 5.72 (s, 1H, 3-NH-4), 3.51 (s, 4H, 6, 7), 3.41-3.35 
(m, 12H, 5, 8, 25), 3.07 (dd, J = 5.55 Hz / 10.95 Hz, 2H, 4), 2.74-2.71 (m, 2H, 9), 1.39 (s, 9H, 
1), 1.25-1.08 (m, 12H, 26). 
13C NMR (75 MHz, DMSO, δ [ppm])‡: 
169.70 (1C, 10), 156.08 (2 C, 3, 14), 153.20/152.73/149.67/149.27 (6C, 15, 18, 22, 24), 
139.66 (1C, 11), 129.07 (2C, 20), 125.36 (3C, 12, 16, 17), 123.22 (1C, 13), 108.58 (2C, 21), 
106.74 (2C, 19), 97.35 (2C, 23), 78.11 (1C, 2), 69.91 (4C, 5-8), 44.26 (1C, 9), ~ 40.12 (1C, 4 
in solvent signal), 34.82 (4C, 25), 30.87 ([4-x-y]C, 26), 28.66 (3C, 1), 21.48 (xC, 26), 12.79 
(yC, 26) [x,y < 4]. 
MS (ESI, m/z)  
[M+H]+ calculated: 478.37, found: 478.40 
 
Compound 3:  
 
Chemical formula: C35H46N5O5S+Cl- 
 
Molecular weight: 683.29 g/mol 
Compound 2 (0.45 g) was dissolved in 25 ml CH2Cl2 and gaseous HCl was bubbled through 
the solution during 15 min. At the end of the reaction the solvent was evaporated under vacuum 
to yield the precipitated compound 3 (quantitative) in salt form as a dark violet solid.  
 
1H NMR (300 MHz, CDCl3 + TEA·HCl§, δ [ppm]): 
8.00-6.12 (m, 9 H, 9, 13, 14, 17, 18, 20), 3.55 – 3.18 (br/m, 20 H, 1, 2-5, 6, 22), 1.18-1.07 (m, 
12 H, 23). 
 
13C NMR (75 MHz, CDCl3 + TEA·HCl**, δ [ppm]):  
169.95 (1C, 7), 155.80 (1 C, 11), 154.23/153.24/152.44/149.49 (6 C, 12, 15, 19, 21), 131.04 
(2C, 17), 129.19 (3C, 9, 13, 14), 129.14 (1C, 8), 127.86 (1C, 10), 108.00 (2C, 18), 106.64 
(2C, 16), 97.35 (2C, 20), 69.91 (4C, 2-5), 44.94 (2C, 1,6), 44.49 ([4-x]C, 22), 29.65 (xC, 22), 
12.69 (4C, 23) [x < 4]. 
 
MS (ESI, m/z)  
[M+H]+ calculated: 648.84, found: 648.3 
 
                                               
‡
 resolution of signals of aromatic carbons of rhodamine was very low 
§
 addition of TEA to obtain better solubility of the compound as free amine 
**
 addition of TEA to obtain better solubility of the compound as free amine 
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Compound 4:  
 
Chemical formula: 
C45H66N6O9SSi 
 
Molecular weight:  
895.20 g/mol 
Compound 3 (1 eq., 0.208 mmol, 0.15 g) was dispersed in 6 ml CH2Cl2, TEA (15 eq., 3.12 
mmol, 435 µl) was added and stirred until compound 3 was solubilized. 
Isocyanatopropyltriethoxysilane (1.2 eq., 0.250 mmol, 61.8 µl) was added and the reaction 
proceeded at room temperature for 16 h. Afterwards the solvent and excess TEA were 
evaporated. The obtained product was washed with pentane (3 x 30 ml). Then, all traces of 
the solvent were evaporated to yield compound 4 as purple solid (~ 90 %).    
 
1H NMR (300 MHz, CDCl3 + TEA·HCl††, δ [ppm]): 
8.03-6.32 (m, 9H, 15, 19, 20, 23, 24, 26), 5.73/5.36/5.12 (br s/s/s, 2H/1H/1H, 4xNH), 3.79-3.72 
(m, 6H, 2), 3.64 (dd, J = 7.05 Hz / 13.95 Hz, 8H, 28), 3.54 (s, 4H, 9, 10), 3.44 (t, J = 5.10 Hz, 
4H, 8, 11), 3.42-3.37 (m, 2H, 12), 3.29 (t, J = 5.36 Hz, 2H, 7), 3.05 (covered by TEA·HCl, 2H, 
5), 1.59-1.54 (m, 2H, 4), 1.19-1.14 (m, 21H, 1, 29), 0.60-0.55 (m, 2H, 3). 
 
13C NMR (75 MHz, CDCl3 + TEA·HCl‡‡, δ [ppm])§§:  
169.95 (1C, 13), 157.68 (1C, 6), 155.28 (1C, 17), 154.23/153.24/152.44/149.49 (6C, 18, 21, 
25, 27), 131.04 (2C, 23), 129.19 (3C, 15, 19, 20), 129.14 (1C, 14), 127.86 (1C, 16), 108.00 
(2C, 24), 106.64 (2C, 22), 97.35 (2C, 26), 70.71/ 70.28 (4C, 8-11), 58.33 (4C, 28), 57.99 (3C, 
2), 44.92 (1C, 12), 42.85 (1C, 5),  40.08 (1C, 7), 23.63 (1C, 4), 18.33 (3C, 1), 12.52 (4C, 29), 
7.56 (1C, 3). 
 
MS (ESI, m/z)  
[M+H]+ calculated: 895.44, found: 895.4 
 
Compound 5: 
 
Chemical formula: C40H52N4O9 
 
Molecular weight: 732.88 g/mol 
Fmoc-lysine-Z-OH (1 eq., 8.725 mmol, 4.385 g) was dissolved in 175 ml CH2Cl2 and cooled 
down to 0 °C. N-hydroxysuccinimide (1.2 eq., 10.47 mmol, 1.205 g) and N,N'-
dicyclohexylcarbodiimide (1.2 eq., 10.47 mmol, 2.160 g) were added and stirred for 6 h (30 
                                               
††
 side product due to reaction of Cl- and TEA  
‡‡
 side product due to reaction of Cl- and TEA  
§§
 resolution of signals of aromatic carbons of rhodamine was very low 
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min at 0 °C and then at room temperature). The reaction mixture was filtered and rinsed with 
CH2Cl2 . The filtrate was mixed with compound 1 (1.2 eq., 10.47 mmol, 2.60 g) and stirred for 
16 h at room temperature. The reaction batch was washed with 3 x 100 ml 10 vol-% acetic 
acid, 3 x 100 ml saturated NaHCO3 and 3 x 100 ml water. The organic phase was evaporated 
to obtain a highly concentrated solution and filtrated. The organic solvent of the filtrate was 
evaporated and the obtained powder was washed with 1 x 80 ml and 3 x 40 ml diethyl ether. 
The crude powder was then again dissolved in 10 ml CH2Cl2 per g powder and was purified by 
column chromatography on 25 g silica gel per g powder with 100% EtOAc as eluent to yield 
the pure compound 5 (61 %) as white powder. 
1H NMR (300 MHz, DMSO, δ [ppm]): 
7.91-7.89 (m, 3H, 19, 9-NH-10), 7.73 (d, J = 7.03 Hz, 2H, 16), 7.42-7.16 (m, 11H, 28-30, 17, 
18, 11-NH-12, 24-NH-25), 6.76 (t, J = 4.88 Hz, 1 H, 3-NH-4), 5.01 (s, 2H, 26), 4.31-4.22 (m, 
3H, 14, 13), 3.97-3.89 (m, 1H, 11), 3.49 (s, 4H, 6, 7), 3.39-3.33 (m, 4H, 5, 8), 3.24-3.16 (m, 
2H, 9), 3.08 (dd, J = 6.15 Hz / 11.85 Hz, 2H, 4), 2.98 (dd, J = 6.52 Hz / 12.75 Hz, 2H, 24), 1.61-
1.49 (br/m, 2H, 21), 1.37 (s, 9H, 1), 1.37-1.24 (br/m, 4H, 23, 22). 
13C NMR (75 MHz, DMSO, δ [ppm]): 
172.50 (1C, 10), 156.53 (1C, 25), 156.38 (1C, 12), 156.04 (1C, 3), 144.35 (2C, 15), 141.17 
(2C, 20), 137.72 (1C, 27), 128.80-127.52 (9C, 17, 18, 28-30), 125.81 (2C, 16), 120.57 (2C, 
19), 78.05 (1C, 2), 69.99/69.91/69.45 (4C, 5-8), 66.25/65.57 (2C, 13, 26), 55.06 (1C, 11), 47.13 
(1C, 14), ~ 40 (3C, 4, 9, 24 in solvent signal), 32.18 (1C, 21), 29.57 (1C, 23), 28.68 (3C, 1), 
23.27 (1C, 22). 
MS (ESI, m/z)  
[M+Na]+ calculated: 755.87, found 755.4 
 
EA  
calculated: C, 65.56; H, 7.15; N, 7.64; O, 19.65 
found: C,  64.72; H, 6.89 ; N,  7.13 
 
Compound 6: 
 
Chemical formula:  C25H42N4O7 
Molecular weight:  510.63 g/mol 
Compound 5 (1 eq., 4.09 mmol, 3.00 g) was dissolved in 30 ml THF and Et2NH (38 eq., 155.42 
mmol, 16.24 ml) was added. The reaction batch was stirred for 16 h at room temperature. The 
product was concentrated under vacuum, then dissolved in 10 ml acetonitrile and 90 ml of 
water was added. The water phase was washed with 3 x 100 ml pentane. To the water phase 
10 ml of 0.5 M NaOH were added and the product was finally extracted with 3 x 100 ml CH2Cl2. 
The combined organic phases were dried over MgSO4, filtrated and concentrated under 
vacuum to yield compound 6 (98 %) as slightly yellow, highly viscous, clear oil.  
1H NMR (300 MHz, DMSO, δ [ppm]): 
7.87 (t, J = 5.79 Hz, 1H, 9-NH-10), 7.41-7.32 (m, 5H, 19-21), 7,20 (t, J = 5.76 Hz, 1H, 15-NH-
16), 6.75 (t, J = 5.63 Hz, 1H, 3-NH-4), 5.01 (s, 2H, 17), 3.50 (s, 4H, 6, 7), 3.44-3.32 (m, 4H, 5, 
8), 3.24-3.15 (m, 2H, 9), 3.13-2.90 (m, 3H, 4,11), 2.96 (dd, J = 6.52 Hz / 12.75 Hz, 2H, 15), 
1.72 (s, 2H, 11-NH2), 1.57-1.48 (br/m, 2H, 12), 1.37 (s, 9H, 1), 1.33-1.25 (br/m, 4H, 14, 13). 
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13C NMR (75 MHz, DMSO, δ [ppm]): 
172.46 (1C, 10), 156.52 (1C, 16), 156.05 (1C, 3), 137.76 (1C, 18), 128.80/128.19 (5C, 19-21), 
78.36 (s, 1C, 2), 69.99/69.58 (4C, 5-8), 65.54 (1C, 17), 55.05 (1C, 11), ~ 40 (2C, 4, 9 in solvent 
signal), 38.70 (1C, 15), 33.30 (1C, 12), 29.82 (1C, 14), 28.69 (3C, 1), 23.04 (1C, 13). 
MS (ESI, m/z)  
[M+H]+ calculated: 511.63, found: 511.3 
[M+Na]+ calculated: 533.62, found: 533.3  
EA 
calculated: C, 58.80; H, 8.29; N, 10.97; O, 21.93 
found: C, 57.38 ; H, 8.44 ; N, 10.25 
 
Compound 7: 
 
Chemical formula:  C54H71N7O10S 
 
Molecular weight:  1010.26 g/mol 
 
Compound 6 (1.2 eq., 0.448 mmol, 0.229 g) was dissolved in 4 ml CH2Cl2, TEA (1.5 eq., 0.560 
mmol, 77.98 µl) was added and stirred for 10 min. Rhodamine B isothiocyanate (RhBitc – 1 
eq., 0.373 mmol, 0.2 g) was dissolved in 2 ml DMF and added to the reaction batch. The 
reaction was carried out for 16 h under stirring at room temperature in darkness. The crude 
compound as powder was obtained by complete removal of all volatile compounds under 
vacuum. It was extensively washed with diethyl ether with the aid of ultrasonic treatment. This 
crude product was dissolved in 5 ml CH2Cl2 and 1 ml 1 M KOH solution was added. The organic 
solvent and liberated TEA were removed under vacuum and the product was extracted from 
the water phase with 3 x 20 ml and 3 x 10 ml CH2Cl2. The combined organic phases were dried 
over MgSO4, filtrated and concentrated under vacuum to yield compound 7 (91 %) as dark 
violet solid. 
1H NMR (300 MHz, DMSO, δ [ppm]): 
8.5-6.0 (m, “9 H”, 14, 18, 19, 22, 23, 25), 7.91 (t, J = 5.25 Hz, 1H, 9-NH-10), 7.39-7.30 (m, 7H, 
36-38, 11-NH-12-NH-13), 7.22 (t, J = 4.95 Hz, 1H, 32-NH-33), 6.78 (t, 1H, 3-NH-4), 5.01 (s, 
2H, 34), 3.50 (s, 4H, 6, 7), 3.38-3.34 (m, 12H, 5, 8, 27), 3.24-3.20 (m, 2H, 9) 3.12-3.03 (m, 3H, 
4,11), 2.96 (dd, J = 6.00 Hz / 11.70 Hz, 2H, 32), 1.71 (br/m, 2H, 29), 1.37 (s, 9H, 1), 1.29 (br/m, 
4H, 30, 31), 1.10 (t, 12 H, 28). 
13C NMR (75 MHz, DMSO, δ [ppm]): 
184.69 (1C, 12), 175.37(1C, 10), 156.53 (1C, 33), 156.05 (2C, 3, 16), 153.15/152.70/149.37 
(6C, 17, 20, 24, 26), 137.76 (2C, 35,13), 129.09 (2C, 22), 128.80/128.18 (5C, 36-38), 123.20 
(4C, 14, 15, 18, 19), 108.58 (2C, 23), 106.76 (1C, 21), 97.32 (1C, 25), 78.06 (1C, 2), 69.99-
69.56 (4C, 5-8), 65.55 (1C, 34), 55.37 (1C, 11), 44.26 (4C, 27), ~ 40 (2C, 4, 9 in solvent signal), 
38.74 (1C, 32), 35.08 (1C, 29), 29.80 (1C, 31), 28.69 (3C, 1), 22.98 (1C, 30), 12.82 (4C, 28). 
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MS (ESI, m/z)  
[M+Na]+ calculated: 1032.5, found: 1032.5 
 
Compound 8: 
 
Chemical formula:  C49H64ClN7O8S 
 
Molecular weight: 946.6 g/mol 
 
First attempt: 
Compound 7 (0.3 g) was dissolved in 17 ml CH2Cl2 and gaseous HCl was bubbled through 
the solution during 4 min. At the end of the reaction the solvent and all volatile side products 
were evaporated under vacuum. Compound 8 was not obtained due to fragmentation of the 
compound 7 and/or 8 during the reaction. 
 
MS (ESI, m/z) – detected fragments: 
Compound 8a: [M + H]+: calculated: 411.25, found: 411.3 
 
 
Compound 8b: [M + H]+: calculated: 458.24, found: 458.2 
 
 
Compound 8c: [M + H]+: calculated: 762.32, found: 762.3 
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Second attempt: 
Compound 7 (1 eq., 0.265 mmol, 0.268 g) was dissolved in 15 ml CH2Cl2 and trifluoroacetic 
acid (15 eq., 3.975 mmol, 0.304 µl) was dropwise added under stirring. The reaction was 
stirred for 16 h. To eliminate all free TFA, a coevaporation with 3 x 20 ml toluene was 
subsequently carried out. Compound 8 was not obtained due to fragmentation of the 
compound 7 and/or 8 during the reaction. 
 
MS (ESI, m/z) – detected fragments: 
Compound 8c: [M + H]+: calculated: 762.32, found: 762.3 
Compound 8d: [M + H]+: calculated: 248.17, found: 249.2  
 
Compound 9: 
 
Chemical formula:  C46H65N7O8S 
 
Molecular weight: 876.13 g/mol 
 
Compound 7 (1 eq., 0.148 mmol, 0.150 g) was dissolved in 4 ml methanol and 100 µl acetic 
acid in 0.9 ml water was added under stirring. The catalyst Pd on C with 10 weight-% loading 
(0.015 g) was added and the flask was set under H2 atmosphere by setting the sample 3 times 
under vacuum and subsequently flooding it with H2. The reaction was stirred for 24 h, the Pd/C 
was filtered off over celite and the solvent was evaporated. Compound 9 was not obtained 
due to fragmentation of the compound 7 during the reaction. 
 
MS (ESI, m/z) – detected fragments: 
Compound 8b: [M + H]+: calculated: 458.24, found: 458.2 
Compound 8c: [M + H]+: calculated: 762.32, found: 762.3 
Compound 8d: [M + H]+: calculated: 248.17, found: 249.2  
Compound 8e: [M + H]+: calculated: 511.31, found: 511.3 
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Compound 10: 
 
Chemical formula: C29H30N2O6 
Molecular weight: 502.57 g/mol 
First attempt: 
Sodiumbicarbonate (2.5 eq., 25 mmol, 2.10 g) was dissolved in 25 ml water, added to Nα-Z-
lysine (1 eq., 10 mmol, 2.80 g) and stirred for 15 min at 0 °C to yield a turbid solution. 15 ml of 
THF was added.  To this batch, 9-Fluorenylmethoxycarbonyl chloride (1 eq., 10 mmol, 2.59 g) 
was stepwise added with a spatula. The reaction was complete after stirring for 3 h at 0 °C and 
1 h at room temperature. 200 ml 0.5 M and 40 ml 1 M potassium hydrogenosulfate solution 
were added under stirring. The precipitate was filtered and washed with 3 x 50 ml water, 
followed by excessive washing with toluene (9 x 20 ml). Finally the precipitate was washed 
with diethyl ether (3 x 100 ml). The ether phases were combined and concentrated to yield 
compound 10 (30 %) as white powder. 
Second attempt: 
The same protocol was followed as in the first attempt but dioxane instead of THF was used 
as solvent. After purification, compound 10 with a yield of 11 % was obtained. 
 
Third attempt: 
The same protocol was followed as in the first attempt but DMF instead of THF was used as 
solvent. After purification, compound 10 with a yield of 68 % was obtained. 
 
1H NMR (300 MHz, DMSO, δ [ppm]): 
12.59 (s, 1H, HO-1), 7.90 (d, J = 7.36 Hz, 2H, 20), 7.69 (d, J = 7.38 Hz, 2H, 17), 7.58 (d, J = 
7.89 Hz, 1H, 12-NH-13), 7.45-7.30 (m, 10H, 18, 19, 6-8, 2-NH-3), 5.04 (s, 2H, 14), 4.30 (d, J 
= 6.76 Hz, 2H, 4), 4.21 (t, J = 6.68 Hz, 1H, 15), 3.96-3.89 (m, 1H, 2), 2.96 (dd, J = 6.00 Hz / 
12.00 Hz, 2H, 12), 1.68-57 (br/m, 2H, 9), 1.39-1.31 (br/m, 4H, 11, 10). 
13C NMR (75 MHz, DMSO, δ [ppm]): 
174.4 (1C, 1), 156.65 (2C, 3, 13), 144.40 (1C, 16), 141.20 (1C, 21), 137.46 (1C, 5),128.80-
128.05 (10C, 18, 19, 6-8), 125.60 (2C, 17), 120.58 (2C, 20), 65.86 (1C, 4), 65.62 (1C, 14), 
54.32 (1C, 2), 47.24 (1C, 15), ~ 40 (2C, 12 in solvent signal), 30.91 (1C, 9), 29.39 (1C, 11), 
23.35 (1C, 10). 
MS (ESI, m/z)  
[M+Na]+ calculated: 525.56, found: 525.2 
[M+K]+ calculated: 541.67, found: 541.2 
 
EA 
calculated: C, 69.31; H, 6.02; N, 5.57; O, 19.10 
found: C, 68.79; H, 4.67; N, 5.42 
Experimental part 
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Compound 11: 
 
Chemical formula:  C40H52N4O9 
 
Molecular weight: 732.88 g/mol 
 
Compound 10 (1 eq., 5.717 mmol, 2.873 g) was dissolved in 115 ml CH2Cl2 and cooled down 
to 0 °C. N-hydroxysuccinimide (1.2 eq., 6.860 mmol, 0.790 g) and then N,N'-
dicyclohexylcarbodiimide (1.2 eq., 6.860 mmol, 1.415 g) were added and stirred for 6 h (30 
min at 0 °C and then at room temperature). The reaction mixture was filtered and rinsed with 
CH2Cl2 . The filtrate was mixed with compound 1 (1.2 eq., 6.680 mmol, 1.703 g) and stirred for 
16 h at room temperature. The reaction batch was washed with 3 x 100 ml 10 vol-% acetic 
acid, 3 x 100 ml saturated NaHCO3 and 3 x 100 ml water. The organic phase was evaporated 
to obtain a highly concentrated solution and filtrated. The organic solvent of the filtrate was 
evaporated and the obtained powder was washed with 1 x 80 ml and 3 x 40 ml diethyl ether. 
The crude powder was then again dissolved in 10 ml CH2Cl2 per g powder and was purified by 
column chromatography on 25 g silica gel per g powder with 100% EtOAc as eluent to yield 
the pure compound 11 (80 %) as white powder. 
1H NMR (300 MHz, DMSO, δ [ppm]): 
7.91-7.89 (m, 5H, 29, 26, 9-NH-10), 7.78-7.68 (m, 2H, 27), 7.42-7.27 (m, 9H, 15-17, 28, 11-
NH-12, 21-NH-22), 6.78 (t, J = 6.20 Hz, 1H, 3-NH-4), 5.02 (s, 2H, 13), 4.31-4.21 (m, 3H, 24, 
23), 3.95-3.90 (m, 1H, 11), 3.49 (s, 4H, 6, 7), 3.40-3.35 (m, 4H, 5, 8), 3.25-3.17 (m, 2H, 9), 
3.06 (dd, J = 5.70 Hz / 11.70 Hz, 2H, 4), 2.97 (dd, J = 6.90 Hz / 12.90 Hz, 2H, 21), 1.61-1.53 
(br/m, 2H, 18), 1.38 (s, 9H, 1), 1.27-1.19 (br/m, 4H, 20, 19). 
13C NMR (75 MHz, DMSO, δ [ppm]): 
172.51 (1C, 10), 156.65 (2C, 22, 12), 156.05 (1C, 3), 144.40 (2C, 25), 144.20 (2C, 30), 137.54 
(1C, 14), 128.80-128.14 (9C, 27, 28, 15-17), 125.60 (2C, 26), 120.50 (2C, 29), 78.05 (1C, 2), 
70.00-69.43 (4C, 5-8), 65.81/65.62 (2C, 23, 13), 55.14 (1C, 11), 47.24 (1C, 24), ~ 40 (3C, 4, 
9, 21 in solvent signal), 33.20 (1C, 18), 29.79 (1C, 20), 28.69 (3C, 1), 23.29 (1C, 19). 
MS (ESI, m/z)  
[M+Na]+ calculated: 755.87, found 755.4 
 
EA  
calculated: C, 65.56; H, 7.15; N, 7.64; O, 19.65  
found: C, 64.91; H, 6.77; N, 6.78 
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Compound 12: 
 
Chemical formula: C25H42N4O7 
Molecular weight: 510.63 g/mol  
Compound 11 (1 eq., 3.14 mmol, 2.30 g) was dissolved in 23 ml THF and diethylamine (38 
eq., 119.26 mmol, 12.5 ml) was added. The reaction batch was stirred for 16 h at room 
temperature. The product was concentrated under vacuum, then dissolved in 10 ml acetonitrile 
and 90 ml of water was added. The water phase was washed with 4 x 100 ml pentane. To the 
water phase 10 ml of 0.5 M NaOH were added and the product was finally extracted with 3 x 
100 ml CH2Cl2. The combined organic phases were dried over MgSO4, filtrated and 
concentrated under vacuum to yield compound 12 (93 %) as slightly yellow, highly viscous, 
clear oil.  
1H NMR (300 MHz, DMSO, δ [ppm]): 
7.92 (t, J = 5.55 Hz, 1H, 9-NH-10), 7.40-7.30 (m, 6H, 15-17, 11-NH-12), 6.79 (t, J = 5.74 Hz, 
1H, 3-NH-4), 5.02 (s, 2H, 13), 3.98-3.89 (m, 1H, 11) 3.49 (s, 4H, 6, 7), 3.42-3.35 (m, 6H, 5, 8, 
21), 3.25-3.12 (m, 2H, 9), 3.06 (dd, J = 6.00 Hz / 12.00 Hz, 2H, 4), 1.61-1.51 (br/m, 4H, 18, 
20), 1.37 (s, 9H, 1), 1.28-1.19 (br/m, 2H, 19). 
13C NMR (75 MHz, DMSO, δ [ppm]): 
172.51 (1C, 10), 156.35 (1C, 12), 156.05 (1C, 3), 137.54 (1C, 14), 128.78/128.14 (5C, 15-17), 
78.36 (1C, 2), 69.99/69.64/69.44 (5C, 5-8, 21), 65.58 (1C, 13), 55.17 (1C, 11), 41.88/~40 (2C, 
4, 9 in solvent signal), 33.35 (1C, 18), 32.40 (1C, 20), 28.69 (3C, 1), 23.29 (1C, 19). 
MS (ESI, m/z)  
[M+H]+ calculated: 511.31, found: 511.3 
[M+Na]+ calculated: 533.32, found: 533.3 
EA 
calculated: C, 58.80; H, 8.29; N, 10.97; O, 21.93 
found: C, 56.65; H, 7.97; N, 10.37 
 
 
Compound 13: 
 Chemical formula: C13H11NO4 Molecular weight: 245.33 g/mol 
N-(2-Hydroxyethyl)phthalimide (1 eq., 35 mmol, 6.69 g) was dissolved in 100 ml CH2Cl2 and 
TEA (1.1 eq., 38.5 mmol, 5.34 ml) was added. The reaction batch was cooled down to 0°C, 
acryloylchloride (1.1 eq, 38.5 mmol, 3.17 ml) was added dropwise over an hour under agitation 
and then the reaction was stirred for 16 h at room temperature. The batch was filtered and the 
residue (TEAxHCl) was rinsed with CH2Cl2. The filtrate was washed with 1 x 100 ml water and 
3 x 100 ml 0.5 M NaOH. The organic phase was dried over MgSO4, filtrated and concentrated 
under vacuum to yield compound 13 (59 %) as white to slightly yellow powder. 
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1H NMR (300 MHz, DMSO, δ [ppm]): 
7.92-7.82 (m, 4H, 8, 9), 6.25 (dd, J = 1.81 Hz / 17.16 Hz, 1H, 1), 6.07 (dd, J = 10.26 Hz / 17.16 
Hz, 1H, 2), 5.86 (dd, J = 1.81 Hz / 10.26 Hz, 1H, 1), 4.33 (t, J = 5.34 Hz, 2H, 4), 4.03 (t, J = 
5.34 Hz, 2H, 5). 
13C NMR (75 MHz, DMSO, δ [ppm]): 
168.03 (2C, 6), 165.80 (1C, 3), 134.08 (2C, 9), 131.98 (2C, 7), 131.43 (1C, 1), 127.91 (1C, 2), 
123.39 (2C, 8), 61.70 (1C, 4), 36.96 (1C, 5). 
MS (ESI, m/z)  
[M+Na]+ calculated: 268.32, found: 268.1 
 
EA 
calculated: C, 63.67; H, 4.52; N, 5.71; O, 26.1;  
found: C, 63.62; H, 4.4 ; N, 5.5   
 
Compound 14: 
 
Chemical formula: 
C51H64N6O15 
 
Molecular weight:  
1001.10 g/mol  
 
Compound 12 (1 eq., 0.930 mmol, 0.500 g) was dissolved in 20 ml THF and compound 13 
(5 eq., 4.896 mmol, 1.201 g) was added. The reaction batch was stirred for 6 days at 65 °C. 
The solvent was evaporated and the crude product was dissolved in CH2Cl2. Over a short 
column (10 g silica per g crude product), the excess acrylate was removed with 100 % CH2Cl2. 
To obtain the product, 10 % methanol in CH2Cl2 was used. The solvent was evaporated to 
obtain the pure compound 14 (91 %) as orange, clear, highly viscous liquid. 
1H NMR (300 MHz, DMSO, δ [ppm]): 
7.93-7.80 (m, 9H, 9-NH-10, 29, 30), 7.34-7.29 (m, 6H, 15-17, 11-NH-12), 6.76 (t, J = 5.49 Hz, 
1H, 3-NH-4), 5.01 (s, 2H, 13), 4.21 (t, J = 5.29 Hz, 4H, 25), 3.91 (dd, J = 8.21 Hz / 13.66 Hz, 
1H, 11), 3.81 (t, J = 5.29 Hz, 4H, 26), 3.44 (s, 4H, 6, 7), 3.39-3.36 (m, 4H, 5, 8), 3.25-3.16 (m, 
2H, 9), 3.05 (dd, J = 5.85 Hz / 11.85 Hz, 2H, 4), ~2.5 (4H, 23 in solvent signal), 2.26 (t, J = 
6.98 Hz, 4H, 22), 2.16 (t, J = 5.55 Hz, 2H, 21), 1.61-43 (br/m, 2H, 18), 1.37 (s, 9H, 1), 1.28-
1.16 (br/m, 4H, 20, 19). 
13C NMR (75 MHz, DMSO, δ [ppm]): 
172.33 (3C, 10, 24), 169.03 (4C, 27), 156.32 (1C, 12), 156.02 (1C, 3), 137.51 (1C, 
14),134.91 (4C, 30), 131.94 (4C, 28), 128.76/128.14 (5C, 15-17), 123.53 (4C, 29), 78.04 (1C, 
2), 69.99/69.91/69.63/69.44 (4C, 5-8), 65.79 (1C, 13), 61.39 (2C, 25), 55.17 (1C, 11), 53.13 
(1C, 21), 48.66 (2C, 22), ~40 (2C, 4, 9 in solvent signal), 37.14 (2C, 23), 32.54 (1C, 18), 
32.08 (2C, 26), 28.67 (3C, 1), 26.48 (1C, 20),  23.67 (1C, 19). 
MS (ESI, m/z)  
[M+Na]+ calculated: 1023.44, found: 1023.4 
Experimental part 
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EA 
calculated: C, 61.19; H, 6.44; N, 8.39; O, 23.97 
found:  C, 60.51; H, 6.27; N, 8.22 
 
 
Compound 15: 
 
Chemical formula: 
C43H58N6O13 
 
Molecular weight:   
866.97 g/mol 
 
Compound 14 (1 eq., 0.100 mmol, 0.100 g) was dissolved in 2 ml methanol and 100 µl 1 M 
HCl was added under stirring. The catalyst Pd on C with 10 weight-% loading (0.030 g) was 
added and the flask was set under H2 atmosphere by setting the sample 3 times under vacuum 
and subsequently flooding it with H2. The reaction was stirred for 24 h, the Pd/C was filtered 
off over celite and the solvent was evaporated. During this synthesis, the ester moieties of the 
molecule have react with the present methanol via transesterification so compound 15 was 
not obtained. To examine the stability of compound 14, various synthesis conditions have 
been tested (Table - EP - 2). 
Table - EP - 2. Stability tests of compound 14 under different synthesis conditions. 
starting 
material 
0.020 g compound 14 
solvent 0.4 ml 
MeOH 
0.4 ml 
MeOH 
0.5 ml 
MeOH 
0.5 ml 
THF 
0.4 ml THF 1.6 ml EtOH 
345 µl H2O 
catalyst 20 µl  
1 M HCl 
20 µl  
1 M KOH 
4 mg 
Pd/C, 
H2 
4 mg 
Pd/C, H2 
20 µl  
1 M KOH 
50 µl NH3 (28 
% in water) 
duration stirring for 24 h at room temperature 16 h 
 
Compound 16:  Chemical formula: C6H10ClNO Molecular weight: 147.60 g/mol 
2-Chloropropylamine hydrochloride (1 eq., 100 mmol, 11.002 g) was dissolved in 50 ml CH2Cl2. 
Acryloylchloride (1.2 eq, 120 mmol, 9.874 ml) was dissolved in 50 ml CH2Cl2 and quickly added 
under agitation to the 2-chloropropylamine hydrochloride solution at 0 °C. Then TEA (2.2 eq., 
220 mmol, 30.496 ml) was also diluted with 50 ml CH2Cl2 and dropwise added to the reaction 
at 0 °C under agitation over 1 h. The reaction was finally stirred for 3.5 h at room temperature. 
The batch was filtered and the residue (TEAxHCl) was rinsed with CH2Cl2. To the filtrate, 8 g 
NaOH in 30 ml water was added. The phases were separated and the water phase was 
extracted with 2 x 30 ml CH2Cl2. The combined organic phases were dried over MgSO4, 
filtrated and concentrated under vacuum to yield compound 16 (88 %) as orange to brown oil. 
Experimental part 
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1H NMR (300 MHz, CDCl3, δ [ppm]): 
6.53 (br/s, 1H, 3-NH-4), 6.29 (dd, J = 1.66 Hz / 16.97 Hz, 1H, 1), 6.16 (dd, J = 10.08 Hz / 16.97 
Hz, 1H, 2), 5.69 (dd, J = 1.66 Hz / 10.08 Hz, 1H, 1), 3.65 (t, J = 6.33 Hz, 2H, 6), 3.54 (q, J = 
6.48 Hz, 2H, 4), 2.09 (p, J = 6.52 Hz, 2H, 5). 
13C NMR (75 MHz, CDCl3, δ [ppm]): 
166.02 (1C, 3), 130.81 (1C, 2), 126.42 (1C, 1), 42.55 (1C, 6), 37.03 (1C, 4), 32.05 (1C, 5). 
EA 
calculated: C, 48.82; H, 6.83; Cl, 24.02; N, 9.49; O, 10.84 
found:  C, 47.92; H, 6.74; N, 9.08 
 
Compound 17:  
 Chemical formula: C14H14N2O3 Molecular weight: 258.28 g/mol 
Potassium phthalimide (1 eq., 46 mmol, 8.52 g) was dissolved in 24 ml DMF. N-Acryloyl-3-
chloropropylamine (1 eq, 46 mmol, 6.79 g) was dissolved in 25 ml DMF and quickly added 
under agitation to the potassium phthalimide solution. Then the reaction was stirred for 15 h at 
75 °C. The batch was filtered and the residue (KCl) was rinsed with DMF. The solvent of the 
filtrate was evaporated and the crude solid was dissolved in 50 ml CH2Cl2. The organic phase 
was washed with 3 x 30 ml brine, dried over MgSO4, filtrated and concentrated under vacuum. 
The obtained orange to brown crude product was then again dissolved in 10 ml CH2Cl2 per g 
powder and was purified by column chromatography on 50 g silica gel per g powder with 50 % 
ethyl acetate in CH2Cl2 to yield the pure compound 17 (55 %) as white powder. 
1H NMR (300 MHz, CDCl3, δ [ppm]): 
7.93-7.86 (m, 2H, 9), 7.84-7.74 (m, 2H, 10), 6.49 (br/s, 1H, 3-NH-4), 6.30 (dd, J = 1.73 Hz / 
17.04 Hz, 1H, 1), 6.17 (dd, J = 10.00 Hz / 17.04 Hz, 1H, 2), 5.66 (dd, J = 1.73 Hz / 10.00 Hz, 
1H, 1), 3.80 (t, J = 6.30 Hz, 2H, 6), 3.37 (q, J = 6.28 Hz, 2H, 4), 1.94 (p, J = 6.23 Hz, 2H, 5). 
 
13C NMR (75 MHz, CDCl3, δ [ppm]): 
168.79 (2C, 7), 165.73 (1C, 3), 134.77 (2C, 10), 131.92 (2C, 8), 131.01 (1C, 1), 126.33 (1C, 
2), 123.39 (2C, 9), 36.06 (1C, 4), 34.92 (1C, 6), 28.21 (1C, 5). 
MS (EI, m/z)  
[M] calculated: 258.10, found: 258.10 
EA 
calculated: C, 65.11; H, 5.46; N, 10.85; O, 18.58 
found: C, 64.45; H, 5.39; N, 10.45 
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Compound 18:  
 
Chemical formula: 
C53H70N8O13 
 
Molecular weight: 
1027.19 g/mol 
 
Compound 12 (1 eq., 2.651 mmol, 1.354 g) was dissolved in 35 ml methanol and compound 
17 (5 eq., 13.258 mmol, 3.424 g) was added. The reaction batch was stirred for 7 days at 75 
°C. The solvent was evaporated and the crude product was dissolved in CH2Cl2. Excess 
acrylamide (compound 17) was removed over a column (25 g silica per g crude product) with 
5 % methanol in CH2Cl2. To obtain the product (compound 18), the polarity of the eluent was 
increased (10 % methanol in CH2Cl2). The solvent was evaporated to obtain the pure 
compound 18 (57 %) as orange, clear, highly viscous liquid. 
1H NMR (300 MHz, DMSO, δ [ppm]): 
7.92 (t, J = 5.40 Hz, 2H, 24-NH-25), 7.88-7.81 (m, 9H, 9-NH-10, 30, 31), 7.36-7.31 (m, 6H, 15-
17, 11-NH-12), 6.78 (t, J = 5.73 Hz, 1H, 3-NH-4), 5.01 (s, 2H, 13), 3.95-3.88 (m, 1H, 11), 3.57 
(t, J = 7.14 Hz, 4H, 27), 3.49 (s, 4H, 6, 7), 3.39-3.33 (m, 4H, 5, 8), 3.20-3.16 (m, 2H, 9), 3.07-
3.01 (m, 6H, 4, 25), 2.59 (t, J = 6.74 Hz, 4H, 22), 2.31 (t, J = 6.00 Hz, 2 H, 21), 2.18 (t, J = 6.75 
Hz, 4 H, 23), 1.74 (p, J = 7.06 Hz, 4 H, 26),1.59-48 (br/m, 2H, 18), 1.37 (s, 9H, 1), 1.28-1.15 
(br/m, 4H, 20, 19). 
13C NMR (75 MHz, DMSO, δ [ppm]): 
172.45 (1C, 10), 171.73 (2C, 24), 168.32 (4C, 28), 156.34 (1C, 12), 156.03 (1C, 3), 137.49 
(1C, 14),134.77 (4C, 31), 132.09 (4C, 29), 128.75/128.12 (5C, 15-17), 123.42 (4C, 30), 78.03 
(1C, 2), 69.99/69.91/69.63/69.43 (4C, 5-8), 65.80 (1C, 13), 55.14 (1C, 11), 53.00 (1C, 21), 
49.83 (2C, 22), ~40 +38.98 (2C, 4, 9 in solvent signal), 36.57 (2C, 25), 35.95 (2C, 27), 33.50 
(2C, 23), 32.47 (1C, 18), 28.68 (5C, 1, 26), 26.58 (1C, 20), 23.83 (1C, 19). 
MS (FD)  
[M+H]+ calculated: 1027.51, found: 1027.52 
EA 
calculated: C, 61.97; H, 6.87; N, 10.91; O, 20.25 
found: C, 62.27; H, 7.04; N, 11.37 
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Compound 19: 
 
Chemical formula: 
C45H64N8O11 
 
Molecular weight: 
893.05 g/mol  
 
Compound 18 (1 eq., 0.574 mmol, 0.590 g) was dissolved in 4 ml methanol and 1 ml water. 
Acetic acid (4 eq, 2.298 mmol, 131.5 µl) is added under stirring. The catalyst Pd on C with 10 
weight-% loading (0.059 g) was added and the flask was set under H2 atmosphere by setting 
the sample 3 times under vacuum and subsequently flooding it with H2. The reaction was 
stirred for 24 h under H2 atmosphere, the Pd/C was filtered off over celite and the solvent was 
evaporated. The crude product was dissolved in 10 ml water and washed with 3 times 10 ml 
CH2Cl2 to remove unreacted compound 18. The water phase was then neutralized with 
saturated NaHCO3 and extracted with 3 times 10 ml CH2Cl2. The combined organic phases 
were dried over MgSO4, filtrated and concentrated under vacuum to yield compound 19 (54 
%) as transparent solid. 
1H NMR (300 MHz, DMSO, δ [ppm]): 
7.92 (m, 2H, 18-NH-19), 7.88-7.80 (m, 9H, 9-NH-10, 24, 25), 6.75 (t, J = 5.47 Hz, 1H, 3-NH-
4), 3.56 (t, J = 7.16 Hz, 4H, 21), 3.49 (s, 4H, 6, 7), 3.43-3.29 (m, 4H, 5, 8), 3.27-3.13 (m, 2H, 
9), 3.10-2.99 (m, 7H, 4, 19, 11), 2.59 (t, J = 7.10 Hz, 4H, 16), 2.32 (t, J = 6.95 Hz, 2 H, 15), 
2.15 (t, J = 7.06 Hz, 4 H, 17), 1.71 (p, J = 7.03 Hz, 4 H, 20),1.59-48 (br/m, 2H, 12), 1.36 (s, 9H, 
1), 1.28-1.15 (br/m, 4H, 14, 13). 
13C NMR (75 MHz, DMSO, δ [ppm]): 
175.41 (1C, 10), 171.76 (2C, 18), 168.33 (4C, 22), 156.02 (1C, 3), 134.78 (4C, 25), 132.09 
(4C, 23), 123.42 (4C, 24), 78.04 (1C, 2), 69.91-69.56 (4C, 5-8), 54.98 (1C, 11), 53.12 (1C, 
15), 49.90 (2C, 16), ~40 +38.98 (2C, 4, 9 in solvent signal), 36.68 (2C, 19), 35.96 (2C, 21), 
35.34 (1C, 12), 33.56 (2C, 17), 28.65 (5C, 1, 20), 26.86 (1C, 14), 23.61 (1C, 13). 
MS (EI, m/z)  
[M+H]+ calculated: 893.47; found: 893.5 
[M+Na]+ calculated: 915.47; found: 915.5 
 
EA 
calculated: C, 60.52; H, 7.22; N, 12.55; O, 19.71 
found: C, 58.66; H, 7.17; N, 11.42 
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Compound 20:  
 
Chemical Formula:   
C70H84N10O15 
 
Molecular Weight:   
1305.50 g/mol 
 
Compound 19 (1.2 eq., 0.056 mmol, 0.050 g) was dissolved in 0.25 ml DMF, TEA (2 eq., 
0.093 mmol, 13.00 µl) was added and stirred for 10 min. NHS-Rhodamine (5-/6-
carboxytetramethylrhodamine, succinimidyl ester, 1 eq., 0.047 mmol, 0.025 g) was dissolved 
in 0.3 ml DMF and added to the reaction batch. The reaction was carried out for 16 h under 
stirring at room temperature in darkness. All volatile compounds were evaporated and the 
crude product was dissolved in 5 ml CH2Cl2. The organic phase was washed with 3 x 5 ml 
saturated NaHCO3 and 3 x 1 ml 10 vol-% acetic acid in water. The organic phase was 
subsequently dried over MgSO4, filtrated and concentrated under vacuum to yield compound 
20 (85 %) as pink highly viscous liquid. 
1H NMR (300 MHz, CDCl3, δ [ppm]): 
8.66 (s, 1H, 33), 8.25 / 8.14 (d / d, J = 8.02 / 9.43 Hz, 1H, 27/28 5/6-isomere), 7.78-7.76 (m, 
5H, 24, 9-NH-10), 7.68-7.64 (m, 6H, 25, 18-NH-19), 7.20 (d, J = 7.97 Hz, 1H, 29), 6.90-6.87 
(m, 2H, 36), 6.62-6.59 (m, 6H, 37, 39, 3-NH-4, 11-NH-26), 4.73 (m, 1H, 11), 3.68 (t, J = 6.90 
Hz, 4H, 21), 3.57-3.46 (m, 10H, 5-8, 9), 3.26-3.20 (m, 10H, 4, 16, 19), 3.11 (s, 12H, 41), 2.89 
(br/s, 2H, 15), 2.69 (t, J = 6.67 Hz, 4H, 17), 1.86-1.75 (m, 8H, 20, 12, 14), 1.42-39 (m, 11H, 1, 
13). 
13C NMR (151 MHz, CDCl3, δ [ppm]): 
172.18 (1C, 10), 170.98 (2C, 18), 168.98 (1C, 26), 168.33 (4C, 22), 166.29 (1C, 32), 162.75 
(1C, 34), 156.07 (1C, 3), 154.41 (2C, 40), 153.79 (2C, 38), 135.35 (1C, 27/28 5/6-isomere), 
133.93/133.89 (5C, 25, 30), 132.30 (1C, 27/28 5/6-isomere), 131.88 (4C, 23), 129.68 (2C, 
36), 126.04 (1C, 33), 125.68 (1C, 31), 123.14 (5C, 24, 29), 110.47 (2C, 37), 108.76 (2C, 35), 
97.61 (2C, 39), 79.11 (1C, 2), 70.07/69.47 (4C, 5-8), 53.45 (1C, 11), 52.52 (1C, 15), 49.34 
(2C, 16), 40.27/39.31 (6C, 4, 9, 41), 36.64 (2C, 19), 35.33 (2C, 21), 31.72 (2C, 17), 29.58 
(1C, 12), 28.31/28.17 (5C, 1, 20), 23.57 (1C, 14), 22.95 (1C, 13). 
 
MS (ESI, m/z)  
[M+H]+ calculated: 1305.61, found: 1305.6 
[M+Na]+ calculated: 1327.60, found: 1327.6 
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Compound 21:  
 
Chemical Formula:   
C65H77N10O13+ C2F3O2- 
 
Molecular Weight:   
1206.39 g/mol  
+ 113.02 g/mol 
 
Compound 20 (1 eq., 0.038 mmol, 0.050 g) was dissolved in 3 ml CH2Cl2 and trifluoroacetic 
acid (15 eq., 0.575 mmol, 44 µl) was dropwise added under stirring. The reaction was stirred 
for 16 h at room temperature. At the end of the reaction the solvent and all volatile side products 
were evaporated under vacuum. To eliminate all free TFA, a coevaporation with 3 x 5 ml 
toluene was carried out to yield the pure compound 21 (quantitative) as pink solid in TFA-salt 
form.  
 
1H NMR (600 MHz, MeOD, δ [ppm]): 
8.79 (d, J = 1.86 Hz, 1H, 30), 8.42 (dd, J = 1.88 / 7.87 Hz, 1H, 24/25 5/6-isomere), 7.76 (s, 8H, 
21, 22), 7.56 (d, J = 7.89 Hz, 1H, 26), 7.08 (dd, J = 6.02 / 9.48 Hz, 2H, 33),  7.01 (dd, J = 2.42 
/ 9.48 Hz, 2H, 34), 6.85 (dd, J = 2.42 / 10.90 Hz, 2H, 36), 4.63-4.58 (m, 1H, 8), 3.77-3.72 (m, 
2H, 2), 3.69 (s, 6H, 3-5), 3.65-3.54 (m, 8H, 18, 13), 3.53-3.41 (m, 4H, 12, 6), 3.26 (s, 12H, 38), 
3.42-3.12 (m, 6H, 16, 1), 2.81 (br/s, 4H, 14), 2.06-1.95 (m, 2H, 9), 1.95-1.89 (m, 2H, 11), 1.80 
(br/s, 4H, 17), 1.65-1.58 (m, 2H, 10). 
13C NMR (151 MHz, MeOD, δ [ppm]): 
173.04 (1C, 7), 171.07 (2C, 15), 168.75 (4C, 19), 167.10 (1C, 23), 165.94 (1C, 29), 159.09 
(1C, 31), 157.53/157.43 (4C, 35, 37), 136.84 (1C, 24/25 5/6-isomere), 135.85 (1C, 27), 134.02 
(4C, 22), 131.79 (4C, 20), 131.53 (1C, 28), 131.17 (3C, 24/25 5/6-isomere, 30), 130.43 (3C, 
26, 33), 122.72 (4C, 21), 114.12 (2C, 34), 113.27 (2C, 32), 96.06 (2C, 36), 69.97/69.13/66.52 
(4C, 2-5), 54.30 (1C, 8), 52.92 (1C, 12), 50.08 (2C, 13), 39.53 (4C, 38), 39.33/39.00 (3C, 6, 
16), 36.64 (1C, 1), 35.03 (2C, 18), 30.94 (1C, 9), 27.75 (4C, 17, 14), 23.19 (1C, 11), 22.60 (1C, 
10). 
MS (ESI, m/z)  
[M+H]+ calculated: 1205.57, found: 1305.5 
[M+Na]+ calculated: 1227.58, found: 1227.2 
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Compound 22:  
 
Chemical Formula:  C75H97N11O17Si 
Molecular Weight:  1452.75 g/mol 
Compound 21 (1.05 eq., 0.0288 mmol, 0.038 g) was dispersed in 6 ml CH2Cl2, TEA (8.4 eq., 
0.2304 mmol, 32.11 µl) was added and stirred until compound 21 was solubilized. 
Isocyanatopropyltriethoxysilane (1.0 eq., 0.0274 mmol, 6.78 µl) was added and the reaction 
proceeded at room temperature for 16 h. Afterwards the solvent and excess TEA were 
evaporated to yield compound 22 as purple solid (quantitative).    
 
1H NMR (600 MHz, CDCl3, δ [ppm]): 
8.50 (s, 1H, 36), 8.13 (d, J =8.74 Hz, 1H, 30/31 6/5-isomere), 7.77-7.74 (m, 5H, 27, 12-NH-
13), 7.68-7.64 (m, 5H, 28, 14-NH-29), 7.58 (br/s, 2H, 21-NH-22), 7.20 (d, J = 7.93 Hz, 1H, 32), 
6.64 (br/s, 2H, 39), 6.50 (s, 2H, 40), 6.45-6.43 (m, 2H, 42), 5.59-5.53 (br/m, 2H, 5-NH-6-NH-
7), 4.71-4.64 (m, 1H, 14), 3.80-3.76 (m, 6H, 2), 3.70-3.63 (m, 4H, 24), 3.55-3.14 (m,18H, 7-12, 
5, 22), 3.01 (s, 12H, 44), 2.85-2.83(m, 4H, 19), 2.53 (br/s, 2H, 18), 2.42 (br/s, 4H, 20), 2.02-
1.95 (m, 2H, 15), 1.86-1.79 (m, 6H, 23, 17), 1.60-1.53 (m, 4H, 4, 16), 1.21-1.15 (m, 9H, 1), 
0.60-0.57 (m, 2H, 3). 
13C NMR (151 MHz, CDCl3, δ [ppm]): 
172.13 (1C, 13), 169.02 (2C, 21), 168.48 (4C, 25), 168.33 (1C, 29), 166.13 (1C, 35), 162.01 
(1C, 37), 158.95 (1C, 6), 153.59 (2C, 43), 152.85 (2C, 41), 135.72 (2C, 33, 30/31 6/5-isomere), 
133.99 (4C, 28), 131.98 (4C, 26), 131.88 (3C, 30/31 5/6-isomere, 23), 129.09 (2C, 39), 126.81 
(1C, 36), 123.21 (4C, 27), 119.75 (1C, 32), 109.50 (2C, 40), 107.18 (2C, 38), 98.12 (2C, 42), 
70.62/70.30/69.60 (4C, 8-11), 58.34 (3C, 2), 54.07 (1C, 14), 53.44 (1C, 18), 49.98 (2C, 19), 
42.95 (1C, 5), 40.29/40.20 (5C, 44, 7), 39.55 (1C, 12), 36.48 (2C, 22), 35.48 (2C, 24), 
28.54/28.41 (4C, 20, 23), 23.74/23.63/23.38 (3C, 4, 17, 16), 18.30 (3C, 1), 7.62 (1C, 3). 
 
MS (ESI, m/z)  
[M+H]+ calculated: 1452.68, found: 1452.7 
[M+Na]+ calculated: 1474.69, found: 1474.7 
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Compound 23:  
 
Chemical formula: C39H52N6O10 
Molecular weight: 764.88 g/mol 
Compound 1 (1 eq., 3.020 mmol, 0.750 g) and compound 17 (5 eq., 15.101 mmol, 3.901 g) 
were dissolved in a total volume of 30 ml methanol and the reaction mixture was stirred at 75 
°C for 7 days. The solvent was evaporated and the crude product was dissolved in CH2Cl2. 
Over a column (25 g silica per g crude product), the excess acrylamide (compound 17) was 
removed with 2 % methanol in CH2Cl2. To obtain the product, the polarity of the eluent was 
increased (6 % methanol and in CH2Cl2). The solvent was evaporated to obtain the pure 
compound 23 (46 %) as slightly yellow, clear, highly viscous liquid. 
1H NMR (300 MHz, CDCl3, δ [ppm]): 
7.81-7.79 (m, 4H, 18), 7.71-7.68 (m, 4H, 19), 7.31 (br/s, 2H, 12-NH-13), 5.13 (br/s, 1H, 3-
NH-4), 3.73 (t, J = 6.90 Hz, 4H, 15), 3.61-3.57 (m, 6H, 5-7), 3.54-3.47 (m, 2H, 8), 3.29-3.25 
(m, 6H, 4,13), 2.85 (t, J = 6.53 Hz, 4H, 10), 2.74 (t, J = 5.58 Hz, 2 H, 9), 2.43 (t, J = 6.47 Hz, 
4 H, 11), 1.87 (p, J = 6.77 Hz, 4 H, 14), 1.42 (s, 9H, 1) 
13C NMR (75 MHz, DMSO, δ [ppm]): 
171.73 (2C, 12), 171.73 (4C, 16), 156.01 (1C, 3), 134.78 (4C, 19), 132.07 (4C, 17), 123.41 
(4C, 18), 78.02 (1C, 2), 70.00/69.91/69.63 (4C, 5-8), 52.70 (1C, 9), 50.39 (2C, 10), ~40.00 
(1C, 4), 36.69 (2C, 13), 35.94 (2C, 15), 33.72 (2C, 11), 28.67 (5C, 1, 14) 
MS (ESI, m/z)  
[M+H]+ calculated: 765.37, found: 765.4 
[M+Na]+ calculated: 787.36, found: 787.4 
EA 
calculated: C, 61.24; H, 6.85; N, 10.99; O, 20.92 
found: C, 59.82; H, 6.69; N, 10.84  
 
Compound 24:  
 
Chemical formula:  
C34H45N6O8+ C2F3O2- 
Molecular weight:  
664.76 g/mol + 113.02 g/mol 
Compound 23 (1 eq., 0.870 mmol, 0.650 g) was dissolved in 40 ml CH2Cl2 and trifluoroacetic 
acid (15 eq., 13.054 mmol, 999 µl) was dropwise added under stirring. The reaction was stirred 
for 16 h at room temperature. At the end of the reaction the solvent and all volatile side products 
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were evaporated under vacuum. To eliminate all free TFA, a coevaporation with 3 x 20 ml 
toluene was carried out to yield the pure compound 24 (quantitative) as yellowish, clear, highly 
viscous liquid in TFA-salt form.  
 
1H NMR (300 MHz, CDCl3, δ [ppm]):  
8.11 (s, 3H, H3N+-1), 7.78-7.76 (m, 4H, 15), 7.73-7.68 (m, 6H, 16, 9-NH-10), 3.85-3.83 (m, 2H, 
5), 3.75-3.67 (m, 6H, 2, 12), 3.64 (s, 4H, 3, 4),  3.57-3.56 (m, 4H, 7), 3.45-3.43 (m, 2H, 6), 
3.28-3.19 (m, 6H, 1, 10), 2.84 (t, J = 5.97, 4H, 8), 1.86 (p, J = 6.58 Hz, 4H, 11) 
13C NMR (75 MHz, CDCl3, δ [ppm]): (signals of TFA are not attributed) 
170.12 (2C, 9), 168.24 (4C, 13), 133.83 (4C, 16), 131.59 (4C, 14), 122.95 (4C, 15), 69.82 (2C, 
3, 4), 66.06 (1C, 2), 64.00 (1C, 5), 53.16 (1C, 6), 50.53 (2C, 7), 39.52 (1C, 1), 36.65 (2C, 10), 
34.86 (2C, 12), 28.95 (2C, 8), 27.58 (2C, 11) 
MS (ESI, m/z)  
[M-TFA+H]+ calculated: 665.32 found: 665.3 
[M-TFA+Na]+ calculated: 687.31 found: 687.3 
EA 
calculated: C, 61.43; H, 6.67; N, 12.64; O, 19.25 
found: C, 59.4; H, 6.57; N, 10.71 
 
Compound 25: 
 
Chemical formula: 
C44H65N7O12Si 
 
Molecular weight: 
912.13 g/mol 
 
Compound 24 (1.05 eq., 0.210 mmol, 0.163 g) was dissolved in 6 ml CH2Cl2 and TEA (8.4 
eq., 1.68 mmol, 234.2 µl) was added. Subsequently isocyanatopropyltriethoxysilane (1 eq., 
0.200 mmol, 49.5 µl) was added under stirring and the reaction proceeded at room temperature 
for 16 h. Then the solvent and excess TEA were evaporated to yield compound 25 as yellow 
highly viscous liquid (quantitative).    
 
1H NMR (300 MHz, CDCl3, δ [ppm]): (signals of TFA-TEA are not attributed) 
7.83-7.72 (m, 4H, 22), 7.72-7.64 (m, 4H, 21), 7.48 (br/s, 2H, 15-NH-16), 5.58/5.47 (2*br/s, 2H, 
5-NH-6, 6-NH-7), 3.82-3.68 (m, 10H, 2, 18), 3.62-3.46 (m, 10H, 8-12), 3.34-3.22 (m, 8H, 7, 16, 
5), ~3.12 (m, 4H, 13), 1.85 (p, J = 6.70 Hz, 4 H, 17), 1.55 (p, J =7.71, 2H, 4), 1.25-1.16 (m, 
13H, 14, 1), 0.61-0.58 (m, 2H, 3). 
13C NMR (75 MHz, CDCl3, δ [ppm]): (signals of TFA-TEA are not attributed) 
168.80 (4C, 19), 162.61 (2C, 15), 159.17 (1C, 6), 134.39 (4C, 22), 132.27 (4C, 20), 123.55 
(4C, 21), 71.39/70.76/70.68 (4C, 8-11), 58.78 (3C, 2), 53.42 (1C, 12), 51.06 (2C, 13), 43.19 
(1C, 5), 40.45 (1C, 7), 36.76 (2C, 16), 35.70 (2C, 18), 30.00 (2C, 14), 28.76 (2C, 17), 24.13 
(1C, 4), 18.61 (3C, 1), 8.00 (1C, 3). 
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MS (ESI, m/z)  
[M+H]+ calculated: 912.45, found: 912.4 
[M+Na]+ calculated: 934.44, found: 934.4 
 
Compound 26:***  
 
Chemical formula: C19H36N2O8 
Molecular weight: 420.50 g/mol 
Compound 1 (1 eq., 24.16 mmol, 6.00 g) was dissolved in 100 ml methanol and 
methylacrylate (10 eq., 241.6 mmol, 20.8 g) was added. The reaction mixture was stirred at  
50 °C for 3 days. The solvent and the excess methyl acrylate were evaporated to obtain the 
pure compound 26 (quantitative) as slightly yellow oil. 
1H NMR (300 MHz, CDCl3, δ [ppm]): 
5.09 (s, 1H, 3-NH-4), 3.66 (s, 6H, 13), 3.58 (s, 4H, 7, 6), 3.52 (t, J = 5.4 Hz, 4H, 8, 5), 3.31 
(dd, J = 10.4 Hz, 2H, 4), 2.83 (t, J = 7.1 Hz, 4H, 10), 2.67 (t, J = 6.1 Hz, 2H, 9), 2.46 (t, J = 
7.1 Hz, 4H, 11), 1.38 (s, 9H, 1).   
13C NMR (75 MHz, CDCl3, δ [ppm]): 
172.92 (2C, 12), 156.01 (1C, 3), 79.16 (1C, 2), 70.39/70.28 (4C, 5-8), 53.23 (1C, 9), 51.58 
(2C, 13), 49.91 (2C, 10), 40.38 (1C, 4), 32.52 (2C, 11), 29.57 (3C, 1). 
MS (ESI, m/z)  
[M+H]+ calculated: 421.25, found: 421.2 
[M+Na]+ calculated: 443.24, found: 443.2 
 
Compound 27:††† 
 
Chemical formula: C21H44N6O6 
Molecular weight: 467.62 g/mol 
Compound 26 (1 eq., 22.8 mmol, 9.57 g) was dissolved in 100 ml methanol and 
ethylenediamine (80 eq., 1824 mmol, 109.4 g) was added. The reaction mixture was stirred at 
25 °C for 5 days. The solvent and the excess diamine were evaporated. The compound was 
then washed with 3 x 20 ml diethyl ether to remove di-boc protected 2,2-
(ethylenedioxy)bis(ethylamine) which was a side product of compound 1. This compound was 
soluble in diethylether while the desired product was not and thus sedimented. The pure 
compound 27 (92 %) was obtained as yellow oil. 
1H NMR (300 MHz, CDCl3, δ [ppm]): 
7.40 (s, 2H, 12-NH-13),  5.69 (s, 1H, 3-NH-4), 3.57 (s, 4H, 7, 6), 3.52 (m, 4H, 8, 5), 3.27 (dd, 
                                               
***
 This synthesis route was not completed; the reaction is therefore not discussed in Chapter III 
†††
 This synthesis route was not completed; the reaction is therefore not discussed in Chapter III 
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J = 11.7, 6H, 4, 13), 2.81-2.73 (m, 8H, 10, 14), 2.65 (t, J = 5.3 Hz, 2H, 9), 2.35 (t, J = 6.2 Hz, 
4H, 11), 1.57 (s, 4H, 14-NH2), 1.42 (s, 9H, 1).   
13C NMR (75 MHz, CDCl3, δ [ppm]): 
172.88 (2C, 12), 156.26 (1C, 3), 79.23 (1C, 2), 70.39 (2C, 6, 7), 69.39 (2C, 5, 8), 53.81 (1C, 
9), 51.07 (2C, 10), 42.24 (2C, 13), 41.56 (2C, 14), 40.38 (1C, 4), 34.42 (2C, 11), 28.55 (3C, 
1). 
MS (ESI, m/z) – exact mass 
[M+Na]+ calculated: 499.3214, found: 499.3199 
 
Compound 28:‡‡‡ 
 
Chemical formula: 
C77H100N14O18 
 
Molecular weight: 
1509.73 g/mol 
 
Compound 27 (1 eq., 1.621 mmol, 0.758 g) and compound 17 (8 eq., 12.970 mmol, 3.350 g) 
were dissolved in a total volume of 30 ml methanol and the reaction mixture was stirred at 75 
°C for 14 days. The solvent was evaporated and the crude product was dissolved in CH2Cl2. 
Over a column (25 g silica per g crude product), the excess of reactant (compound 17) and 
side products were removed with 1 % methanol and 2 % TEA in CH2Cl2. To obtain the product 
(compound 28), the polarity of the eluent was slightly increased (2 % methanol and 2 % TEA 
in CH2Cl2). The solvent was evaporated to obtain the pure compound 28 (21 %) as yellow, 
highly viscous liquid. 
1H NMR (300 MHz, CDCl3, δ [ppm]): 
7.79-7.76 (m, 8H, 23), 7.69-7.66 (m, 8H, 24), 7.48 (t, J = 5.42, 2H, 12-NH-13),  7.23 (br/s, 
4H, 17-NH-18), 5.25 (br/s, 1H, 3-NH-4), 3.81-3.67 (m, 8H, 20), 3.55-3.44 (m, 8H, 5-8), 3.29-
3.18 (m, 14H, 4, 13, 18), 2.78-2.74 (m, 12H, 10, 15), 2.68-2.65 (m, 4H, 14), 2.54 (t, J = 5.89 
Hz, 2H,  9), 2.36 (t, J = 6.15 Hz, 8H, 16), 2.27 (t, J = 6.06 Hz, 4 H, 11), 1.87 (p, J = 6.63 Hz, 8 
H, 19), 1.39 (s, 9H, 1).   
13C NMR (75 MHz, CDCl3, δ [ppm]): 
172.71 (2C, 12), 172.28-171.97 (4C, 17), 168.13 (8C, 21), 155.75 (1C, 3), 133.72 (8C, 24), 
131.68 (8C, 22), 122.92 (8C, 23), 79.23 (1C, 2), 69.91/69.79.39 (2C, 6, 7), 68.51 (2C, 5, 8), 
                                               
‡‡‡
 This synthesis route was not completed; the reaction is therefore not discussed in Chapter III 
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52.69/52.39 (3C, 9, 14), 49.95/49.68 (6C, 10, 15), 37.63/37.56 (5C, 4, 18), 36.12 (2C, 13), 
36.12 (4C, 20), 35.09 (2C, 11), 33.96 (4C, 16), 28.23/28.10 (7C, 1, 19). 
MS (ESI, m/z)  
[M+H]+ calculated: 1509.73, found: 1509.7  
[M+Na]+ calculated: 1531.72, found: 1531.7 
 
Compound 29:§§§  
 
Chemical formula: 
C33H54N4O11 
Molecular weight:   
682.81 g/mol 
  
Compound 12 (1 eq., 0.257 mmol, 0.131 g) was dissolved in 2.1 ml methanol and methyl 
acrylate (10 eq., 2.565 mmol, 0.231 ml) was added. The reaction batch was stirred for 3 days 
at 30 °C. The excess methyl acrylate and solvent were evaporated to obtain the pure 
compound 29 (quantitative) as yellow, clear liquid. 
1H NMR (300 MHz, DMSO, δ [ppm]): 
7.92 (t, J = 5.55 Hz, 1H, 9-NH-10), 7.38-7.30 (m, 6H, 15-17, 11-NH-12), 6.77 (br/s, 1H, 3-NH-
4), 5.02 (s, 2H, 13), 3.99-3.91 (m, 1H, 11), 3.59 (s, 6H, 25), 3.50 (s, 4H, 6, 7), 3.41-3.34 (m, 
4H, 5, 8), 3.24-3.18 (m, 2H, 9), 3.08 (appears q, J = 5.97, 2H, 4), 2.72-2.60 (m, 4H, 22), 2.44-
2.27 (m, 6H, 23, 21), 1.61-46 (br/m, 2H, 18), 1.38 (s, 9H, 1), 1.28-1.16 (br/m, 4H, 20, 19) 
13C NMR (75 MHz, DMSO, δ [ppm]): 
172.86 (2C, 24), 172.46 (1C, 10), 156.34 (1C, 12), 156.04 (1C, 3), 137.53 (1C, 14), 
128.76/128.14 (5C, 15-17), 78.04 (1C, 2), 70.00/69.64/69.44 (4C, 5-8), 65.80 (1C, 13), 55.10 
(1C, 11), 53.23 (1C, 21), 51.63 (2C, 25), 49.08 (2C, 22), ~40 (2C, 4, 9 in solvent signal), 32.42 
(2C, 23), 32.40 (1C, 18), 29.65 (1C, 20), 28.68 (3C, 1), 23.60 (1C, 19) 
MS (ESI, m/z)  
[M+Na]+ calculated: 705.38, found: 705.4 
[M+H]+ calculated: 683.38, found: 683.4 
EA 
calc: C, 58.05; H, 7.97; N, 8.21; O, 25.77 
found: C, 58.91; H, 7.82; N, 7.16 
                                               
§§§
 This synthesis route was not completed; the reaction is therefore not discussed in Chapter III 
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Compound 30:**** 
 
Chemical formula: 
C35H62N8O9 
Molecular weight:   
738.93 g/mol 
Compound 29 (1 eq., 0.158 mmol, 0.108 g) was dissolved in 2.1 ml methanol and ethylene 
diamine (80 eq., 12.64 mmol, 0.846 ml) was added. The reaction batch was stirred for 5 days 
at 25 °C. The excess ethylene diamine and solvent were evaporated to obtain the pure 
compound 30 (quantitative) as yellow, clear and viscous liquid. 
1H NMR (300 MHz, DMSO, δ [ppm]): 
8.03-7.91 (m, 1H, 9-NH-10), 7.37-7.30 (m, 8H, 24-NH-25, 15-17, 11-NH-12), 6.78 (br/s, 1H, 3-
NH-4), 5.02 (s, 2H, 13), 4.06 (br/s, 4H, 26-NH2), 4.11-3.90 (m, 1H, 11), 3.50 (s, 4H, 6, 7), 3.39-
3.45 (m, 4H, 5, 8), 3.22-3.16 (m, 2H, 9), 3.10-3.06 (m, 6H, 4, 25), 2.70-2.60 (m, 8H, 22, 26), 
2.37-2.25 (m, 2 H, 21), 2.20 (t, J = 6.79, 4H, 23), 1.59-49 (br/m, 2H, 18), 1.38 (s, 9H, 1), 1.28-
1.16 (br/m, 4H, 20, 19) 
13C NMR (75 MHz, DMSO, δ [ppm]): 
172.50 (2C, 10), 171.96 (1C, 24), 156.37 (1C, 12), 156.05 (1C, 3), 137.51 (1C, 14), 
128.78/128.22 (5C, 15-17), 78.06 (1C, 2), 69.99/69.63/69.44 (4C, 5-8), 65.82 (1C, 13), 55.18 
(1C, 11), 53.14 (1C, 21), 49.93 (2C, 22), ~40 (2C, 4, 9, 25, 26 in solvent signal), 33.64 (2C, 
23), 32.48 (1C, 18), 29.65 (1C, 20), 28.68 (3C, 1), 23.83 (1C, 19)  
MS (FD)  
[M+H]+ calculated: 739.46, found: 739.47 
  
                                               
****
 This synthesis route was not completed; the reaction is therefore not discussed in Chapter III 
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4. Grafting protocols 
4.1. Optimization of grafting protocols with commercial silanes 
Grafting of 3-(2-aminoethyl-amino)propyl-trimethoxy-silane onto AA-TiO2 under acidic 
conditions, adding the base after silane addition 
200 mg AA-TiO2 NPs as synthesized in water (30 mg/ml) were mixed with 24 ml ethanol and 
100 µl of 1 M nitric acid. 3-(2-aminoethyl-amino)propyl-trimethoxy-silane (50, 10, 5, 1 and 0.5 
µmol/mg particles) was mixed with 8 ml anhydrous ethanol and added to the particle solution 
in 50 addition steps under agitation over 2.5 h (every 3 min) at 50 °C. The reaction was then 
stirred for 1 h at 50 °C and subsequently the pH was changed to 9.5 to 10 via addition of 28-
30 % ammonium hydroxide in water solution. Afterwards the reaction batch was heated up to 
70 °C for one hour. 
Grafting of 3-(2-aminoethyl-amino)propyl-trimethoxy-silane onto AA-TiO2 under basic 
conditions 
200 mg AA-TiO2 NPs as synthesized in water (30 mg/ml) were mixed with 24 ml ethanol and 
1 ml of 28-30 % ammonium hydroxide in water solution. 3-(2-aminoethyl-amino)propyl-
trimethoxy-silane (50, 10, 5, 1 and 0.5 µmol/mg particles) was mixed with 8 ml anhydrous 
ethanol and added in 50 addition steps to the particle solution under agitation over 2.5 h (every 
3 min at room temperature). Then the reaction batch was heated up to 40 °C for one hour. 
Grafting of (3-Trimethoxysilylpropyl)-diethylenetriamine onto AA-TiO2 under basic conditions 
The grafting protocol as described above (Grafting of 3-(2-aminoethyl-amino)propyl-
trimethoxy-silane onto AA-TiO2 under basic conditions) was carried out with the following 
change: as organo-silane (3-Trimethoxysilylpropyl)-diethylenetriamine in concentrations from 
1, 0.5, 0.1 and 0.05 µmol/mg particles was used. 
Grafting of (3-Trimethoxysilylpropyl)-diethylenetriamine onto MEEAA-TiO2 (200 °C, 4 h) under 
basic conditions 
The grafting protocol as described above (Grafting of 3-(2-aminoethyl-amino)propyl-
trimethoxy-silane onto AA-TiO2 under basic conditions) was carried out with the following 
changes: as organo-silane (3-Trimethoxysilylpropyl)-diethylenetriamine in concentrations from 
4, 2, 1 and 0.5 µmol/mg particles was utilized and as particle samples MEEAA-TiO2 (200 °C, 
4 h) was chosen. 
Purification of the obtained functionalized particle samples 
After reaction, the samples were centrifuged at 10.000 rpm for 1 h and redispersed in 10 ml 
water. For zeta potential titrations and photocatalysis tests, 75 % of each sample was dialysed 
against water (including 3 water changes). For DLS and DRIFT examinations, the rest of each 
sample was washed with ethanol via centrifugation (3 times at 30000 rpm for 1 h and 
subsequent redispersion) and dried under vacuum if necessary (DRIFT). 
 
4.2. Grafting of synthesized coupling agents onto MEEAA-TiO2 (200 °C, 4 h) 
Grafting of coupling agent I onto MEEAA-TiO2 (200 °C, 4 h) under basic conditions 
100 mg MEEAA-TiO2 NPs as synthesized in water (30 mg/ml) were mixed with 12 ml ethanol 
and 0.5 ml of 28 % ammonium hydroxide in water solution. Coupling agent I (2 µmol/mg 
particles) was mixed with 4 ml freshly distilled ethanol and added in 50 addition steps to the 
particle solution under agitation over 2.5 h (every 3 min at room temperature). Then the 
reaction batch was heated up to 40 °C for one hour. 
Grafting of coupling agent IV onto MEEAA-TiO2 (200 °C, 4 h) under basic conditions 
100 mg MEEAA-TiO2 NPs as synthesized in water (30 mg/ml) were mixed with 12 ml ethanol 
and 0.5 ml of 28 % ammonium hydroxide in water solution. Coupling agent IV (2 µmol/mg 
particles) was mixed with 4 ml freshly distilled ethanol and added in 50 addition steps to the 
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particle solution under agitation over 2.5 h (every 3 min at room temperature). Then the 
reaction batch was heated up to 40 °C for one hour. 
Washing of the obtained functionalized particle samples 
After reaction, the samples were centrifuged at 8.000 rpm for 1 h and redispersed in 10 ml 
water. The samples were subsequently dialysed against water (including 5 water changes) 
and dried under vacuum if necessary (DRIFT).  
Phthalimide cleavage attempt of coupling agent IV grafted onto MEEAA-TiO2 (200 °C, 4 h) 
The dispersion of coupling agent IV-MEEAA-TiO2 (5 mg NPs, 10 µmol coupling agent IV) in 
water in a concentration of 3 mg/ml was transferred into an Eppendorf cap and the desired 
amount of base was added (Table - EP - 3). The reaction mixture was stirred for 16 h at room 
temperature. Then, each batch was transferred into a dialysis bag and dialysed against 1 l of 
water including 3 water changes (after 3 h, 8 h and 24 h) and dried under vacuum if necessary 
(DRIFT). 
Table - EP - 3. Amount of base used for the phthalimide deprotection procedure. 
ratio of primary amine (from 
base) to phthalimide group of 
the grafted coupling agent IV  
(on MEEAA-TiO2 NP) 
methylamine 40 w%  
 
hydrazine monohydrate  
65 %  
3:1 60 µmol 5.194 µl 30 µmol 1.433 µl 
10:1 200 µmol 17.31 µl 100 µmol 4.778 µl 
100:1 2 000 µmol 173.13 µl 1 000 µmol 47.778 µl 
1000:1 20 000 µmol 1731.33 µl 10 000 µmol 477.787 µl 
unmodified MEEAA-TiO2 as 
reference 
20 000 µmol 1731.33 µl 10 000 µmol 477.787 µl 
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5. Cell culture tests 
Stabilisation of particles in cell culture media 
The as synthesized samples AA-TiO2 (160 °C, 4 h) and MEEAA-TiO2 (160 °C, 4 h) in a 
concentration of 3 mg/ml in water were ultrasonically treated (Branson Sonifier 450, 4 min, 
duty cycle 30 %, strength 7); if a stabilisation of the particles was chosen, the selected stabiliser 
was added at this time point under magnetic stirring. Finally the pH was adjusted to 7 adding 
1 M sodium hydroxide solution and the stabilised dispersion was transferred into the selected 
cell culture media (DMEM, RPMI and BEGM) resulting in NP concentrations of 0.5 mg/ml. 
From this standard dilution, the required particle concentrations for cytotoxicity tests were 
generated by dilution with cell culture medium. 
Cytotoxicity tests 
From the standard dilution (0.5 mg/ml NPs in cell culture medium), the required particle 
concentrations for cell culture tests were generated by dilution with cell culture medium, 
respectively. For cytotoxicity assessment cells were seeded into 96 well round bottom culture 
plates (1x104 cells per well). Cells were allowed to attach and proliferate for 24 h. The particle 
dispersions were added at working concentrations on the second day and incubated with the 
cells for 24 h. After that, the exposure medium was removed by suction and the cells were 
then washed three times with PBS in order to remove residual NPs. Then, the MTT colorimetric 
staining method was applied to study cell viability. All plates were incubated with cell culture 
medium containing 1 mg/ml of MTT-solution for 4 h. The MTT solution from each well was 
replaced by isopropanol after 4 h of inoculation at 37 °C with 5 % CO2. Isopropanol was used 
to solubilise the resulting formazan crystals overnight at 37 °C with 5 % CO2. The colour 
conversion of the blue formazan dye was measured by a spectrophotometer at a wavelength 
of 570 nm. All cytotoxicity studies were carried out on 8 technical and 3 biological replicates. 
Positive control samples (non-cellular controls) were carried out and confirmed that there are 
no interferences between the tested nanomaterials and the biochemical assay reagents. 
Statistical analysis of the results was performed using Graph Pad Prism software 4. The 
Wilcoxon test was used to evaluate statistical significance of the mean viability values 
compared to the untreated control, which was defined to be 100%. Differences were 
considered statistically significant when the P-value was less than 0.05. 
24 h UV light pre-activation of particles  
The as synthesized MEEAA-TiO2 (160 °C, 4 h) samples in a concentration of 3 mg/ml in water 
were neutralized with 1 M NaOH (when necessary). Then they were transferred into a glass 
petri dish and covered with a fused silica lid. UV-light (0.3-0.5 mW/cm2, 366 nm) was applied 
on its top for 24 h. The samples were then diluted with the selected cell culture medium (in 
general RPMI) to obtain a stock solution with a NP concentration of 0.5 mg/ml. From this 
standard dilution, the required particle concentrations for cytotoxicity tests were generated by 
dilution with cell culture medium.  
For further studies on the 24 h UV light pre-activation of particles and the resulting anti-tumour 
effect (described in Chapter IV.3.), following protocols were carried out:  
- “pure MEEAA”: MEEAA as commercially obtained was diluted in water to a concentration of 
12.6 mg/ml which is the same concentration present in a 3 mg/ml MEEAA-TiO2 (160°C, 4) NP 
sample. The sample was neutralized, pre-activated, diluted with cell culture medium and tested 
for cytotoxicity as described before.  
- “TiO2 NPs”: MEEAA-TiO2 (160°C, 4) were washed with HNO3 water (pH = 3) via repeated 
centrifugation and redispersion. The sample was neutralized, pre-activated, diluted with cell 
culture medium and tested for cytotoxicity as described before. 
- “MEEAA separated from the TiO2 NPs after pre-activation”: The sample was neutralized and 
pre-activated as described before. Then, the particles were sedimented via centrifugation and 
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only the supernatant containing the MEEAA was diluted with cell culture medium and tested 
for cytotoxicity as described before. 
- “pre-activated samples stored for 1 or 5 days”: The samples were neutralized and pre-
activated as described before. Then, the samples were stored at room temperature in a closed 
flask for 1 or 5 days. They were diluted with cell culture medium and tested for cytotoxicity as 
described before. 
- comparison of MEEAAs with different purity grades: For cell culture tests, the commercially 
obtained MEEAA compounds (12.6 mg/ml) with either 70 % purity which is the standard 
sample used or 95 % purity were intermixed with commercial P25 TiO2 NPs (3 mg/ml) in water 
and ultrasonically treated (ultrasound bath, 1 h). The samples were then neutralized, pre-
activated, diluted with cell culture medium and tested for cytotoxicity as described before. 
- NMR analysis of UV light activated compounds: 3 mg/ml P25 NPs, 12.6 mg/ml MEEAA 
compound (or other compounds to be examined) were intermixed in D2O. One part of this 
solution was transferred into a UV light transparent cuvette, air-sealed and 24 h UV light treated 
while the other part was stored as reference. Both sample parts were then centrifuged at  
13 000 rpm for 1 h in order to remove the P25 NPs and the supernatants were transferred into 
NMR tubes for analysis. 
- distillation of MEEAA: MEEAA was distilled under dynamic vacuum (~9 mbar), increasing the 
heating temperature up to 250 °C, the heating temperature, appearance, name of the fraction 
and the amount of each distilled fraction is shown in the following Table - EP - 4. The most 
interesting fractions were chosen based on the cytotoxicity results, analytically analysed and 
are presented in the following section. For cell culture tests, all obtained fractions (12.6 mg/ml) 
were intermixed with commercial P25 TiO2 NPs (3 mg/ml) in water and ultrasonically treated 
(ultrasound bath, 1 h). The samples were then neutralized, pre-activated, diluted with cell 
culture medium and tested for cytotoxicity as described before. 
Table - EP - 4. MEEAA fractions obtained at different distillation temperatures; their 
appearance, name and obtained amount. 
T appearance name of fraction amount 
 starting material, slightly 
yellow 
MEEAA before distillation 151 g 
< 194 °C yellow fraction I 57 g 
194 °C slightly yellow fraction II 54 g 
194 °C – 204 °C slightly yellow fraction III 20 g 
204 °C – 250 °C slightly yellow fraction IV 15 g 
residue in the flask dark brown residue (discarded) 4 g  
 
Analysis of fraction II: 
 
Chemical formula: C7H14O5 
Molecular weight: 178.18 g/mol 
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Compound name: 2-[2-(2-methoxyethoxy)ethoxy]acetic acid 
1H NMR (300 MHz, CDCl3, δ [ppm]): 
7.96 (br/s, 1H, HO-1), 4.19 (s, 2H, 2), 3.79-3.77 (m, 2H, 3), 3.73-3.69 (m, 4H, 4, 5), 3.60-3.57 
(m, 2H, 6), 3.40 (s, 3H, 7). 
 
13C NMR (75 MHz, CDCl3, δ [ppm]): 
173.31 (1C, 1), 71.69 (1C, 6), 71.12 (1C, 5), 70.46 (1C, 4), 70.27 (1C, 3), 68.51 (1C, 2), 58.95 
(1C, 7). 
 
MS (ESI, m/z) 
[M+Na]+ calculated: 201.09, found: 201.1 
 
Analysis of fraction IV:  
A column chromatography of fraction IV was carried out over 50 g silica per g product, starting 
with 2 % MeOH in CH2Cl2 as eluent and then increasing to 5 % MeOH in CH2Cl2. Fraction IV-
a and IV-b were obtained and analysed. 
Fraction IV-a:  
 
Chemical formula: C12H24O7 
Molecular weight: 280.32 g/mol 
Yield: 76 % 
1H NMR (300 MHz, D2O, δ [ppm]): 
4.39-4.36 (m, 2H, 5), 4.30 (s, 2H, 7), 3.82-3.77 (m, 4H, 4, 8), 3.75-3.69 (m, 6H, 9, 3, 10), 3.66-
3.59 (m, 4H, 2, 11), 3.40 (s, 3H, 1), 3.39 (s, 3H, 12). 
 
13C NMR (75 MHz, D2O, δ [ppm]): 
172.22 (1C, 6), 70.96/70.91 (2C, 2, 11), 70.21 (1C, 8), 69.49/69.43/69.40 (3C, 9, 3, 10), 
68.28 (1C, 4), 67.75 (1C, 7), 64.13 (1C, 5), 58.03 (2C, 1, 12). 
MS (ESI, m/z) – exact mass 
[M+Na]+ calculated: 303.1414, found: 303.1419 
 
Fraction IV-b:  
 
Chemical formula: C7H14O5 
Molecular weight: 178.18 g/mol 
Yield: 8 % 
Compound name: 2-[2-(2-methoxyethoxy)ethoxy]acetic acid 
 
1H NMR (300 MHz, D2O, δ [ppm]): 
4.23 (s, 2H, 2), 3.76-3.74 (m, 2H, 3), 3.73-3.67 (m, 4H, 4, 5), 3.64-3.62 (m, 2H, 6), 3.38 (s, 3H, 
7). 
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13C NMR (75 MHz, D2O, δ [ppm]): 
174.29 (1C, 1), 70.94 (1C, 6), 70.07 (1C, 5), 69.51 (1C, 4), 69.38 (1C, 3), 67.58 (1C, 2), 58.01 
(1C, 7). 
 
MS (ESI, m/z) – exact mass 
[M+Na+Na]+ calculated: 223.0552, found: 223.0560 
X-ray fluorescence spectroscopy  
Table - EP - 5. X-ray fluorescence spectroscopy of fraction IV, compared to the MEEAA 
before distillation and pure MEEAA. Due to the small concentration of the detected elements, 
the obtained results cannot be taken as quantitative values. 
element MEEAA purity = 70% 
[weight-%] 
distilled fraction IV 
[weight-%] 
MEEAA purity > 95% 
[weight-%] 
Al - 0.001 0.002 
Br 0.006 - - 
Cl 0.117 0.014 - 
Fe 0.003 - - 
Si 0.004 0.002 0.002 
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Appendix I: Influence of hydrothermal processing parameters on AA-
TiO2 particle 
 
Table A I - 1. Particle (XRD, TEM) and agglomerate sizes (DLS) as well as experimental 
(BET) compared to theoretic specific surface area of AA-TiO2 samples treated with varied 
autoclaving parameters. Additionally, pHs at IEP of AA-TiO2 determined by zeta potential 
titrations. 
sample: 
treatment 
time / 
temperature 
crystallite 
size  
[nm]  
 
 
(XRD) 
NP size 
[nm]  
 
 
(TEM) 
hydrodynamic 
diameter [nm] 
/ PDI [-] 
pH 2-3,  
US-treated  
(DLS) 
specific 
surface 
area 
[m²/g]   
(BET, N2 
sorption) 
theoretic 
specific 
surface 
area 
[m²/g]   
pH at 
IEP [-] 
1 h / 160 °C 4.9 5.2 ± 1.0 13.0 ± 0.1 / 
0.3 
249.9 314.0 6.2 
4 h / 160 °C 
(standard 
sample) 
5.6 6.3 ± 1.5 22.5 ± 0.8 / 
0.2 
207.5 274.7 6.9 
16 h / 160 
°C 
6.7 7.2 ± 1.3 22.7 ± 0.3 / 
0.2 
176.3 229.6 6.3 
4 h / 180 °C 6.1 6.3 ± 1.3 22.2 ± 0.4 / 
0.2 
186.5 254.3 6.8 
4 h / 200 °C 6.8 6.6 ± 1.3 25.9 ± 0.6 / 
0.2 
168.7 226.2 6.9 
 
 
Figure A I - 1. Powder X-ray diffraction (XRD) patterns of AA-TiO2 samples treated with 
varied autoclaving parameters. 
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Figure A I - 2. Transmission electron microscopy (TEM) of AA-TiO2 samples treated with varied 
hydrothermal processing parameters and their size distributions, obtained from counting at 
least 100 particles per sample: a) 1 h, 160 °C; b) 4 h, 160 °C; c) 16 h, 160 °C; d) 4 h, 180 °C; 
e) 4 h, 200 °C. 
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Figure A I - 3. IR (DRIFT) spectra of AA-TiO2 samples synthesized with varied hydrothermal 
treatment parameters. [the attribution of vibration band can be found in II.1.2. Figure II – 4.] 
 
 
Figure A I - 4. a) Simultaneous thermogravimetric (TGA) and b) differential thermal analysis 
(DTA) performed on dried AA-TiO2 particle samples synthesized with varied hydrothermal 
processing parameters. 
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Figure A I - 5. Evolved gas analysis by mass spectrometry during TGA/DTA experiments on 
dried AA-TiO2 particle samples synthesized with varied hydrothermal processing parameters 
(only the most interesting spectra shown). 
 
 
Figure A I - 6. Photocatalytic activity of AA-TiO2 samples synthesized with varied processing 
parameters normed on the commercial standard TiO2 NP (P25); determined by measurement 
of produced Cl- during the degradation of dichloroacetic acid (DCA). The values are normed 
on the amount of degraded DCA (produced Cl-) by P25 after 3 h photocatalysis test (= 
100%). 
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Appendix II: Cleavage of the phthalimide protecting group of the 
coupling agent IV grafted onto MEEAA-TiO2 (200 °C, 4 h) 
 
Table A II - 2. IEP (zeta potential) and agglomerate size (DLS) of MEEAA-TiO2 functionalized 
with coupling agent IV and treated with either methylamine or hydrazine. 
 amount of amine 
(from base) per 
phthalimide group of 
the grafted coupling 
agent IV  (on 
MEEAA-TiO2 NP)  
pH(IEP) 
determined by 
zeta potential 
titration 
Agglomerate size [nm] 
(PDI [-]) 
in water pH = 3 
methylamine 3 5.8 319.1 ± 30.2 (0.6) 
10 5.9 283.0 ± 6.0 (0.4) 
100 6.0 288.9 ± 17.2 (0.4) 
1000 6.1 544.3 ± 113.5 (0.9) 
hydrazine 3 5.8 285.1 ± 7.0 (0.4) 
10 5.8 406.5 ± 47.4 (0.7) 
100 6.0 198.5 ± 2.0 (0.3) 
1000 6.1 1059.2 ± 105.1 (0.7) 
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Appendix III: Stabilization of MEEAA-TiO2 in cell culture media with 
FBS, BSA, Melflux, Melpers or Sika ViscoCrete 
 
Table A III - 3. MEEAA-TiO2 (0.5 mg/ml) in different cell culture media (DMEM, BEGM, 
RPMI) stabilized with 1 mg, 10 mg, 50 mg or 100 mg BSA, FBS, Melflux, Melpers or Sika 
ViscoCrete per 1 mg NP. a) Percentage of particles still stably dispersed after 24 h with 
decreasing dispersion stability from A: 100% (dark green) to E: <25 % (dark red). b) 
Agglomerate size (Z-average) with increasing hydrodynamic diameter from a: <100 nm (dark 
green) to f: >700 nm (dark red).  
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AA   acetyl acetone 
AMEO   aminopropyltriethoxy silane 
ATR   attenuated total reflection 
BEGM   bronchial epithelial cell growth medium 
BET    Brunauer-Emmett-Teller 
BMSC   bone marrow-derived mesenchymal stem cells 
Boc   tert-butyloxycarbonyl 
BSA   bovine serum albumin 
DAISY-MAT  Darmstadt Integrated System for MATerial research 
DCA   dichloroacetic acid 
DCC   N,N'-dicyclohexylcarbodiimide 
DCU   dicyclohexylurea 
DLS   dynamic light scattering 
DLVO    Derjaguin-Landau-Verwey-Overbeek 
DMEM   Dulbecco’s modified eagle medium 
DMF   dimethylformamide 
DRIFT   diffuse reflectance infrared Fourier transformed (spectroscopy) 
DTA    differential thermal analysis 
EA   elemental analysis 
EXAFS   extended X-ray absorption fine structure 
FBS    fetal bovine serum 
FFT    fast Fourier transformation 
Fmoc   Fluorenylmethoxycarbonyl 
FTIR    Fourier transformed infrared (spectroscopy) 
IARC   International Agency for Research on Cancer 
HNSCC  head and neck squamous cell carcinoma 
HPLC   high pressure liquid chromatography 
IR    infrared 
JECFA  Joint FAO/WHO Expert Committee on Food Additives 
MEEAA  2-[2-(2-methoxyethoxy)ethoxy]acetic acid 
MS    mass spectrometry 
MTT   3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide 
NHS   N-hydroxysuccinimide 
NHS-R hodamine  5-/6-carboxytetramethylrhodamine, succinimidyl ester 
NMR    nuclear magnetic resonance (spectroscopy) 
NP   nanoparticle 
PAMAM  polyamidoamine 
PEG             polyethylene glycol 
PC   photocatalytic 
PDI   polydispersity index 
PL   photoluminescence 
PTSA   para-toluene sulfonic acid 
P25   commercial Degussa P25 TiO2 nanoparticles 
RhBitc   Rhodamine B isothiocyanate 
ROS   reactive oxidizing species 
RPMI   Roswell Park Memorial Institute medium 
rt   room temperature 
TEA   triethylamine 
TEM    transmission electron microscopy 
TFA   trifluoroacetic acid 
TGA    thermogravimetric analysis 
TG   thermogravimetric 
THF   tetrahydrofuran 
TiO2   titanium dioxide 
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TLC   thin layer chromatography 
US   ultrasonic 
UV   ultraviolet 
XAFS    X-ray absorption fine structure 
XANES   X-ray absorption near edge structure 
XPS   X-ray photoelectron spectroscopy 
XRD    X-ray diffraction 
XRF   X-ray fluorescence spectroscopy 
Z   benzyloxycarbonyl 
  
Functional coupling agents 
S. Koch: Dendritic surface modification of photocatalytic nanoparticles for tumour therapy  
 
 
